Stroke and its management in Australia: an update by unknown
CARDIOVASCULAR DISEASE SERIES NO. 37
Stroke and its management in
Australia: an update
 
 
CARDIOVASCULAR DISEASE SERIES 
Number 37 
Australian Institute of Health and Welfare 
Canberra 
Cat. no. CVD 61 
Stroke and its management in 
Australia: an update 
    
The Australian Institute of Health and Welfare is a major national agency 
which provides reliable, regular and relevant information and statistics 
on Australia’s health and welfare. The Institute’s mission is 
 authoritative information and statistics to promote better health and wellbeing. 
© Australian Institute of Health and Welfare 2013 
This product, excluding the AIHW logo, Commonwealth Coat of Arms and any material owned by a 
third party or protected by a trademark, has been released under a Creative Commons BY 3.0 
(CC-BY 3.0) licence. Excluded material owned by third parties may include, for example, design and 
layout, images obtained under licence from third parties and signatures. We have made all reasonable 
efforts to identify and label material owned by third parties. 
You may distribute, remix and build upon this work. However, you must attribute the AIHW as the 
copyright holder of the work in compliance with our attribution policy available at 
<www.aihw.gov.au/copyright/>. The full terms and conditions of this licence are available at 
<http://creativecommons.org/licenses/by/3.0/au/>. 
Enquiries relating to copyright should be addressed to the Head of the Communications, Media and 
Marketing Unit, Australian Institute of Health and Welfare, GPO Box 570, Canberra ACT 2601. 
This publication is part of the Australian Institute of Health and Welfare’s Cardiovascular disease 
series. A complete list of the Institute’s publications is available from the Institute’s website 
<www.aihw.gov.au>. 
ISSN 1323-9236 
ISBN 978-1-74249-441-8 
Suggested citation 
Australian Institute of Health and Welfare 2013. Stroke and its management in Australia: an update. 
Cardiovascular disease series no. 37. Cat. no. CVD 61. Canberra: AIHW. 
Australian Institute of Health and Welfare 
Board Chair 
Dr Andrew Refshauge 
Director 
David Kalisch 
Any enquiries about or comments on this publication should be directed to: 
Communications, Media and Marketing Unit 
Australian Institute of Health and Welfare 
GPO Box 570 
Canberra ACT 2601 
Tel: (02) 6244 1032 
Email: info@aihw.gov.au 
Published by the Australian Institute of Health and Welfare 
 
Please note that there is the potential for minor revisions of data in this report. 
Please check the online version at <www.aihw.gov.au> for any amendments.
  Stroke and its management in Australia: an update i 
Contents 
Acknowledgments.............................................................................................................................. iii 
Abbreviations ...................................................................................................................................... iv 
Summary .............................................................................................................................................. vi 
1 Introduction .................................................................................................................................... 1 
Background ..................................................................................................................................... 1 
What is stroke? ................................................................................................................................ 1 
What is transient ischaemic attack? ............................................................................................. 1 
What are the major risk factors? ................................................................................................... 2 
Community awareness of stroke signs and symptoms ............................................................ 3 
Aims of this report ......................................................................................................................... 4 
Overview of this report ................................................................................................................. 4 
Data sources and methods ............................................................................................................ 4 
2 Impact of stroke ............................................................................................................................. 6 
Incidence .......................................................................................................................................... 6 
Prevalence ....................................................................................................................................... 8 
3 Stroke treatment in hospital ...................................................................................................... 22 
Hospitalisations in 2009–10......................................................................................................... 24 
Stroke units and clinical audit .................................................................................................... 39 
Rehabilitation of stroke or its sequelae ..................................................................................... 46 
4 Stroke treatment in the community ......................................................................................... 48 
The management of stroke in general practice ........................................................................ 48 
Supply of stroke medications in the community ..................................................................... 51 
5 Managing the consequences of stroke .................................................................................... 56 
Assistance for people with stroke-related disability ............................................................... 56 
Community services for stroke survivors................................................................................. 60 
Impact of stroke on primary carers............................................................................................ 64 
6 Social and geographical inequalities for stroke .................................................................... 69 
Aboriginal and Torres Strait Islander people ........................................................................... 69 
Remoteness .................................................................................................................................... 74 
Socioeconomic status ................................................................................................................... 76 
7 Discussion..................................................................................................................................... 79 
Appendix A Methods and definitions ....................................................................................... 82 
 ii Stroke and its management in Australia: an update 
Age-specific rates ......................................................................................................................... 82 
Age-standardised rates ................................................................................................................ 82 
Average annual rate of change ................................................................................................... 82 
Significance testing ....................................................................................................................... 83 
Reporting deaths .......................................................................................................................... 84 
Reporting hospitalisations .......................................................................................................... 85 
Reporting Indigenous data ......................................................................................................... 86 
Reporting data by remoteness .................................................................................................... 86 
Reporting data by socioeconomic group .................................................................................. 87 
Appendix B Classifications ......................................................................................................... 90 
Anatomical therapeutic chemical (ATC) classification ........................................................... 90 
International Classification of Disease (ICD) codes ................................................................ 90 
Classifications from other sources ............................................................................................. 93 
Appendix C  Main data sources ................................................................................................... 94 
ABS National Aboriginal and Torres Strait Islander Health Survey (NATSIHS)  
(2004–05) ................................................................................................................................. 94 
ABS National Health Survey (NHS) (2007–08) ........................................................................ 94 
ABS Surveys of Disability, Ageing and Carers (SDAC) (1998, 2003 and 2009) ................... 94 
AIHW Disease Expenditure Database ...................................................................................... 97 
AIHW National Hospital Morbidity Database ........................................................................ 98 
AIHW National Mortality Database .......................................................................................... 99 
Drug Utilisation Sub-Committee database (DUSC) .............................................................. 100 
The Bettering the Evaluation and Care of Health (BEACH) program ............................... 100 
World Health Organization Global Health Observatory ..................................................... 101 
Appendix D Supplementary tables .......................................................................................... 102 
Appendix E ........................................................................................................................................ 133 
Thrombolysis exclusion/inclusion criteria ............................................................................. 133 
Glossary .............................................................................................................................................. 135 
References .......................................................................................................................................... 139 
List of tables ...................................................................................................................................... 144 
List of figures .................................................................................................................................... 147 
 
  Stroke and its management in Australia: an update iii 
Acknowledgments 
This report was prepared by Lany Trinh, Anne-Marie Waters, Lynelle Moon and Helena 
Hurst of the National Centre for Monitoring Cardiovascular Disease at the Australian 
Institute of Health and Welfare (AIHW). 
The report was prepared under the guidance of the Cardiovascular Disease Monitoring 
Advisory Committee. 
Valuable input was gratefully received from:  
• Cardiovascular Disease Monitoring Advisory Committee members: Andrew 
Tonkin (Chair), Tom Briffa, Derek Chew, Annette Dobson, Jeff Flack, Louise Gates, 
Rob Grenfell, Noel Hayman, Ian Ring, John Lynch, Timothy Mathew, Lynelle Moon 
and Amanda Thrift. 
• Australian Institute of Health and Welfare: Lisa McGlynn, Judith Abercromby, 
Evon Bowler, Peter Braun, Louise Catanzariti, Liz Gilbert, Wen Xingyan and Michael 
Bourchier. 
The Department of Health and Ageing (DoHA) funded this report. The authors acknowledge 
the valuable comments from individual staff members of DoHA. 
 iv Stroke and its management in Australia: an update 
Abbreviations 
ABS Australian Bureau of Statistics 
ACAP Aged Care Assessment Program 
ACAT Aged Care Assessment Team 
ACHI Australian Classification of Health Interventions 
ACFI Aged Care Funding Instrument 
AROC 
AIHW 
Australasian Rehabilitation Outcomes Centre 
Australian Institute of Health and Welfare 
ASR Age-standardised rate 
BEACH Bettering the evaluation and care of health  
CACP Community Aged Care Packages 
CHC Complex Health Care 
CT Computerised tomography  
CVD Cardiovascular disease 
DALY Disability Adjusted Life Year 
DDD Defined Daily Dose 
DoHA Department of Health and Ageing 
DTC Day Therapy Centres 
DUSC Drug Utilisation Sub-Committee 
EACH 
EACHD 
Extended Aged Care at Home packages 
Extended Aged Care at Home Dementia packages 
ERP Estimated Resident Population 
GP General Practitioner 
HACC Home and Community Care 
INR International Normalised Ratio 
MRA Magnetic resonance angiography 
MRI Magnetic resonance imaging 
NATSIHS National Aboriginal Torres Strait Islander Health Survey 
NCCH National Centre for Classification in Health 
  Stroke and its management in Australia: an update v 
NEMESIS North East Melbourne Stroke Incidence Study 
NHMD National Hospital Morbidity Database 
NHS National Health Survey 
OECD Organisation for Economic Co-operation and Development 
PAR Population attributable risk 
PBS/RPBS Pharmaceutical Benefits Scheme and Repatriation Pharmaceutical Scheme 
PCCL Patient Complication and Comorbidity Level 
PCSS The Perth Community Stroke Study 
RCS Resident Classification Scale 
Rt-PA Intravenous tissue plasminogen activator 
SEIFA Socio-Economic Index For Areas 
SLA Statistical Local Area 
TIA Transient ischaemic attack 
WHO World Health Organization 
Symbols 
— nil or rounded to zero 
. . not applicable 
n.a. not available 
n.p. not publishable because of small numbers, confidentiality or other concerns 
about the quality of the data 
 
 vi Stroke and its management in Australia: an update 
Summary 
Stroke poses a burden on patients, their families and services 
• Although stroke event rates fell by 25% between 1997 and 2009, the estimated number of 
stroke events increased by almost 6% in the same period due to the ageing of the 
population. 
• Stroke death rates declined in Australia by 70% between 1979 and 2010. In 2010, stroke 
caused 8,300 deaths in Australia, accounting for 6% of all deaths.  
• More people are now surviving a stroke, with an estimated 375,800 people surviving in 
2009. 
• Between 1998 and 2009, disability caused by stroke declined from 45% to 35%. 
• In 2009–10, there were more than 35,300 hospitalisations for stroke and 25,800 
hospitalisations for rehabilitation care associated with stroke.  
• Informal carers play an important role in the care of stroke survivors. In 2009, an 
estimated 75,000 primary carers provided assistance to people with stroke and disability. 
More than half of primary carers spend 40 hours or more each week in their caring role. 
• In 2008–09, total health-care expenditure for stroke in Australia was $606 million, which 
accounts for 7.8% of the estimated health-care expenditure of all cardiovascular disease 
and is second only to coronary heart disease. 
• Stroke prevalence rates were higher in Aboriginal and Torres Strait Islander people than 
in the non-Indigenous population, and higher in people from the lowest socioeconomic 
group than in those in the highest socioeconomic group. 
Specialised care facilities for patients increase 
• Stroke units significantly improve health outcomes of stroke patients. Between 2007 and 
2011, the number of stroke units in public hospitals increased from 54 to 74 and the 
proportion of patients receiving stroke unit care increased from 50% to 60%. 
But there is still room for improvement 
• Thirty-nine per cent of hospitals required to admit and manage people with acute stroke 
reported having a stroke unit. Although this is an improvement compared with 2004 
(19%), it is still low compared with some other countries with similar sized economies to 
Australia.  
• From 2007 to 2010, the number of patients admitted for ischaemic stroke who received 
thrombolysis increased from 461 to 1,170. This could be related to an increase in the 
number of stroke units offering this service (from 24% in 2007 to 36% in 2011).  
• Although discharge planning is recommended for all stroke survivors, and is a pivotal 
point in the journey to recovery, only 50% of stroke patients received such a plan in 2011. 
Data gaps limit our knowledge in several areas 
• There are limited national data on: the time elapsed between onset of stroke symptoms 
and the start of emergency care; uptake of best practice guidelines; or medications given 
in acute care or at discharge. 
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1 Introduction 
Background 
What is stroke? 
Stroke occurs when an artery supplying blood to the brain either suddenly becomes blocked 
or begins to bleed (National Stroke Foundation 2012a). This may result in part of the brain 
dying, leading to a sudden impairment that can affect a range of activities such as speaking, 
thinking, movement and communication (National Stroke Foundation 2012b).  
There are two main types of stroke: a blood clot or other particles blocking a blood vessel 
causes one type (ischaemic stroke, which is also known as cerebral infarction) and the 
rupturing and subsequent bleeding of a blood vessel causes the other (haemorrhagic stroke). 
Ischaemic stroke accounts for about 80% of stroke and haemorrhagic stroke accounts for 
about 20% (National Stroke Foundation 2012c). 
Symptoms and signs of stroke include one or more of the following: 
• motor impairments (weakness or paralysis of parts of the body, including the face, on 
one or both sides) 
• sensory impairments (touch, pain, warm/cold), most often on one side 
• speech difficulties or slurred speech 
• vision difficulties (sudden loss of vision, blurred vision), most often on one side 
• dizziness, loss of balance or unexplained fall 
• sudden severe headache 
• difficulty swallowing. 
Stroke is sometimes referred to as cerebrovascular disease, but cerebrovascular disease is 
actually a broad category of diseases that include stroke and other disorders of the blood 
vessels supplying the brain or its covering membranes. In 2010, there were 8,304 deaths from 
stroke, accounting for 74% of cerebrovascular disease deaths (11,204 deaths) in that year. 
More detailed information about deaths from stroke is provided in Chapter 2. Where the 
terms stroke and cerebrovascular disease are used interchangeably in this report, this is 
noted. 
What is transient ischaemic attack? 
A condition related to stroke is transient ischaemic attack (TIA), which results from a 
temporary blockage of the blood supply to the brain, usually lasting only a few minutes, and 
producing stroke-like symptoms that disappear within 24 hours (National Stroke Foundation 
2012a). It is a very important predictor of stroke.  
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What are the major risk factors? 
The INTERSTROKE study found that 10 risk factors accounted for 90% of the population 
attributable risk (PAR) for stroke worldwide (O'Donnell et al. 2010). These risk factors 
included high blood pressure, physical inactivity, high waist-to-hip ratio and smoking. 
People who have had a TIA are at high risk of stroke. Meta-analysis has shown that the risk 
of early stroke after TIA is 3.5% at 2 days, 8.0% at 30 days and 9.2% at 90 days (Wu et al. 
2007). Thus, TIAs provide a warning and an opportunity for preventing stroke, and must be 
treated as an emergency. 
As shown by the following estimates based on the Australian Bureau of Statistics (ABS) 
2007–08 National Health Survey (NHS), some of the risk factors for stroke are very common 
(unpublished AIHW analysis of 2007–08 NHS; ABS 2009a; AIHW 2011a; AIHW 2011c; and 
AIHW 2008): 
• In 2007–08, 25% of Australians aged 18 and over (about 2.8 million) were obese (ABS 
2009a). In addition, 37% of Australians (about 4.1 million) were overweight but not 
obese. 
• In 2007–08, 41% of Australians aged 18 and over (6.4 million) were abdominally obese 
(i.e. waist to hip ratio > 0.90 for men and > 0.85 for women). 
• In 2007–08, 72% of Australians aged 15 and over (around 12.0 million) did not undertake 
sufficient physical activity, being either sedentary or having low levels of activity. 
• 1999–00, 51% of Australians aged 25 and over (6.4 million) had high blood cholesterol 
levels.  
• 1999–00, 30% of Australians aged 25 and over (about 3.7 million) had hypertension—that 
is, had high blood pressure or were on blood-pressure lowering medication according to 
the World Health Organization guidelines (Guidelines Subcommittee 1999).  
• In 2010, 15% of Australians aged 14 and over (2.8 million) smoked daily. 
• In 1999–00, 7.4% of Australians aged 25 and over (about 880,000) had diabetes. 
A recent clinical audit of patient records from hospitals participating in the 2011 National 
Stroke Audit in Australia has also shown these risk factors are quite common in patients 
admitted to stroke units (National Stroke Foundation 2011a). The comorbidity and risk factor 
profile of these stroke patients at the time of admission was as follows: 
• Almost 30% had diabetes, a third had recent ischaemic heart disease or acute myocardial 
infarction, 36% had atrial fibrillation, 40% had a previous stroke or a TIA, and 9% had 
rheumatic or other valvular heart disease. 
• Seventy-three per cent had high blood pressure. 
• Fifty per cent had high blood cholesterol. 
• Thirty-one per cent were current or past smokers. 
• Fourteen per cent had high alcohol consumption. 
The 2011 National Stroke Audit also found that most stroke patients with high blood 
pressure or high blood cholesterol levels were receiving medication for these conditions 
(82% for high blood pressure and 71% for high blood cholesterol) before having their stroke 
(National Stroke Foundation 2011a). However, only 30% of stroke patients with atrial 
fibrillation were medicated for this condition before their stroke.  
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Stroke and the recurrence of stroke are preventable (Hankey 2011; Vecchione 2011; Silver 
2012; National Stroke Foundation 2010). Reducing the high prevalence of the modifiable risk 
factors could prevent many strokes. In people who have had TIAs, rapid access to 
investigations and starting preventive measures immediately are essential.  
Community awareness of risk factors for stroke appears to be somewhat limited. A study 
conducted in Adelaide before and after the National Stroke Foundation’s 2009 National 
Stroke Week found that, of 251 respondents, 71% recognised high blood pressure as a risk 
factor for stroke and 53% recognised smoking (Spark et al. 2011). Fewer than 50% of 
respondents recognised other risk factors for stroke—obesity (44%), high cholesterol (40%), 
physical inactivity (23%), family history of stroke (18%) and diabetes (16%). 
Community awareness of stroke signs and 
symptoms 
Early recognition of stroke signs and symptoms is critical in ensuring that a person who is 
having a stroke presents at hospital in time to receive urgent treatment, such as access to a 
stroke unit and thrombolysis, that can improve their chance of survival and subsequent 
quality of life (Trobbiani et al. 2012). A systematic review of the barriers to rapid treatment 
for acute stroke found that two barriers were: lack of recognition of the symptoms of stroke 
by the patient and their family or failure to seek urgent help; and calling a general 
practitioner before calling an ambulance (Kwan et al. 2004).  
Since 2006, the National Stroke Foundation has run annual stroke awareness campaigns 
during Stroke Week using FAST (face, arm, speech, time) (Bray et al. 2011). The FAST test 
asks three questions related to facial weakness, arm weakness and difficulty with speech 
(National Stroke Foundation 2012d). 
A recent study in Adelaide assessed public awareness of the symptoms, signs and risk 
factors for stroke and TIA before, immediately after and 3 months after the National Stroke 
Foundation’s National Stroke Week in 2009 (Spark et al. 2011). The findings indicated that 
there was limited awareness of stroke symptoms among the general public, or what to do 
about them if they developed any symptoms. Overall, 61% of respondents identified slurred 
speech as a stroke warning sign, but less than half identified dizziness (42%), numbness 
(42%) and visual disturbances (41%) as warning signs. Among participants in the survey 
conducted before National Stroke Week, 62% reported that they would attend a hospital 
emergency department immediately if they experienced slurred speech and upper limb 
sensory loss. This was not significantly different from the corresponding proportion of 
respondents to the surveys conducted immediately after (66%), and 3 months after (60%), 
National Stroke Week, which suggests that public awareness of what to do if people 
experienced these symptoms did not improve after the national campaign. Overall, 35% of 
respondents had heard of FAST, and this proportion did improve significantly across the 
three surveys, from 22% before National Stroke Week to 40% immediately after, and 39% at 
3 months.  
An evaluation of stroke awareness campaigns in Australia, England and Canada found that 
such campaigns could improve knowledge of stroke warning signs in the population 
(Trobbiani et al. 2012). The Australian component of this study involved an evaluation of a 
campaign based on the FAST message that was conducted in Victoria in November 2009. 
Before the campaign, 59% of respondents could correctly identify at least two warning signs 
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of stroke compared with 68% after the campaign. Ninety per cent of participants reported 
that they would call emergency services in the event of a stroke.  
Aims of this report 
In February 2006, the Australian Institute of Health and Welfare (AIHW) published How we 
manage stroke in Australia (AIHW: Senes 2006). Since that time, there have been changes in the 
treatment of stroke such as the increased availability of more specialised stroke units in 
hospitals and increasing prescription of antithrombotic medicines. Thus it is timely to update 
the previous report. 
The aims of this current report are to present a comprehensive picture about stroke and how 
it is managed in Australia using the latest available data. The report includes assessment of 
the impact of stroke on patients, their carers, the health system and aged–care services. In 
particular for stroke patients, the report includes information on incidence, prevalence, 
hospitalisation, disability, treatment and deaths. Where data are available, trends and 
inequalities in stroke and its management in Australia are also reported, along with 
international comparisons. 
In addition to providing information about stroke, the report includes information about 
TIA, which is an important predictor of stroke. 
Overview of this report 
This chapter briefly describes stroke and TIA, and the major risk factors for stroke. 
Chapter 2 examines the impact of stroke in Australia. It presents the latest available national 
estimates, as well as trends over time, of: the incidence and prevalence of stroke; the 
prevalence of stroke-related disability; deaths from stroke and TIA; the burden of stroke and 
health-care expenditure on stroke. This chapter also includes international comparisons of 
incidence, prevalence, burden of disease and mortality. 
Chapter 3 presents information on stroke treatment in hospital, including treatment in 
specialised stroke units.  
Chapter 4 describes the latest information, and changes over time, in general practice care of 
stroke and the supply of stroke medications in the community.  
Chapter 5 examines the management of the consequences of stroke in terms of: the assistance 
needed and received by people with stroke and disability; rehabilitation of stroke or its 
sequelae; formal care services in the community; and the impact of stroke on primary carers 
of people with stroke.  
Chapter 6 examines inequalities in the prevalence of stroke, hospitalisations for stroke, and 
death from stroke by Indigenous status, remoteness and socioeconomic status. 
Data sources and methods 
The report draws on a range of data sources and these are described in detail in Appendix C. 
Briefly, the main data sources used are the AIHW National Hospital Morbidity Database; the 
AIHW National Mortality Database and the AIHW General Record of Incidence of Mortality 
(GRIM) Books; the ABS 1998, 2003 and 2009 Surveys of Disability Ageing and Carers 
(SDAC); the Australian Government Pharmaceutical Benefits Database; Bettering the 
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evaluation and care of health (BEACH) Survey of General Practice; and the AIHW Disease 
Expenditure Database.  
The statistical methods used in this report are described in Appendix A. 
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2 Impact of stroke  
Key findings  
• In 2009, around 375,800 Australians had had a stroke at some time in their lives. The 
majority (70%) were aged 65 and over. 
• In 2009, it is estimated that just over a third (131,100) of Australians with stroke had a 
disability from their stroke. People with disability resulting from stroke were much 
more likely to be profoundly limited (always need help) in core activities (56%) than 
people with other disabilities. 
• Between 1998 and 2009, the stroke prevalence rate fell for females but did not change 
for males.  
• In 2010, stroke was the underlying cause of just over 8,300 deaths in Australia—on 
average, 23 people died from stroke every day. The good news is that the death rate 
has fallen by around 70% since 1979. However, although the average rate of decline in 
stroke death rates has accelerated for people aged 55 and over, it has slowed for those 
aged 35–54. 
• In 2003, stroke accounted for 4.5% of the total burden of disease in Australia. 
• In 2008–09, total health-care expenditure for stroke in Australia was $606 million, 
which is 8% of health-care expenditure for all cardiovascular disease and 0.5% of total 
health-care expenditure. Hospital-admitted patients accounted for the majority of the 
health expenditure for stroke. 
Incidence 
There are no national data on the incidence (number of new cases) of stroke in Australia. 
However, stroke incidence data are available from two population-based studies conducted 
in Perth and North East Melbourne. It is acknowledged that these studies are not very recent 
and therefore the estimates from them may not reflect the current incidence of stroke in 
Australia. The Perth Community Stroke Study (PCSS) was conducted in 1989–1990, 1995–
1996 and 2000–2001 (Anderson et al. 1993; Jamrozik et al. 1999; Islam et al. 2008). The original 
North East Melbourne Stroke Incidence Study (NEMESIS) was conducted between 1 May 
1996 and 30 April 1997, and a second study was conducted between 1 May 1997 and 30 April 
1999 (Thrift et al. 2000; Thrift et al. 2006).  
The majority of strokes (around 70%) are first-ever strokes (Jamrozik et al. 1999; Thrift et al. 
2000). The incidence of stroke increases markedly from about 65 years of age. Results from 
the PCSS show that the median age of patients having a first-ever stroke during each 12-
month study period was 76 in 1989–1990, 79 years in 1995–1996 and 77 in 2000–2001 (Islam et 
al. 2008). The mean age of patients having a first-ever stroke in the 1997–1999 NEMESIS 
study was 72 for males and 77 for females (Thrift et al. 2009). 
Across the three PCSS studies, the age-adjusted stroke incidence rates were 57% higher in 
males than females (Islam et al. 2008). Investigators in both the Melbourne and Perth studies 
found that males tended to have strokes at younger ages than females, with just over 50% of 
first-ever strokes occurring in males aged under 75. In contrast, for females aged under 75, 
the corresponding proportion of first-ever strokes was 32% across the three Perth studies, 
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36% in the 1996–1997 NEMESIS study and 39% in the 1997–1999 NEMESIS study (Islam et al. 
2008; Thrift et al. 2000; Thrift et al. 2009). 
The 1997–1999 NEMESIS study found that the incidence of ischaemic stroke and 
intracerebral haemorrhage was significantly greater in males than females, while females 
had a greater incidence of subarachnoid haemorrhage than males (Thrift et al. 2009). 
Changes in incidence over time  
As discussed above, the PCSS study is the only Australian population-based study that 
enables trends in stroke incidence to be examined. Islam et al. (2008) studied trends in stroke 
incidence in Perth by comparing data collected over three 12-month study periods in 1989–
1990, 1995–1996 and 2000–2001. It was found that age-adjusted stroke incidence rates fell 
significantly between the first and third study periods, by 49% for males and 37% for 
females. Overall, there were also significant declines in the age-adjusted incidence rates for 
ischaemic stroke, primary intracerebral haemorrhage and undetermined stroke type; 
however, the rate for subarachnoid haemorrhage was stable.  
A more recent Western Australian study examined trends in the incidence of hospitalised 
cerebrovascular disease in 35–84 year olds between 2000 and 2007 (Nedkoff et al. 2012). For 
both men and women, there were significant falls in the age-adjusted rate over the 8-year 
period.  
A hospital-based study in the Hunter region, conducted from 1 January 1996 to 31 December 
2008, provides information about trends in stroke attack rates that could be used as a related 
measure of incidence (Marsden et al. 2010). Over the 13-year period, there were nearly 9,800 
stroke events registered at 14 public acute hospitals among individuals aged 20 and over. 
The majority (91%) of patients had one stroke event registered, while the remainder had 
between two and six events registered. Between 1996 and 2008, the age-standardised stroke 
attack rates fell from 129 to 106 stroke attacks per 100,000 population, which equated to a 
statistically significant average rate of decline of 2.4% per annum. 
Recently, Thrift et al. (2012) compared national estimates of hospitalisations for acute stroke 
and deaths from stroke in 1997 with estimates derived from NEMESIS. There was evidence 
that national hospital and mortality data provide a reasonable approximation of the actual 
number of strokes occurring in Australia each year. Based on this assumption, national 
trends in stroke event rates have been estimated.  
Using the method in Thrift et al. (2012), incidence rates for stroke events declined by a 
quarter between 1997 and 2009. The age-standardised incidence rate for males fell from 213 
per 100,000 population to 157 per 100,000 (Figure 2.1, Table D2.1). The comparable rates for 
females were 163 per 100,000 population, declining to 123 per 100,000. Over the 13-year 
period, stroke event rates were consistently 30% higher in males than females. Although 
stroke event rates fell, the estimated number of stroke events increased by almost 6% from 
31,900 to 33,700 over the same period due to the ageing of the population. The increase in the 
number of stroke events between 1997 and 2009 was greater for males than females (Figure 
2.1, Table D2.1). 
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Note: Age-standardised to the Australian population as at 30 June 2001. 
Source: AIHW analysis of the National Hospital Morbidity Database and the AIHW National Mortality Database. 
Figure 2.1: Estimated number and rate of stroke events, by sex, 1997–2009 
Prevalence 
The estimates of stroke prevalence reported here are based on self-reported data from the 
1998, 2003 and 2009 Surveys of Disability, Ageing and Carers (SDACs) conducted by the 
ABS. Information about these surveys and their sample sizes is provided in Appendix C.  
In 2009, an estimated 375,759 Australians had had a stroke at some time in their lives, and 
the prevalence rate increased with age (Figure 2.2). Overall, after adjusting to account for age 
differences, the prevalence of stroke was significantly greater in males (1.9%) than females 
(1.3%) (Table D2.2). The largest, and statistically significant, differences in the prevalence of 
stroke between males and females occurred between the ages of 65 and 84 (Figure 2.2). 
Overall, 70% of people who had had a stroke were aged 65 and over, although the 
proportion of males aged 65 and over who had had a stroke (72%) was slightly higher than 
that for females of the same age (68%) (Table D2.2). 
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Source: AIHW analysis of ABS 2009 Survey of Disability, Ageing and Carers Basic Confidentialised Unit Record File on CD-ROM. 
Figure 2.2: Stroke prevalence, by age and sex, 2009 
 
 
(a) Age-standardised to the Australian population as at 30 June 2001. 
Source: AIHW analysis of ABS 1998, 2003 and 2009 Survey of Disability, Ageing and Carers Basic Confidentialised Unit Record Files on  
CD-ROM. 
Figure 2.3: Stroke prevalence(a), by sex, 1998, 2003 and 2009 
Changes in prevalence over time 
National trend data on the prevalence of stroke are available from the ABS 1998, 2003 and 
2009 SDACs, which all used a comparable measure of stroke. Between 1998 and 2009, the 
prevalence of stroke fell from 1.5% to 1.3% in females but increased from 1.7% to 1.9% in 
males; however, neither change was statistically significant (Figure 2.3). Although the 
prevalence rate of stroke did not change significantly over the 12-year period, the estimated 
number of males who had survived a stroke increased by more than 50% from 131,535 in 
1998 to 205,798 in 2009, while, for females, the number of stroke survivors increased from 
150,532 in 1998 to 168,377 in 2003 and then increased slightly to 169,961 in 2009 (Table D2.3). 
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Although not a national study, nor specifically measuring stroke alone, the prevalence of 
hospitalised atherothrombotic cerebrovascular disease in Western Australia fell significantly 
between 2000 and 2007 in both men and women aged 35–84 (Briffa et al. in press).  
Disability resulting from stroke 
In 2009, it is estimated that just over a third (131,130) of people with stroke had a disability 
that resulted from their stroke. That is, they had suffered a stroke that interfered with 
everyday activities (Table 2.1). This represents 3% of all people with disability and 46% of all 
people with stroke and disability that was not necessarily caused by stroke. Of people with 
stroke-related disability, 28% were aged under 65 and 72% were aged 65 and over. In 
contrast, 39% of all people with disability were aged 65 and over (Table 2.1).  
Table 2.1: Estimated prevalence of stroke and disability, 2009 
Age 
group 
(years) 
Persons 
with 
stroke 
and 
disability 
resulting 
from 
stroke 
Persons 
with 
stroke 
and 
disability 
Persons 
with 
stroke 
All 
persons 
with 
disability 
Persons with disability resulting from 
stroke 
 
Number Number Number Number 
Percentage 
of all people 
with stroke 
and 
disability 
Percentage 
of all people 
with stroke 
Percentage 
of all 
people 
with 
disability 
0–44  7,154  11,611   19,896  1,099,166  61.6 36.0 0.7 
45–54  9,824  19,208   30,637   529,498  51.1 32.1 1.9 
55–64  19,107  43,515   62,709   766,143  43.9 30.5 2.5 
65–74  28,895  64,918   90,240   668,127  44.5 32.0 4.3 
75–84  38,822  91,071   114,410   577,468  42.6 33.9 6.7 
85+  27,327  54,990   57,867   297,352  49.7 47.2 9.2 
All 
ages  131,130  285,312   375,759   3,937,754  46.0 34.9 3.3 
Source: AIHW analysis of ABS 2009 Survey of Disability, Ageing and Carers Basic Confidentialised Unit Record File on CD-ROM. 
Overall, there was no difference in the proportion of males and females with disability 
resulting from stroke even after adjusting for age. However, females aged 85 or over had a 
significantly higher prevalence of disability due to stroke than those aged 55–84 but no 
significant differences by age group were found for males (Figure 2.4,Table D2.4). The most 
common types of disability resulting from stroke were: restriction in physical activities or 
work; incomplete use of limbs; difficulty gripping or holding things; slow at learning or 
understanding; and speech difficulties (Table 2.2). 
People with disability resulting from stroke were much more likely to be profoundly limited 
in core activities (56%) than all people with stroke who had a disability that was not 
necessarily caused by stroke (38%) and all people with disability (16%) (Table 2.3). Persons 
with profound limitations of activity are unable to do, or always needs help with, a core 
activity task. 
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Note: Estimates for males aged 0–54 and females aged 0–44 have an associated relative standard error (RSE) of greater than 25% and should be 
interpreted with caution. 
Source: AIHW analysis of ABS 2009 Survey of Disability, Ageing and Carers Basic Confidentialised Unit Record File on CD-ROM. 
Figure 2.4: Estimated prevalence of disability resulting from stroke, by age and sex, 2009 
Table 2.2: Estimated disability types resulting from stroke, 2009 
Disability type(a) People with disability resulting from stroke 
 Number Per cent 
Restriction in physical activities or work  70,876  54.1 
Incomplete use of feet or legs  52,914  40.4 
Incomplete use of arms or fingers  46,325  35.3 
Difficulty gripping or holding things  41,790  31.9 
Slow at learning or understanding  34,263  26.1 
Speech difficulties  33,192  25.3 
Chronic or recurring pain or discomfort  25,044  19.1 
Nervous or emotional condition  20,963  16.0 
Other disability type(s)  19,889  15.2 
Loss of sight  16,110  12.3 
Loss of hearing  10,324  7.9 
Breathing difficulties  9,991  7.6 
Blackouts, fits or loss of consciousness  7,523  5.7 
Mental illness  7,476  5.7 
Disfigurement or deformity  7,172  5.5 
Total persons with a disability caused by stroke  131,130  100.0 
(a) More than one type of disability may be present concurrently therefore the sum of each type of disability does not add to the total number of 
persons with a disability caused by stroke. 
Source: AIHW analysis of ABS 2009 Survey of Disability, Ageing and Carers Basic Confidentialised Unit Record File on CD-ROM. 
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Table 2.3: Estimated disability status of people with disability resulting from stroke 
Disability status(a) 
People with 
disability resulting 
from stroke  
People with stroke and 
disability  
All people with 
disability 
 
Number(b) 
Per 
cent  Number(b) Per cent  Number(b) Per cent 
Profoundly limited in core activities(c) 72,873 55.6  108,006 37.9  615,817 15.6 
Severely limited in core activities(c) 22,386 17.1  52,025 18.2  615,956 15.6 
Moderately limited in core activities(c) 16,885 12.9  41,828 14.7  647,819 16.5 
Mildly limited in core activities 13,244 10.1  66,289 23.2  1,199,806 30.5 
Not limited in core activities(c) but 
restricted in schooling or 
employment *2,245 1.7  *4,891 1.7  332,929 8.5 
Not limited in core activities(c) or 
restricted in schooling or 
employment *3,496 2.7  12,272 4.3  525,427 13.3 
Total 131,130 100.0  285,312 100.0  3,937,754 100.0 
(a) For an explanation of levels of activity limitation, refer to Box 1 in Appendix C. 
(b) Estimates marked with an asterisk have an associated relative standard error (RSE) of between 25% (with one asterisk) and 50% (with two 
asterisks) and should be interpreted with caution. 
(c) Core activities include communication, mobility and self-care. 
Source: AIHW analysis of ABS 2009 Survey of Disability, Ageing and Carers Basic Confidentialised Unit Record File on CD-ROM. 
Changes in disability resulting from stroke over time 
Between 1998 and 2009, there was a significant change in the proportion of females with 
disability resulting from stroke, with the prevalence falling from 46.1% in 1998 to 32.4% in 
2009 (Figure 2.5, Table D2.5). Although the prevalence of disability resulting from stoke in 
males fell from 44.8% in 2003 to 36.8% in 2009, the difference was not statistically significant.  
 
Note: Age-standardised to the total estimated number of people with stroke in 2003. 
Source: AIHW analysis of ABS 1998, 2003 and 2009 Survey of Disability, Ageing and Carers Basic Confidentialised Unit Record Files on CD-
ROM. 
Figure 2.5: Prevalence of disability resulting from stroke, by sex, 1998, 2003 and 2009 
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Deaths from stroke and transient ischaemic attack 
All stroke 
In 2010, there were 8,304 deaths with an underlying cause of stroke registered in Australia. 
This means that, on average, 23 people died from stroke every day in that year. Stroke deaths 
represented 6% of all deaths in 2010 (143,473 deaths) and 18% of all cardiovascular disease 
deaths (45,499 deaths), making stroke the second most common cause of cardiovascular 
death after coronary heart disease (21,708 deaths). 
Stroke death rates increased greatly with age, with 81% of stroke deaths occurring among 
those aged 75 or over. More females (5,055) died from stroke than males (3,249) but age-
specific rates were higher in males than females between the ages of 55 and 84 (Figure 2.6). 
However, after adjusting for age, there no little difference in the stroke death rate between 
males and females (31 per 100,000 population for both) (Table D2.6). 
 
Note: Data for 2010 are preliminary and are subject to further revision. 
Source: AIHW analysis of the AIHW National Mortality Database. 
Figure 2.6: Stroke death rates, by age and sex, 2010 
Type of stroke 
Of all deaths from stroke registered in 2010, 29% were recorded as haemorrhagic stroke and 
11% as ischaemic stroke (i.e. cerebral infarction) (Table 2.4). The majority (60%) of deaths 
from stroke were not specified as either haemorrhagic or ischaemic, which makes it difficult 
to make any meaningful interpretation of stroke deaths by type of stroke.  
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Table 2.4: Stroke deaths, by type of stroke, 2010 
 Number of deaths  Percentage of all stroke deaths 
Type of stroke  Males Females Persons  Males Females Persons 
Subarachnoid haemorrhage  225   325   550   6.9 6.4 6.6 
Intracerebral haemorrhage  582   704   1,286   17.9 13.9 15.5 
Other non-traumatic intracranial haemorrhage  307   285   592   9.4 5.6 7.1 
All haemorrhagic stroke  1,114   1,314   2,428   34.3 26.0 29.2 
Ischaemic stroke (i.e. cerebral infarction)  393   537   930   12.1 10.6 11.2 
Stroke, not specified as haemorrhage or 
infarction  1,742   3,204   4,946   53.6 63.4 59.6 
All stroke  3,249   5,055   8,304   100.0 100.0 100.0 
Note: Data for 2010 are preliminary and are subject to further revision. 
Source: Analysis of the AIHW National Mortality Database. 
Transient ischaemic attack 
Between 2006 and 2010, there were 261 deaths registered in Australia with an underlying 
cause of TIA (Table 2.5). Although it is rare for TIA to cause death, it may have been 
recorded as the underlying cause for some of these deaths if it started the train of events that 
lead to the death. 
Almost three quarters of TIA deaths occurred in people aged 85 and over. Although two-
thirds of TIA deaths over the 5-year period occurred in females, there was no difference in 
the age-adjusted death rate by sex. 
Table 2.5: TIA deaths, by age and sex, 2006–2010 
 Number of deaths  Deaths per 100,000 population 
Age group (years) Males Females Persons  Males Females Persons 
< 80 15 11 26  < 0.1 < 0.1 < 0.1 
80–84 16 26 42  1.8 2.1 2.0 
85+ 55 138 193  9.3 11.7 10.9 
All ages 86 175 261     
All ages (crude rate)     0.2 0.3 0.2 
All ages (age-standardised rate)(a)    0.2 0.2 0.2 
(a) Age-standardised to the Australian population as at 30 June 2001. 
Note: Data for 2009 and 2010 are revised and preliminary data respectively and are subject to further revision. 
Source: Analysis of the AIHW National Mortality Database. 
Changes in deaths over time  
Stroke mortality rates have been declining for several decades. The age-standardised death 
rate for stroke in males fell from 108 deaths per 100,000 population in 1979 to 31 deaths per 
100,000 in 2010: a fall of 71% over the 32-year period (Figure 2.7). A similar decline was seen 
among females over this period, with the age-adjusted stroke death rate falling from 99 to 32 
deaths per 100,000 population (Table D2.7). The decline in stroke mortality can be attributed, 
at least partly, to a reduction in risk factors such as tobacco smoking and hypertension 
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(Gillum 1997; OECD 2011). Improvements in medical treatment for stroke have also 
increased survival (National Stroke Foundation 2010; OECD 2011). 
However, although stroke death rates are declining overall, the rates of decline are not 
consistent across age groups. For example, the rate of decline among 35–54-year-old females 
has slowed over time from an average of 8.9% per annum in 1979–1988 to 4.2% per annum in 
1989–1998 to 2.1% per annum in 1999–2010 (Figure 2.8). Similarly, stroke death rates among 
males aged 35–54 fell significantly between 1979 and 1998 by an average of 8.5% per annum, 
but then the rate of decline slowed to 2.2% per annum between 1989 and 1998 and to 1.6% 
per annum between 1999 and 2010. In contrast, since 1989, the average rate of decline has 
accelerated over time for both males and females aged 55–74 and 75 and over. 
 
Notes: 
1.  Age-standardised to the Australian population as at 30 June 2001. 
2.  Death rates for 1979–1996 have been adjusted to ICD-10 standards using a comparability factor of 0.83. 
3.  Data for 2009 and 2010 are revised and preliminary data respectively and are subject to further revision. 
Sources: Analysis of the AIHW National Mortality Database; AIHW 2010b. 
Figure 2.7: Stroke death rates, by sex, 1979–2010 
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Notes 
1.  Age-standardised to the Australian population as at 30 June 2001. 
2.  Death rates for 1979–1996 have been adjusted to ICD-10 standards using a comparability factor of 0.83. 
3.  Data for 2009 and 2010 are revised and preliminary data respectively and are subject to further revision. 
Sources: Analysis of the AIHW National Mortality Database; AIHW 2010b. 
Figure 2.8: Average annual percentage changes in age-standardised death rates for stroke, by age 
and period of registration, 1979 to 2010 
The burden of stroke 
Burden of disease provides an estimate of healthy life lost due to premature death and 
prolonged illness or disability (AIHW 2012a). The latest available national burden of disease 
estimates are based on 2003 data from a study conducted by the AIHW and the University of 
Queensland (Begg et al. 2007). 
In 2003, stroke accounted for 4.5% of the total burden of disease in Australia. It accounted for 
5.1% of the overall disease burden for females, making it the third major contributor behind 
anxiety and depression and CHD. Among males, stroke was the fifth leading contributor, 
accounting for 3.9% of the overall disease burden (Begg et al. 2007). 
In 2003, 75% of the stroke burden for females, and 68% for males, resulted from years of life 
lost to premature death. The balance, 25% for females and 32% for males, was the result of 
years of healthy life lost because of poor health or disability. 
Health-care expenditure on stroke 
In 2008–09, total estimated health-care expenditure for stroke (ICD-10 codes I60–I64) in 
Australia was $606 million, which accounted for 7.8% of total estimated health-care 
expenditure for all cardiovascular disease ($7,731 million) and 0.5% of total health-care 
expenditure ($113.6 billion) (AIHW 2012c). It should be noted that health-care expenditure 
data do not include expenditure from residential aged–care facilities. The categories of 
expenditure that are covered in this report are expenditure for hospital-admitted patients, 
out-of-hospital medical services and prescription pharmaceuticals. More information about 
the disease expenditure data included in this report is provided in Appendix C.  
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Most (92.4%) of the estimated total health-care expenditure for stroke in 2008–09 was spent 
on hospital-admitted patients ($560.1 million), 4.2% ($25.7 million) on prescription 
pharmaceuticals and 3.4% ($20.6 million) on out-of-hospital medical services.  
In 2008–09, prescriptions for blood-pressure lowering drugs for cardiovascular disease 
(CVD) cost $685 million. Of this, only $1 million was estimated to be for stroke. Many drugs 
prescribed to treat or reduce the risk of stroke are also widely used for people with other 
CVD.  
In 2008–09, total estimated expenditure on stroke was slightly higher for males ($312.9 
million) than females ($293.5 million). The health expenditure on stroke per person in 
2008–09 was higher for males ($29) than females ($27). 
Expenditure on stroke for both sexes increased sharply from about age 35 (Figure 2.9). 
Expenditure for males aged 45–74 was higher than that for females of the same age, but, 
from the age of 75, expenditure for females was higher than that for males. The higher 
expenditure for women among those aged 75 and over relates to the greater life expectancy 
of women—because stroke mainly affects the elderly, and there are more elderly women 
than men, it also follows that overall expenditure for stroke was higher for women. 
Note: Does not include expenditure on research. 
Source: AIHW Disease Expenditure Database. 
Figure 2.9: Estimated health-care expenditure for stroke, by age and sex, 2008–09 
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Notes 
1. Does not include expenditure on research. 
2. Per person expenditure was calculated using the estimated resident population for Australian at 31 December 2008. 
Source: AIHW Disease Expenditure Database. 
Figure 2.10: Estimated health-care expenditure for stroke per person, by age and area of 
expenditure, 2008–09 
In 2008-09, total estimated expenditure for hospital-admitted patients for stroke was 
$290 million for males and $270 million for females (Table D2.9). Expenditure for out-of-
hospital medical services for stroke was estimated to be $9.6 million for males and 
$11 million for females, while expenditure for prescription pharmaceuticals was 
$13.4 million for males and $12.3 million for females.  
Estimated expenditure per person for hospital-admitted patients for stroke increased sharply 
with age, as did expenditure per person for prescription pharmaceuticals (Figure 2.10; Table 
D2.10). Expenditure per person for out-of-hospital medical services for stroke increased with 
age until the age of 84, but then fell considerably for those aged 85 and over (Table D2.10). 
The decline could indicate that stroke care is increasingly being delivered to this elderly 
group in hospital or in a residential aged-care facility rather than in the community. 
International comparisons 
The international comparisons of the impact of stroke presented in this section are sourced 
from World Health Organization (WHO) data. The WHO classifies countries into 
14 subregions of the world on the basis of regional boundaries and on their levels of child 
and adult mortality (WHO 2004). The latter usually reflect the development level of a region. 
Under the WHO classification, Australia is part of the subregion of developed countries in 
Western Pacific region (i.e. Western Pacific Region A) together with Brunei Darussalam, 
Japan, New Zealand and Singapore. This region has a very low level of child and adult 
mortality (WHO 2004). It should be noted that the WHO international incidence and 
prevalence data are only available by region and therefore there are no Australia-only data. 
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Incidence  
Between 2000 and 2004, the estimated number of first-ever strokes in the world increased 
from 3.8 million to 9 million; however, it should be noted that improvements in WHO data 
and methods between the two years might explain some of this increase (WHO 2012).  
Of the estimated number of first-ever strokes worldwide in 2004, 3% (274,000) occurred in 
Western Pacific Region A: the Western Pacific subregion of developed countries that 
includes Australia (WHO 2012). The estimated number of first ever-strokes in Western 
Pacific Region A increased almost 3-fold between 2000 (97,000) and 2004. Compared with the 
13 other WHO subregions of the world, Western Pacific Region A ranked 3rd lowest for 
stroke incidence (i.e. first-ever strokes) in 2004 and 4th lowest in 2000. The Americas 
subregion that includes Bolivia, Ecuador, Guatemala, Haiti, Nicaragua and Peru (Americas 
Region D) ranked lowest for stroke incidence in 2000 (19,000 first-ever strokes) and 2004 
(50,000), while Western Pacific Region B, the WHO subregion of developing countries in the 
Western Pacific, ranked highest for incidence in both years (1.3 million first-ever strokes in 
2000 and 3 million in 2004) (WHO 2012).  
Prevalence 
In contrast to incidence, the estimated number of stroke survivors worldwide fell by 21% 
between 2000 and 2004, from 38.6 million to 30.5 million (WHO 2012). However, as noted 
above, differences between the two years are partly due to improvements in data and 
methods, and so comparisons may not provide accurate estimates of trends over time.  
Despite the decrease in global stroke prevalence between 2000 and 2004, there was little 
change in Western Pacific Region A over the same period, with an estimated 2.0 million 
stroke survivors in 2000 and 1.9 million in 2004 (WHO 2012). Of the 14 WHO subregions of 
the world, Western Pacific Region A ranked 7th lowest for stroke prevalence in 2000 and 8th 
lowest in 2004. The Americas Region D ranked lowest for stroke prevalence in 2000 (174,999 
stroke survivors) and in 2004 (139,000 stroke survivors), while Western Pacific Region B 
ranked highest in both years (11.3 million stroke survivors in 2000 and 7 million in 2004) 
(WHO 2012).  
Burden of disease 
In 2004, cerebrovascular disease was the 6th leading cause of burden of disease worldwide 
with an estimated 46.6 million disability adjusted life years (DALYs) lost, representing 3% of 
total DALYs in that year (1,523 million) (WHO 2008). 
Among the 34 Organisation for Economic Co-operation and Development (OECD) countries, 
Australia’s age-adjusted cerebrovascular disease rate of 228 DALYs per 100,000 population 
ranked 4th lowest in 2004—Switzerland had the lowest rate (184 DALYs per 100,000 
population) and Turkey the highest (1,232 DALYs per 100,000) (WHO 2008). Australian 
males ranked 3rd lowest (237 DALYs per 100,000 population), while Australian females 
ranked 6th lowest (219 per 100,000) compared with their OECD counterparts.  
Between 2002 and 2004, Australia’s ranking with respect to its burden of cerebrovascular 
disease death remained the same compared with other OECD countries. In 2002, Australia’s 
age-standardised cerebrovascular disease rate of 246 DALYs per 100,000 population ranked 
4th lowest of the OECD countries, while Switzerland had the lowest rate (200 DALYs per 
100,000 population) and Turkey the highest (1,132 DALYs per 100,000) (WHO 2008).  
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Deaths  
International data are available from the WHO for deaths from cerebrovascular disease but 
not specifically from stroke. However, most deaths from cerebrovascular disease are due to 
stroke, with stroke accounting for 74% of all cerebrovascular disease deaths (11,204 deaths) 
in Australia in 2010.  
In 2008, there were an estimated 6.2 million deaths from cerebrovascular disease worldwide, 
representing 11% of all deaths in that year (an estimated 56.9 million deaths) (WHO 2012).  
Compared with other OECD countries, Australia’s age-standardised cerebrovascular death 
rate ranked 8th lowest in 2008. Israel had the lowest age-standardised cerebrovascular 
disease death rate (19.7 per 100,000 population) of all OECD countries and Turkey had the 
highest rate (116.5 per 100,000) (Figure 2.11). Among males in OECD countries, Australia 
ranked 6th lowest (27.5 deaths per 100,000 population), with the lowest rate occurring in 
Israel (22.2 per 100,000) and the highest in Turkey (140.5 per 100,000). Among females in 
OECD countries, Australia ranked 11th lowest (28.4 deaths per 100,000 population), with the 
lowest rate occurring in Israel (17.5 per 100,000) and the highest in Turkey (96.3 per 100,000). 
Between 2002 and 2008, Australia’s ranking with respect to its cerebrovascular disease death 
rate slipped from 6th lowest to 8th lowest compared with other OECD countries. In 2002, 
Australia had an age-standardised cerebrovascular disease death rate of 33.4 per 100,000 
population, while Switzerland had the lowest rate (26.2 per 100,000 population) and Turkey 
the highest (139.7 per 100,000) (WHO 2008).  
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Notes 
1. Cerebrovascular deaths occurring in 2008. 
2. Rates have been age-standardised to the WHO global standard population. 
3. Where 2008 data unavailable, data prior to 2008 were projected for some countries. See (WHO 2011). 
Source: (WHO 2012) 
Figure 2.11: Cerebrovascular death rates in OECD countries by sex, 2008 
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3 Stroke treatment in hospital  
Key findings  
• In 2009–10, there were 35,300 hospitalisations with a principal diagnosis of stroke and 
15,700 hospitalisations with a principal diagnosis of TIA. Males had higher stroke 
hospitalisation rates than females in all age groups. 
• Between 1998–99 and 2009–10, hospitalisation rates for stroke declined by 15% for 
males and 17% for females. 
• In 2009–10, just over three-quarters (77%) of stroke hospitalisations had at least one 
allied health intervention and 71% had at least one imaging procedure. 
• Between 2000–01 and 2009–10, the proportion of stroke hospitalisations with at least a 
magnetic resonance imaging (MRI) brain scan more than doubled, increasing from 8% 
to 20%.  
• Between 2007 and 2011, the number of stroke units in Australia increased from 54 to 
74, and the proportion of patients receiving care in a stroke unit during their admission 
increased from 50% to 60%.  
• Despite these improvements, there are a number of apparent gaps in treatment. 
This chapter examines data on the management of stroke in hospitals including specialised 
stroke units in 2009–10. The management and treatment of stroke is complex because a wide 
range of interventions and health-care specialities are required. The interventions that are for 
the immediate care needs of patients at the onset of a stroke mostly take place in hospitals.  
The care required for stroke differs somewhat with the type of stroke. Where possible, this 
chapter compares management for different types of stroke. 
The Clinical guidelines for stroke management 2010 provide a series of evidence-based 
recommendations relating to the management of stroke and TIA in Australia (National 
Stroke Foundation 2010).These guidelines cover stroke in adults aged 18 and over and all 
types of stroke except subarachnoid haemorrhagic stroke. The continuum of care covered by 
the guidelines includes pre-hospital, acute, post-acute and community care, secondary 
prevention of stroke and management of TIA. The key guidelines assessed as part of the 
National Stroke Foundation’s 2011 National Stroke Audit are shown in Box 3.1.  
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Box 3.1: Key guidelines for stroke management assessed as part of the National 
Stroke Foundation’s 2011 National Stroke Audit 
The Clinical guidelines for stroke management 2010 (National Stroke Foundation 2010) 
recommend: 
Admission 
• All people with stroke should be admitted to hospital and be treated in a stroke unit 
 with a multidisciplinary team. 
• All people with stroke should be admitted directly to a stroke unit, preferably within 
 3 hours of stroke onset. 
• If people with suspected stroke present to non-stroke unit hospitals, transfer protocols 
 should be developed and used to guide urgent transfers to the nearest stroke unit 
 hospital. 
• Emergency department staff should use a validated stroke-screening tool to assist in 
 rapid, accurate assessment for all people with stroke. 
Early assessment and diagnosis 
• All patients with suspected stroke should have a brain CT or MRI immediately where 
 facilities are available or within 24 hours. Patients eligible for thrombolysis should 
 undergo brain imaging immediately. 
• All patients with carotid territory symptoms who would potentially be candidates for 
 carotid re-vascularisation should have urgent carotid imaging. 
Acute treatment 
• Thrombolysis (i.e. intravenous tissue plasminogen activator or rt-PA) in acute 
 ischaemic stroke should only be undertaken in patients satisfying specific inclusion 
 and exclusion criteria (see Appendix E). 
• Aspirin should be given as soon as possible after the onset of stroke symptoms (i.e. 
 within 48h) if CT/MRI excludes haemorrhage. 
Assessment and management of the consequences of stroke 
• Multidisciplinary assessments should take place as soon as possible after admission 
 and ideally with 2 days. 
• For dysphagia, all patients should be screened for swallowing deficits before being 
 given any food, drinks or oral medication within 24 hours after the admission. 
• Coordination of care in the multidisciplinary team and communication with patient by 
 undertaking regular meeting between the team, patient and the family.  
Secondary prevention and management of complications 
• Every stroke patient should be assessed and informed of their risk factors for a further 
 stroke and possible strategies to modify identified risk factors. The risk factors and 
 interventions include: stopping smoking; improving diet; increasing regular exercise; 
 and avoiding excessive alcohol. 
• All stroke and TIA patients, whether normotensive or hypertensive, should receive 
 blood-pressure lowering therapy, unless contraindicated by symptomatic hypotension. 
• Long-term antiplatelet therapy should be prescribed to all people with ischaemic 
 stroke or TIA who are not prescribed anticoagulation therapy. 
• Therapy with a statin should be used for all patients with ischaemic stroke or TIA. 
(Continued) 
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Box 3.1 (continued): Key guidelines for stroke management assessed as part of the 
National Stroke Foundation’s 2011 National Stroke Audit 
Discharge plan 
Hospital services should ensure that a documented post-discharge care plan is developed in 
collaboration with the patient and family and a copy provided to them. This may include 
relevant community services, self-management strategies (e.g. information on medications, 
and compliance advice, goals and therapy to continue at home), stroke support services, 
any further rehabilitation or outpatient appointments, and an appropriate contact number 
for any queries. 
Source: National Stroke Foundation 2010. 
Hospitalisations in 2009–10 
Stroke  
In 2009–10, there were 35, 345 hospitalisations with a principal diagnosis of stroke. Of these, 
52% were for males and 48% for females (Table D3.1). Of all hospitalisations where stroke 
was the principal diagnosis, 48% were for ischaemic stroke, 29% for haemorrhagic stroke and 
23% for unspecified stroke (Table D3.4).  
The stroke hospitalisation rate in 2009–10 increased substantially with age, and rates were 
higher for males than females at all ages (Figure 3.1).  
 
Source: AIHW analysis of the National Hospital Morbidity Database. 
Figure 3.1: Stroke hospitalisation rates, by age and sex, 2009–10 
Similar age and sex patterns occurred for ischaemic stroke although the hospitalisation rate 
for females aged 85 and over was higher than that for males of the same age (Table D3.2). 
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Hospitalisation rates for both intracerebral haemorrhage and subarachnoid haemorrhage 
also increased with age (Figure 3.2).  
However, although age-specific intracerebral haemorrhage hospitalisation rates were higher 
in males than females at all ages, the opposite was true for subarachnoid haemorrhage from 
the age of 35 (Figure 3.2; Table D3.3).  
 
Source: AIHW analysis of the National Hospital Morbidity Database. 
Figure 3.2: Haemorrhagic stroke hospitalisation rates, by type, age and sex, 2009–10 
Transient ischaemic attack 
In 2009–10, TIA was the principal diagnosis for 15,734 hospitalisations. As for stroke 
hospitalisation rates, TIA hospitalisation rates increased with age (Figure 3.3). TIA 
hospitalisation rates were higher in males than females from the age of 25 and, overall, the 
age-adjusted TIA hospitalisation rate was higher in males (72.9 per 100,000 population) than 
in females (59.2 per 100,000) (Table D3.5). 
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 Source: AIHW analysis of the National Hospital Morbidity Database. 
Figure 3.3: Hospitalisation rates for transient ischaemic attack, by age and sex, 2009–10 
Changes in hospitalisations over time  
This section examines changes in stroke hospitalisations between 1998–99 and 2009–10. The 
reason that 1998–99 has been chosen as the starting point is that the ICD-10-AM classification 
(International Statistical Classification of Diseases and Related Health Conditions, Tenth 
Revision, Australian Modification) has been used to code hospital diagnoses and procedures 
since 1998–99. However, it is possible that the trends reported here could be affected by the 
change from ICD-9-CM (International Statistical Classification of Disease and related Health 
Conditions, Ninth revision, Clinical Modification) to ICD-10-AM. Despite this change in 
classification, the trends remained consistent during the whole period as shown in Figure 
3.4. 
Between 1998–99 and 2009–10, overall hospitalisation rates for stroke have consistently 
declined for both males and females. Over the 12-year period, the age-standardised 
hospitalisation rate for males fell by 15% (from 202 per 100,000 in 1998–99 to 172 per 100,000 
in 2009–10) and the rate for females fell by 17% (from 150 per 100,000 in 1998–99 to 125 per 
100,000 in 2009–10) (Figure 3.4). Hospitalisation rates for stroke were consistently higher in 
males than females over the 12-year period, with male rates between 1.3 and 1.4 times as 
high those of females (Table D3.6). 
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Note: Age-standardised to the Australian population as at 30 June 2001. 
Source: AIHW analysis of the National Hospital Morbidity Database.  
Figure 3.4: Trends in stroke hospitalisation rates, by sex, 1998–99 to 2009–10 
 
 
Note: Age-standardised to the Australian population as at 30 June 2001. 
Source: AIHW analysis of the National Hospital Morbidity Database. 
Figure 3.5: Trends in hospitalisation rates for main types of stroke, 1998–99 to 2009–10 
Age-adjusted stroke hospitalisation rates declined by an average of 1.6% annually between 
1998–99 and 2009–10. The decline was faster for females (1.7%) than for males (1.6%). Most of 
the decline was driven by a significant decrease in the hospitalisation rates for unspecified 
stroke (4.9%), although smaller declines were also observed in hospitalisation rates for 
haemorrhagic and ischaemic stroke (Figure 3.5; Tables D3.7, D3.8 and D3.9).  
Alongside these declines, there has been an increase in TIA hospitalisation rates.  
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Both the decrease in hospitalisation rates for unspecified stroke over time, and the increase in 
TIA hospitalisation rates since 2004–05, could be related to improved diagnosis of these 
conditions. Improved diagnosis may have led to some unspecified stroke being recorded as 
non-stroke conditions, thereby contributing to the decline in the hospitalisation rate for 
unspecified stroke (Figure 3.5; Table D3.8).  
Over the 12-year period, age-adjusted hospitalisation rates for ischaemic stroke fell by an 
average of 0.5% per year, although the average annual rate of decline was faster between 
1998–99 and 2004–05 (1.4% per year) than between 2004–05 and 2009–10 (0.01% per year) 
(Figure 3.5; Table D3.7). Between 1998–99 and 2009–10, the trends in the age-adjusted 
hospitalisation rates for haemorrhagic stroke differed by sex—male rates have been 
increasing by 0.3% per year and female rates have been declining by 0.5% per year (Table 
D3.7).  
Age-adjusted hospitalisation rates for TIA declined between 1998–99 and 2004–05 by an 
average of 2.0% per year, but started to increase between 2004–05 and 2009–10 at an average 
annual rate of 1.9%. The rate of increase in TIA hospitalisation rates since 2004–05 was 
greater in females than males (2.3% compared with 1.5%) (Table D3.9). Similar to the 
decrease in hospitalisation rates for unspecified stroke over time, the increase in TIA 
hospitalisation rates since 2004–05 might be related to improvements in diagnosis. Such 
improvements may in part be a result of the national stroke guideline recommendation that 
all patients presenting with suspected TIA should undergo a complete assessment at the 
initial point of healthcare contact (National Stroke Foundation 2010). 
Main characteristics of stroke and TIA hospitalisations 
Urgency of admission 
Admission can be categorised as ‘Emergency’ (required within 24 hours) or ‘Elective’ 
(required at some stage beyond 24 hours). Emergency/elective status is not assigned for 
some admissions (e.g. obstetric care and planned care such as dialysis) (AIHW 2012b). 
Stroke is a condition that requires urgent care because the timeliness of care can have a large 
impact on the severity of its sequelae. In 2009–10, most stroke hospitalisations were 
emergency admissions (84%), while close to one in 10 stroke hospitalisations (9%) were 
elective (Table 3.1). Similarly, the majority (90%) of TIA hospitalisations were emergency 
admissions. 
Table 3.1: Urgency of admission(a) of stroke and TIA hospitalisations, 2009–10 
 Percentage of hospitalisations 
 
Haemorrhagic 
stroke 
Ischaemic 
stroke 
Unspecified 
stroke All stroke TIA 
Elective 9.1 7.7 10.5 8.8 7.2 
Emergency 82.6 84.9 83.0 83.8 90.4 
Other(b) 8.3 7.4 6.5 7.5 2.4 
Total 100.0 100.0 100.0 100.0 100.0 
(a) Note that this variable was incomplete for public hospitals in Tasmania and private hospitals in Northern Territory. 
(b) ‘Other’ includes hospitalisation where the urgency of admission was not assigned such as for obstetric care or planned care, such as 
dialysis, as well those with missing information on the status of urgency of their admission. 
Source: AIHW analysis of the National Hospital Morbidity Database. 
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Patient days and length of stay 
In 2009–10, total patient days for all stroke hospitalisations amounted to 331,363 days and the 
average length of stay for these hospitalisations was 9 days. There was some variation by 
type of stroke, with haemorrhagic and ischaemic stroke having an average length of stay of 
around 10 days, while unspecified stroke had an average (mean) length of stay of almost 8 
days. Overall, 11% of stroke hospitalisations were same-day admissions, but this varied by 
type of stroke, with around 17% of hospitalisations for haemorrhagic and unspecified stroke 
being same-day compared with only 4% of ischaemic stroke hospitalisations. Over 17% of 
TIA hospitalisations were same-day hospitalisations (Table 3.2).  
Small differences in the average duration of hospitalisations by type of stroke hide variations 
in the distribution of the length of stay by stroke type. In 2009–10, the median length of stay 
for unspecified stroke was 4 days compared with 5 days for haemorrhagic stroke and around 
7 days for ischaemic stroke (Table 3.2). The higher mean than median length of stay indicates 
that some hospitalisations have a very long length of stay. 
Table 3.2: Length of stay and bed days for stroke and TIA hospitalisations, 2009–10 
 All stroke 
Haemorrhagic 
stroke 
Ischaemic 
stroke 
Unspecified 
stroke TIA 
 Length of stay (days) 
10th percentile 1 1 1 1 1 
25th percentile 2 1 3 1 1 
Median 6 5 7 4 2 
75th percentile 11 12 12 8 4 
90th percentile 21 23 22 17 7 
Mean 9.4 9.6 9.9 7.8 3.4 
 Percentage of hospitalisations 
Same-day patients 10.9 17.3 4.2 16.7 17.2 
 Patient days 
Total days 331,363 10,245 17,079 8,021 15,734 
Source: AIHW analysis of the National Hospital Morbidity Database. 
Care type and sector 
Care type describes the overall nature of a clinical service provided to an admitted patient 
during an episode of care. Care type can be classified as acute, rehabilitation, geriatric 
evaluation and management, psychogeriatric, maintenance, newborn and other admitted 
patient care (AIHW 2012b). 
In 2009–10, the vast majority of stroke hospitalisations (95%) were acute episodes of care 
(Table 3.3). Most (89%) of the stroke hospitalisations were managed in public hospitals and 
11% in private hospitals (Table 3.3). Fourteen per cent of patients with unspecified stroke 
were treated in private hospitals. The comparable rates for ischaemic and haemorrhagic 
stroke were 10% and 9% respectively, although the greatest number of private 
hospitalisations (1766) was for ischaemic stroke followed by unspecified stroke (1143) and 
haemorrhagic stroke (904). 
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Almost all TIA hospitalisations (99.5%) were acute episodes of care (Table 3.3). The 
proportion of TIA hospitalisations in private hospital was slightly higher than for all stroke 
hospitalisations (14% compared with 11%). 
Separation mode 
The mode of separation records the status of the patient at the time of separation and, for 
some categories, the place to which the person was discharged or transferred (AIHW 2012b). 
The most common separation mode for stroke hospitalisations was ‘other’, where a patient 
was discharged to their usual residence, their own accommodation or a welfare institution 
that could include prison, a hostel or a group home providing primarily welfare services 
(38%). About one in four hospitalisations were transferred to another acute hospital (Table 
3.3). A third of hospitalisations for haemorrhagic stroke were transferred to another acute 
hospital, compared with around a quarter of hospitalisations for ischaemic and unspecified 
stroke.  
In 2009–10, 14% of all stroke hospitalisations and 21% haemorrhagic stroke hospitalisations 
ended with death in hospital.  
Not surprisingly, the great majority of TIA hospitalisations (85%) were discharged to home 
and only 9% were transferred to another acute hospital (Table 3.3).  
Patient complication and comorbidity level 
The patient complication and comorbidity level (PCCL) is a measure of the cumulative effect 
of a patient’s complications and comorbidities, and is calculated for each episode as part of 
the Australian Refined Diagnosis Related Groups classification. PCCLs can be used to gauge 
the ‘severity’ of a patient’s condition (AIHW 2012b). 
The majority of stroke hospitalisations had a severe or catastrophic comorbidity or 
complication level (59%), particularly hospitalisations for ischaemic stroke (67%). In contrast, 
58% of TIA hospitalisations had no complication or comorbidity and 20% had a severe or 
catastrophic level of complication and comorbidity (Table 3.3). 
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Table 3.3: Characteristics of stroke and TIA hospitalisations, 2009–10 
 Percentage of hospitalisations  
Characteristic All stroke 
Haemorrhagic 
stroke 
Ischaemic 
stroke 
Unspecified 
stroke TIA 
Care type      
Acute 95.2 95.3 95.2 95.0 99.5 
Palliative 2.4 2.9 1.9 2.6 0.0 
Geriatric evaluation and management 2.1 1.5 2.5 1.8 0.4 
Maintenance 0.2 0.2 0.2 0.3 0.1 
Other care(a) 0.2 0.0 0.3 0.3 0.0 
Not reported 0.0 0.0 0.0 0.0 0.0 
Sector      
Public 89.2 91.2 89.7 85.7 86.4 
Private 10.8 8.8 10.3 14.3 13.6 
Separation mode      
Transfer to other acute hospital 26.4 32.5 23.0 26.0 8.9 
Transfer to a residential aged–care service, 
unless this is the usual place of residence 3.8 2.7 4.1 4.8 2.1 
Transfer to other health-care accommodation 
(includes mother craft hospitals) 1.0 0.9 1.2 0.8 0.3 
Statistical discharge/type change 16.3 12.7 20.3 12.5 2.4 
Died 14.3 21.4 10.3 13.8 0.2 
Other(b) 37.6 29.4 40.7 41.5 85.1 
Includes: discharge/transfer to an (other) 
psychiatric hospital; left against medical 
advice/ discharge at own risk; and statistical 
discharge from leave. 
0.5 0.4 0.5 0.6 1.0 
Patient complication and comorbidity 
Level (PCCL)      
No complication or comorbidity 20.7 31.5 13.9 21.5 58.2 
Minor complication or comorbidity 0.4 0.9 0.3 0.2 0.1 
Moderate complication or comorbidity 19.5 16.0 19.2 24.5 21.3 
Severe complication or comorbidity 30.0 22.7 33.2 32.7 15.8 
Catastrophic complication or comorbidity 29.3 28.9 33.4 21.1 4.6 
(a)  Includes rehabilitation, psychogeriatric and newborn care; and other admitted patient care where the principal clinical intent does not meet the 
criteria for any of the above. 
(b)  Discharge to usual residence/own accommodation/welfare institution (includes prisons, hostels and group homes providing primarily welfare 
services).  
Source: AIHW analysis of the National Hospital Morbidity Database. 
Hospital procedures 
A procedure is a clinical intervention that is surgical in nature, carries a procedural risk, 
carries an anaesthetic risk, requires specialised training and/or requires special facilities or 
equipment available only in an acute care setting (NCCH 2008). Procedures include: surgical 
procedures; non-surgical investigative and therapeutic procedures such as X-rays and 
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chemotherapy; allied health interventions; and client support interventions that are neither 
investigative nor therapeutic (such as anaesthesia). It should be noted that the reporting of 
these procedures are guided according to the Australian Coding Standards (NCCH 2008). 
Many procedures that are routinely performed when patients are admitted at the hospital 
are not coded. They can occur multiple times during an episode and usually the resources 
used to perform these procedures are reflected in the diagnosis or in an associated 
procedure. These procedures are normally not coded because they are routine in nature, 
performed for most patients and/or can occur multiple times during an episode. Most 
importantly, the resources used to perform these procedures are often reflected in the 
diagnosis or in an associated procedure. That is, for a particular diagnosis or procedure, 
there is a standard treatment that is unnecessary to code. For example:  
• X-ray and application of plaster is expected with a diagnosis of Colles’ fracture 
• intravenous antibiotics are expected with a diagnosis of septicaemia 
• cardioplegia in cardiac surgery is performed routinely. 
Procedures for stroke patients that may be considered standard treatment, and therefore 
unnecessary to code, include the following: 
• drug treatment, which should not be coded except if: 
– the substance is given as the principal treatment in same-day episodes of care (e.g. 
chemotherapy for neoplasm or HIV, see ACS 0044 Chemotherapy)  
– drug treatment is specifically covered in a coding standard (see ACS 1316 Cement 
spacer/beads and ACS 1615 Specific interventions for the sick neonate) 
• echocardiogram except transoesophageal echocardiogram 
• electrocardiography (ECG) except patient-activated implantable cardiac event 
monitoring (loop recorder) 
• monitoring: cardiac, electroencephalography (EEG), vascular pressure except 
radiographic/video EEG monitoring >=24 hours 
• ultrasound 
• plain X-rays without contrast 
It should be noted that some codes on the above list extract may be required in certain 
standards elsewhere in the Australian Coding Standards. In such cases, the standard 
overrides this list and the stated code should therefore be assigned as described in the 
relevant standard. The listed procedures should be coded if anaesthesia (except local) is 
required for the procedure (see ACS 0031 Anaesthesia). These procedures should be coded if 
they are the principal reason for admission in same-day episodes of care. 
The analysis in this section examines procedures and interventions undertaken during 
hospitalisation for stroke, but excludes related accompanying procedures such as 
anaesthesia. It should be noted that not all procedures are required to be coded, particularly 
those routine in nature that form part of the standard treatment of care. In addition, coding 
changes have had a significant effect on the recording of some procedures over time. For 
example, the number of imaging services procedures reported decreased by over 88% overall 
between 2009–10 and 2010–11 after its addition to the list of procedures for which coding 
was no longer necessary (AIHW 2012b). Stroke-related procedures were selected based on 
their frequency in all stroke hospitalisations, guidance from an expert and recommendations 
of the latest National Stroke Clinical Guidelines. 
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Procedures among all stroke hospitalisations 
Most (91%) hospitalisations in 2009–10 with a principal diagnosis of stroke had at least one 
procedure undertaken during the hospitalisation (Table 3.4). However, this proportion 
varied by type of stroke, being highest for ischaemic stroke (96%) and lowest for unspecified 
stroke (79%).  
Table 3.4: Proportion of stroke hospitalisations with at least one procedure performed, by main 
types of stroke, 2009–10 
 Proportion of hospitalisations with at least one procedure (per cent) 
 
All stroke 
(35,345 
hospitalisations) 
Haemorrhagic 
stroke (10,245 
hospitalisations) 
Ischaemic stroke 
(17,079 
hospitalisations) 
Unspecified 
stroke (8,021 
hospitalisations) 
Had at least one procedure 91.3 92.5 96.2 79.5 
Did not have any procedure 8.7 7.5 3.8 20.5 
Source: AIHW analysis of the National Hospital Morbidity Database. 
Stroke hospitalisations that ended in transfer to another acute hospital or death in hospital 
were around twice as likely as other stroke hospitalisations to have no procedure 
undertaken.  
Allied health interventions  
Allied health interventions were the most common interventions for managing stroke in 
hospital. The main target of these interventions is to restore secondary functions affected by 
the stroke, such as bodily and speech functions. Therefore these interventions play an 
important role in the acute management of stroke. 
In 2009–10, 77% of all stroke hospitalisations had at least one allied health intervention. This 
proportion was higher for hospitalisations with a principal diagnosis of ischaemic stroke 
(88%) than those with other types of stroke (66%) (Table 3.5). The majority of hospitalisations 
for stroke received at least one physiotherapy intervention (66%), more than a half had at 
least one occupational therapy session (52%) and one speech pathology intervention (52%) 
and a third at least one social work intervention (31%) (Figure 3.6). 
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Source: AIHW analysis of the National Hospital Morbidity Database. 
Figure 3.6: Proportion of all stroke hospitalisations with at least one allied health intervention, by 
main type of allied health intervention, 2009–10 
Imaging and diagnostic procedures  
Imaging procedures are essential to diagnose stroke and its type, and guide subsequent 
medical and surgical interventions. The National Stroke Guidelines recommend that all 
stroke patients undergo brain imaging within 24 hours of their admission to hospital 
(National Stroke Foundation 2010).  
Common imaging and diagnostic procedures for stroke are computerised tomography (CT) 
brain scans and magnetic resonance imaging (MRI) brain scans. CT brain scans use cross-
sectional X-rays to generate an image of the brain (AIHW 2011c). This image is used to 
distinguish between the major types of stroke—blockage or bleeding—to guide treatment. 
An MRI brain scan uses magnets and radio waves to generate an image of the brain, and 
show a higher level of detail in soft tissue than CT brain scans.  
The majority of hospitalisations for stroke had at least one imaging procedure (71%) 
undertaken, with higher proportions for ischaemic stroke (77%) and haemorrhagic stroke 
(72%) (Table 3.5). CT brain scans were the most common imaging procedure, with 65% of 
stroke hospitalisations having at least one CT brain scan. This procedure was less common 
for hospitalisation for unspecified type of stroke (53%) compared with haemorrhagic (69%) 
and ischaemic stroke (68%) (Table 3.5).  
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Table 3.5: Stroke hospitalisations with at least one main stroke-related procedure, by procedure 
type, 2009–10 
Procedure type 
All 
stroke 
Haemorrhagic 
stroke 
Ischaemic 
stroke 
Unspecified 
stroke 
 Percentage of hospitalisations with at least one procedure  
Generalised allied health 76.6 66.6 87.8 65.5 
Imaging procedures 71.0 71.9 77.3 56.8 
Head and neck duplex ultrasound  0.6 0.1 0.9 0.8 
Heart ultrasound  3.5 0.5 5.7 2.4 
CT brain scan 64.7 68.6 68.1 52.7 
MRI of the brain 19.8 10.6 30.8 7.9 
MRA of the brain 6.3 2.8 10.5 1.8 
Chest X-ray < 0.1 – < 0.1 – 
Head and neck X-ray < 0.1 – < 0.1 – 
Neck and brain angiography 1.4 2.3 1.3 0.3 
Surgical procedures 3.9 10.2 1.7 0.4 
Carotid endarterectomy 0.6 < 0.1 1.1 0.3 
Carotid embolectomy or thrombectomy 0.1 – 0.1 < 0.1 
Intracranial vein or artery transcatheter 
embolisation 0.1 0.3 < 0.1 – 
Destruction of intracranial aneurysm or other 
vascular lesion 2.4 8.1 < 0.1 – 
Removal of intracranial haematoma or 
abscess 0.6 2.0 0.1 – 
Carotid artery repair – – – – 
Carotid bypass 0.0 – 0.0 – 
Carotid aneurysm graft – – – – 
Carotid resection with reanastomosis 0.1 – 0.2 < 0.1 
Carotid transluminal balloon angioplasty 0.1 0.1 0.2 – 
Pharmacotherapy 0.6 0.4 1.0 0.2 
Invasive administration of thrombolytic 
medicines 0.3 0.3 0.5 0.1 
Non-invasive administration of thrombolytic 
agents 0.3 0.1 0.5 0.1 
Notes 
1. Main stroke-related procedures were procedures defined as being performed to manage acute stroke event and its complications. 
2. Components do not add to 100% because a stroke hospitalisation may have had more than one type of stroke-related procedure 
undertaken. 
3. The coverage for administration of thrombolytics in the National Hospital Morbidity Database is not complete because the  
administration of medicines is not routinely recorded according to the Australian Coding Standard. 
4. X-rays and ultrasound in the National Hospital Morbidity Database are not routinely reported according to the Australian Coding  
Standard.  
Source: AIHW analysis of the National Hospital Morbidity Database. 
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The second most common imaging procedure was MRI brain scans. Almost 20% of stroke 
hospitalisations had at least one MRI brain scan, with a higher proportion for ischaemic 
stroke (31%) than haemorrhagic or unspecified stroke (11% and 8%, respectively) (Table 3.5).  
Magnetic resonance angiography (MRA) of the brain was the third most common imaging 
procedure for hospitalisations for stroke and, in particular, 10% of ischaemic stroke 
hospitalisations had at least one MRA of the brain (Table 3.5). 
Surgical procedures  
At least one surgical procedure was performed in almost 4% of all stroke hospitalisations, 
with a higher proportion being undertaken for haemorrhagic stroke (10%) compared with 
other types of stroke (Table 3.5). For haemorrhagic stroke hospitalisations, the surgical 
procedures undertaken most commonly were destruction of an intracranial aneurysm or 
other vascular lesion (8% of haemorrhagic stroke hospitalisations had at least one of these 
procedures) and removal of an intracranial haematoma or abscess (2%) (Table 3.5).  
Carotid endarterectomy is a procedure used to reduce the risk of stroke caused by the build-
up of plaque in the carotid artery. It involves surgically removing atherosclerotic plaques 
from these arteries in the neck, which supply blood to the brain. In 2009–10, around 0.6%of 
all stroke hospitalisations (215) involved carotid endarterectomy indicating the preventive 
nature of the procedure (Table 3.5). In fact, in 2009–10, carotid endarterectomy was mainly 
performed for hospitalisations with a principal diagnosis of cardiovascular diseases other 
than stroke or TIA, with 2,488 of these hospitalisations having at least one carotid 
endarterectomy (Table D3.12).  
Thrombolysis  
When used to treat stroke, thrombolysis is described as the injection of a chemical agent (rt-
PA) into the veins, which significantly reduces the risk of death or complication in patients 
with ischaemic stroke. Patients need to meet certain criteria to be eligible for this treatment. 
These criteria include the patient’s age, the time from stroke onset to injection and the type of 
stroke. Tissue plasminogen activator was licensed in October 2003 by the Australian 
Therapeutic Good Administration for use in a 3-hour window for patients with ischaemic 
stroke, but, based on further evidence, this window has been extended to 4.5 hours (National 
Stroke Foundation 2010). 
Thrombolysis is not captured comprehensively in the NHMD because its collection is not 
mandated in the Australian Coding Standard. Furthermore, thrombolysis is more likely to be 
administered in an emergency department before, rather than after, hospital admission, and 
when it is performed after admission it is not possible to identify when stroke-specific rt-PA 
has been used.  
In 2009–10, less than 1% of hospitalisations for stroke were recorded to have had 
thrombolytic agents administered (Table 3.5).  
Changes in main hospital investigations and procedures over time  
Magnetic resonance imaging brain scan 
Between 2000–01 and 2009–10, the age-adjusted proportion of hospitalisations with a 
principal diagnosis of stroke that had at least one MRI brain scan undertaken increased 
substantially from 8% to 20%. Over this period, the magnitude of the increase was similar for 
females (from 7% in 2000–2001 to 18% in 2009–10) and males (from 9% in 2000–2001 to 21% 
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in 2009–10) (Table D3.10). Over the 10-year period, males were consistently more likely than 
females to have had a stroke hospitalisation with at least one MRI brain scan undertaken 
(Figure 3.7). 
 
Note: Proportions were age-adjusted to the number of hospitalisations in 2000–01 with a principal diagnosis of stroke. 
Source: AIHW analysis of the National Hospital Morbidity Database. 
Figure 3.7 Trends in the proportion of stroke hospitalisations with at least one MRI brain scan 
undertaken, by sex, 2000–01 to 2009–10 
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Computerised tomography (CT) brain scan 
Between 2000–01 and 2006–07, the age-adjusted proportion of hospitalisations with a 
principal diagnosis of stroke that had at least one CT brain scan undertaken increased from 
62% to 71%. However, after 2006–07, the proportion fell and was 65% in 2009–10 (Table 
D3.11). Over the 10-year period, there was no difference between males and females in the 
proportion of stroke hospitalisations that had at least one CT brain scan undertaken (Figure 
3.8). 
 
Note: Proportions were age-adjusted to the number of hospitalisations in 2000–01 with a principal diagnosis of stroke. 
Source: AIHW analysis of the National Hospital Morbidity Database. 
Figure 3.8: Trends in the proportion of stroke hospitalisations with at least one CT brain scan 
undertaken, by sex, 2000–01 to 2009–10 
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Carotid endarterectomy 
The number of hospitalisations for any principal diagnosis that had at least one carotid 
endarterectomy undertaken fell from 3,415 in 2000–01 to 2,515 in 2009–10 (Figure 3.9; Table 
D3.12).  
 
Source: AIHW analysis of the National Hospital Morbidity Database. 
Figure 3.9: Trends in the number of hospitalisations with at least one carotid endarterectomy 
undertaken, 2000–01 to 2009–10 
Thrombolysis 
Based on the clinical audits conducted by the National Stroke Foundation, the number of 
patients admitted for ischaemic stroke who received thrombolysis has increased from 461 in 
2007 to 1,170 in 2011 (National Stroke Foundation 2011b). This increase could be related to an 
increase in the number of stroke units offering this service over the same period (from 24% in 
2007 to 36% in 2011).  
Stroke units and clinical audit 
This section focuses on specialised care for stroke delivered in stroke units. The information 
is based on a recent organisational and clinical audit conducted in 2011. This audit covered a 
subsample of stroke units in Australia that is large enough to represent the majority of stroke 
units and their activity in Australia. 
What is a stroke unit? 
Specialised units dedicated to stroke and staffed with a multidisciplinary team significantly 
improve the health outcome and recovery of stroke patients (Stroke Unit Trialists' 
Collaboration 2007). The Acute Stroke Services Framework 2011 (National Stroke Foundation 
2011c), recommends that all hospitals with over 350 acute stroke admissions per year should 
develop a ‘comprehensive stroke centre’ with access to advanced capability, while those with 
over 100 stroke admissions per year should develop a ‘primary stroke centre’. A 
comprehensive stroke centre has a dedicated stroke unit with specialised resources and staff 
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available 24 hours a day every day of the year. A primary stroke centre has a dedicated 
stroke unit with clinicians who have: stroke expertise; written stroke protocols for emergency 
services, acute care and rehabilitation; ability to offer thrombolytic therapy or protocols to 
transfer appropriate patients to a comprehensive stroke centre; timely neurovascular 
imaging and timely access to expert interpretation; and coordinated processes for patient 
transition to ongoing rehabilitation and secondary prevention services. 
The minimum criteria for defining a stroke unit are (National Stroke Foundation 2011c):  
1. Co-located beds within a geographically defined unit.  
2. Dedicated, inter-professional team with members who have a special interest in stroke 
and/or rehabilitation. The minimum team would consist of medical, nursing and allied 
health (including occupational therapy, physiotherapy, speech pathology, social work 
and dietician).  
3. Inter-professional team meet at least once per week to discuss patient care.  
4. Regular programs of staff education and training relating to stroke, (e.g. dedicated 
stroke in-service program and/or access to annual national or regional stroke 
conference). 
There are various types of stroke units, with different range of functions and services 
available—acute stroke units, comprehensive stroke units and stroke rehabilitation units 
(Table 3.6). 
Table 3.6: Main types of stroke units and their characteristics 
Type of services 
Acute 
stroke unit 
Comprehensive 
stroke unit 
Stroke 
rehabilitation unit Admits at stroke onset   X Access to 24 hour monitoring, CT brain imaging and IV thrombolysis   X Designated, co-located stroke beds    Admission for hyper-acute and acute management only  X X Access to a specialised multidisciplinary team and early rehabilitation    Access to a specialised multidisciplinary team and specialist rehabilitation X   
Source: National Stroke Foundation 2008.  
The 2011 National Stroke Audit 
The National Stroke Foundation has conducted a National Stroke Audit Program since 2007. 
The main objective of the audit is to measure adherence to the Clinical guidelines for stroke 
management 2010. Hospitals required to admit and manage people with acute stroke were 
considered eligible to participate in the 2011 National Stroke Audit, which included two 
components—an Acute Services Organisational Survey and an Acute Services Clinical Audit 
(National Stroke Foundation 2011b).  
The 2011 Acute Services Organisational Survey examined whether resources such as stroke 
units, imaging and multidisciplinary teams were available in the participating hospitals to 
deliver evidence-based stroke care. The self-reported data were provided by a nominated 
clinician at each hospital (National Stroke Foundation 2011b). The National Stroke 
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Foundation identified 209 eligible public hospitals, out of which 184 participated in the 
audit. Four private hospitals also participated, bringing the total number of hospitals audited 
to 188 (Table 3.7). There were 25,597 patients with acute stroke admitted to these 188 
hospitals in the 12 months before the audit. 
The 2011 Acute Services Clinical Audit involved the retrospective review of up to 
40 consecutive patients admitted to 108 of the 188 hospitals that participated in the 
organisational audit during a defined timeframe (National Stroke Foundation 2011a). The 
clinical audit examined processes of care such as diagnostic procedures, early interventions 
and the way in which the nationally endorsed evidence-based recommendations were 
delivered. Timing of the delivery of various aspects of care and discharge outcomes was also 
measured. The 108 hospitals participating in the clinical audit admitted 88% (22,636 patients) 
of the 25,597 patients with acute stroke admitted to the 188 hospitals participating in the 
organisational survey. Of these 22,636 acute stroke patients, 3,548 had their clinical records 
audited against the recommendations of the Clinical guidelines for stroke management 2010. 
Table 3.7: Participating hospitals and their stroke units in Australia, 2010 
 
Hospitals participating in the Acute Services 
Organisational Survey 
State  Number With stroke units 
ACT/NSW 60 32 
QLD 34 13 
NT 2 1 
SA 33 4 
Tas 3 2 
Vic 37 18 
WA 19 4 
Total 188 74 
Total stroke admissions in 2011 25,597 20,801 
Source: National Stroke Foundation 2011b. 
2011 Acute Services Organisational Survey  
The information presented in this section comes from the National Stroke Foundation’s 2011 
Acute Services Organisational Survey (National Stroke Foundation 2011b). 
Characteristics of participating hospitals 
Over 40% of hospitals participating in the 2011 Acute Services Organisational Survey (81 out 
of 188 hospitals) admitted at least 100 stroke patients per year, and 39% of participating 
hospitals (74 hospitals) reported having a stroke unit. Most (78%) of the 74 stroke units were 
acute stroke units and a minority were integrated stroke units (20%). However, eight stroke 
units did not meet the minimum standards for stroke units and six of these stroke units 
admitted more than 100 stroke patients a year. 
Most stroke units were located in urban areas (70 stroke units) and four were in rural areas. 
Of the 70 stroke units located in urban areas, 80% were in metropolitan areas and the 
remainder were in regional areas.  
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Organisation of care 
Of the 188 hospitals participating in the organisational audit, 41% had arrangements with 
ambulance services to facilitate rapid assessment, 58% had protocols to guide the transfer of 
patients with stroke into or out of the centre and 64% had emergency department protocols 
for the rapid triage of patients. However, 37% of hospitals that needed to transfer patients 
with stroke to larger hospitals did not have documented transfer arrangements. 
In urban areas, most hospitals (99%) admitting acute stroke patients had access to CT within 
24 hours, 91% had access to MRI and 98% had access to Carotid Doppler (an ultrasound scan 
primarily used to assess the blood flow in the arteries of the neck). However, in rural areas, 
access to diagnostic imaging was more limited, with 70% of hospitals having access to CT 
within 24 hours, only 31% having access to MRI and 66% having access to Carotid Doppler. 
Overall, 36% of participating hospitals offered thrombolysis in 2011. Among the 74 hospitals 
with a stroke unit, 74% offered thrombolysis, while 11% of the 114 hospitals with no stroke 
unit offered thrombolysis.  
Just over 60% of hospitals provided routine assessment of patients with stroke for the need 
for ongoing rehabilitation. Almost one in five (19%) hospitals had access to early supported 
discharge teams and 76% had access to community-based rehabilitation. 
Sixty per cent of hospitals routinely provided a discharge care plan to patients. Only 31% of 
hospitals reported using protocols for post-discharge review but 72% provided a post-
discharge contact to patients. 
2011 Acute Services Clinical Audit 
The information presented in this section comes from the National Stroke Foundation’s 2011 
Acute Services Clinical Audit (National Stroke Foundation 2011a). 
Type of stroke 
Over three-quarters of the 3,548 patients whose medical records were included in the clinical 
audit had confirmed ischaemic stroke (2,624 patients), while 16% (531 patients) had 
confirmed intracerebral haemorrhage. Findings from this audit provide insight to the clinical 
pathways undertaken by stroke patients. 
Admission to stroke units 
Only 60% of patients with stroke received care in a stroke unit at some time during their 
admission, although 80% of patients who were admitted to a hospital with a stroke unit 
received care in the stroke unit. However, 42% of all stroke patients admitted to a stroke unit 
were not admitted to that unit on the day of their stroke.  
Early assessment 
The Clinical guidelines for stroke management 2010 recommend that all patients with suspected 
stroke should have brain imaging within 24 hours of admission (National Stroke Foundation 
2010). Of the patients included in the stroke clinical audit, 89% had brain imaging performed 
within 24 hours of their admission.  
Thrombolysis 
As discussed previously, thrombolysis is recommended to be given as early as possible to 
patients with ischaemic stroke who meet the specific eligibility criteria described in 
Appendix E (National Stroke Foundation 2010). Almost half (49%) of patients with ischaemic 
stroke who arrived at hospital within 3 hours of stroke onset were assessed for eligibility for 
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thrombolysis (365 out of 751 patients). Only 7% of all patients with confirmed ischaemic 
stroke (2,624 patients), received thrombolysis, but not all of these patients may have been 
eligible for thrombolysis and/or may not have arrived at hospital within the 4.5-hour 
timeframe for thrombolysis treatment. Of those who did arrive at hospital within 4.5 hours 
of stroke onset (864 patients), only 18% (154 patients) received thrombolysis.  
Aspirin treatment 
The Clinical guidelines for stroke management 2010 recommend that aspirin should be given 
within 48 hours of the onset of stroke symptoms if CT/MRI scans exclude haemorrhage 
(National Stroke Foundation 2010). Of the 2,006 patients with ischaemic stroke who were not 
contraindicated to receive aspirin or had not already received aspirin before transferring to a 
participating hospital, 69% received aspirin at some point during their admission and 64% 
received aspirin within 48 hours of admission. 
Assessment and management of the consequences of stroke 
The Clinical guidelines for stroke management 2010 recommended that assessments from allied 
health professionals (physiotherapist, occupational therapist, speech pathologist, dietitian, 
social worker and psychologist) take place within 48 hours of admission (National Stroke 
Foundation 2010). 
Most stroke patients had an assessment by a multidisciplinary team of allied health 
professionals, but many of these assessments were not delivered within the recommended 
timeframe of 48 hours after presentation. Among patients eligible for assessment, 62% of 
physiotherapy assessments took place with 48 hours, while 40% of occupational health, 62% 
of speech pathology and 22% of dietitian assessments were conducted within this timeframe. 
Less than half of eligible patients were assessed by a social worker during their admission, 
43% were assessed by a dietitian and only 6% of patients with mood impairments had a 
psychological assessment.  
Management of complications 
The most common stroke complications that occurred during patient admissions were 
progression of the stroke, fever, urinary tract infection, pneumonia, and depression or 
anxiety (Table 3.8). In addition, 40% of stroke patients whose continence was assessed and 
documented had continence problems within the first 72 hours of admission, but only a 
quarter were provided with a continence management plan.  
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Table 3.8 Main complications during the admission of stroke patients, 2011 
Complications Number Per cent 
Stroke progression 406 11.0 
Fever 442 12.0 
Urinary tract infection 313 9.0 
Aspiration pneumonia 296 8.0 
Depression/anxiety 273 8.0 
Falls 199 6.0 
Newly diagnosed atrial fibrillation 209 6.0 
Malnutrition 161 5.0 
Raised intracranial pressure 162 5.0 
Shoulder pain 124 3.0 
New stroke 102 3.0 
Pressure sores 90 3.0 
Seizures 87 2.0 
Acute myocardial infarction 67 2.0 
Deep vein thrombosis 19 1.0 
Pulmonary embolism 14 <1.0 
Total stroke admissions 3,548  
Source: National Stroke Foundation 2011a. 
Secondary prevention 
With regard to secondary prevention, more than half of all patients received behaviour 
change education for modifiable risk factors (National Stroke Foundation 2011a). Just over 
80% of patients without contraindications were discharged with antihypertensive 
medications. Among patients with ischaemic stroke, 80% were discharged with lipid-
lowering medications and 96% with antithrombotic medications. 
Discharge plan 
Only half of the patients with stroke received a discharge care plan. Patients admitted to 
hospitals with 100 or more stroke admissions a year were more likely to have a discharge 
care plan than those admitted to hospitals with fewer than 100 stroke admissions per year 
(52% compared with 43%). 
Recent changes in stroke unit care 
Stroke care in Australia has changed significantly in recent years, with improvements in 
access to more specialised care and therapies. In addition to reinforcing the development and 
coverage of more specialised stroke care, the Clinical Guidelines for Stroke Management 2010 
have emphasised the importance of continuity of care for stroke patients, implying better 
processes between multidisciplinary team within the hospital and also in the community. 
Results from the organisational audit conducted by the National Stroke Foundation are 
presented here to illustrate recent changes in coverage and processes in the stroke care 
system in Australia. 
Between 2007 and 2011, the number of stroke units in Australia increased from 54 to 74 and 
the proportion of patients receiving stroke unit care at any point during their admission 
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increased from 50% to 60% (National Stroke Foundation 2011a, b). The number of beds 
dedicated to stroke admissions increased by 40% over the same period (from 391 in 2007 to 
549 in 2011). Other significant improvements in stroke services that have taken place 
between 2007 and 2011 include: 
• an increase in both direct and faster access to stroke units for patients as a result of the 
doubling of the proportion of hospitals with ambulance service arrangements (from 19% 
in 2007 to 41% in 2011) 
• a substantial increase in the proportion of hospitals with emergency department 
protocols for the rapid triage of patients with acute stroke (from 38% in 2007 to 64% in 
2011) 
• an increase in the proportion of hospitals with emergency department protocols for 
transfer of patients to another hospital for care (from 44% in 2007 to 58% in 2011) 
• an increase in the proportion of hospitals with access to imaging facilities such as MRI 
(from 55% in 2007 to 62%) and Carotid Doppler (from 74% in 2007 to 82% in 2011) 
• an increase in the proportion of hospitals with access to telehealth for clinical support 
(from 58% in 2007 to 67% in 2011) and for professional development (from 68% in 2007 to 
80% in 2011) 
• improvements in communication processes between the hospitals and the community 
and the care team and the patients and their family. 
Despite these improvements, the National Stroke Audit identified several issues for further 
improvement: 
• although access to stroke units increased from 50% in 2007 to 60% in 2011, it still 
compares poorly with the United Kingdom (90% access) and Scandinavian countries (> 
80% access) 
• only 58% of stroke patients were admitted to a stroke unit on the day of their stroke in 
2011 and this has not improved since 2009 (59%)  
• although the proportion of ischaemic stroke patients who arrived within 3 hours of 
stroke onset and received thrombolysis increased from 6% in 2007 to 20% in 2011, the 
National Stroke Foundation has recommended that thrombolysis services should be 
established in all stroke unit hospitals so that eligible patients can be assessed and 
administered thrombolysis as quickly as possible 
• since 2009, there has been no improvement in the proportion of hospitals providing 
routine assessments for all patients for the need for further rehabilitation (63% in 2009 
and 62% in 2011) or in the proportion of hospitals routinely providing a discharge care 
plan (58% in 2009 and 60% in 2011). 
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Rehabilitation of stroke or its sequelae 
Stroke rehabilitation encompasses a range of measures designed to help improve a patient’s 
functioning after a stroke and/or to prevent deterioration of functioning. It aims to maximise 
a patient’s physical, psychological, social and financial independence, and ideally begins the 
first day after a stroke. Various elements of stroke rehabilitation have been shown to 
significantly improve outcomes for patients.  
Hospitalisation for rehabilitation of stroke and its sequelae 
Rehabilitation care is care in which the clinical intent or treatment goal is to improve the 
functional status of a patient with an impairment, disability or handicap (AIHW 2012e). It is 
based on a multi-disciplinary rehabilitation plan comprising negotiated goals and indicative 
timeframes, which are evaluated by a periodic assessment using a recognised functional 
assessment measure. It includes care provided:  
• in a designated rehabilitation unit 
• in a designated rehabilitation program 
• under the principal clinical management of a rehabilitation physician or, in the opinion 
of the treating doctor, when the principal clinical intent of care is rehabilitation. 
In 2009–10, the total number of hospitalisations for rehabilitation care (excluding 
rehabilitation for drug or alcohol) was 251,666, of which 10% (25,810) were associated with 
stroke or its sequelae. Hospitalisations for rehabilitation associated with stroke or its 
sequelae accounted for 374,826 patient days in 2009–10.  
The age-adjusted hospitalisation rate for stroke rehabilitation in males was 1.5 times as high 
as that of females (131 compared with 90 per 100,000 population) (Table D3.13). A third of 
hospitalisations for rehabilitation of stroke or its sequelae were for patients aged under 65. 
Just over half (52%) of all hospitalisations for rehabilitation of stroke or its sequelae in 
2009–10 were in public hospitals (excluding public psychiatric hospitals), while 48% were in 
private hospitals. 
Specialised rehabilitation units 
More detailed information on specific rehabilitation outcomes for stroke patients is collected 
by the Australasian Rehabilitation Outcomes Centre (AROC). 
By 2012, the majority of public (101) and private rehabilitation units (83) in Australia had 
joined AROC (Table 3.9). These rehabilitation centres can be attached to a stroke unit and a 
hospital or independent from a hospital. They provide rehabilitation services not only for 
patients with stroke but also to a wide range of patients that may require their services.  
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Table 3.9: Australasian rehabilitation outcomes centres by state and status, 2012 
State  Public Private Total 
ACT/NSW 48 38 86 
Vic 26 22 48 
SA 5 3 8 
WA 1 2 3 
Tas 3 2 5 
NT 2 1 3 
QLD 16 15 31 
Australia 101 83 184 
Source: AROC 2011b. 
In 2010, there were 6,088 stroke rehabilitation discharge episodes from subacute and non-
acute inpatient rehabilitation programs provided by members of the AROC (AROC 2011a). 
Most of the rehabilitation episodes for stroke were managed by public centres (72%). Most 
patients (85%) were later discharged to the community, with the remaining 15% staying in 
the hospital system. Among those discharged to the community, the majority went back to 
live in their private residence with support. Stroke rehabilitation episodes lasted an average 
of 30 days. Just over half (54%) of patients admitted to rehabilitation for stroke were males.  
The number of rehabilitation episodes for stroke increased substantially between 2000 and 
2010 (from 2,314 to 6,088), possibly because of an increase the number of rehabilitation 
centres that were members of AROC.  
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4 Stroke treatment in the community  
Key findings  
• In 2007–08, cerebrovascular problems were managed in general practice at the rate of 
0.5 per 100 encounters.  
• Between 1998–99 and 2007–08, prescription rates have increased significantly in 
general practice for the management of cerebrovascular problems. 
• Between 1995 and 2009, the supply of many medicines commonly used to prevent or 
manage stroke has also increased significantly. 
The management of stroke in general practice 
There is only limited information available on the management of stroke/cerebrovascular 
diseases in Australian general practice. This section presents information based on results 
from the BEACH study (Box 4.1). The latest published data available on the management of 
stroke from the BEACH study are for 2007–08, covering the management of cerebrovascular 
diseases including stroke.  
Box 4.1 The BEACH study of general practice 
The Bettering the Evaluation and Care of Health (BEACH) study is conducted by 
Family Medicine Research Centre at the University of Sydney (in collaboration with the 
AIHW until June 2011) (AIHW 2012a). BEACH began in April 1998 and each year 1,000 
general practitioners participate from a random sample of general practitioners (GPs) 
who claimed at least 375 general practice Medicare items of service in the previous 
3 months. These GPs provide details of about 100,000 GP-patient encounters. Each 
participating GP completes details for 100 consecutive patient encounters on structured 
paper encounter forms, and record their patients’ diagnosis or a description of the 
problem managed, as well as the reasons given by the patient for the visit. No 
information identifying patients is collected. The GPs also provide information about 
themselves and their practice. 
The classification system for health conditions on the BEACH data set is described in 
Appendix B. 
Management rates 
The data presented here are for cerebrovascular problems managed in general practice. 
Cerebrovascular problems include stroke, TIA and other cerebrovascular disease (Britt & 
Miller 2009).  
In 2007–08, the management rate of cerebrovascular problems in general practice was fairly 
low, with a rate of 0.5 per 100 encounters, of which stroke was managed at a rate of 0.2 per 
100 encounters (Table 4.1). This equates to an estimated 514,650 general practice encounters 
for cerebrovascular problems in 2007–08, of which it is estimated that 240,900 encounters 
were for stroke (for method, see Appendix C). In comparison, cardiovascular disease overall 
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was managed at a rate of 17.6 per 100 encounters. The management rate for cerebrovascular 
problems has remained stable since 1998–99 (Britt & Miller 2009). 
Of all cerebrovascular problems managed in 2007–08, stroke/cerebrovascular accident was 
the most common (48%), followed by TIA (33%) (Table 4.1). There was no difference between 
males and females in the management rate of cerebrovascular problems, but a higher 
management rate was found among patients aged 65 and over compared with younger 
patients (Table 4.2). Between 1998–99 and 2007–08, the management rate for cerebrovascular 
problems increased slightly for females but was steady for males (Table 4.2). There were no 
significant changes over time in age-specific management rates for cerebrovascular disease. 
Table 4.1: Types of cerebrovascular problems managed in general practice in 2007–08 
 
Rate per 100 
encounters 
(n=95,898) 95% CI 
Change 
between 
1998–99 
and  
2007–08 
Percentage 
of all 
problems 
(n = 
145,078) 
Change 
between 
1998–99 
and  
2007–08 
Percentage of 
cerebrovascular 
problems 
(n =4 49) 
Change 
between 
1998–99 
and 
2007–08 
All 
cerebrovascular 
problems 0.47 0.41–0.53 steady 0.3 steady 100.0 steady 
Stroke/ 
cerebrovascular 
accident 0.22 0.18–0.26 steady 0.2 steady 47.7 ↑ 
Transient 
cerebral 
ischaemia 0.15 0.12–0.18 steady 0.1 steady 32.6 steady 
Other 
cerebrovascular 
disease 0.09 0.07–0.12 steady 0.1 steady 19.7 ↓ 
Source: Britt & Miller 2009. 
Table 4.2: Management rate of cerebrovascular problems in  
general practice in 2007–08 
 
Rate per 100 
encounters 95% CI 
Change between 1998–99  
and 2007–08 
All patients    
Males 0.5 0.4–0.6 steady  
Females 0.5 0.4–0.6 ↑ 
Age-groups    
<25 – –  
25–44 0.1 0.0–0.1 steady 
45–64 0.3 0.2–0.4 steady 
65–74 1.0 0.7–1.2 steady 
75+ 1.7 1.4–1.9 steady 
Source: Britt & Miller 2009. 
Treatment and pathology rates 
Between 1998–99 and 2007–08, the prescription rate has increased by 34% (from 50 to 67 per 
100 cerebrovascular problems managed) (Britt & Miller 2009). This increase was largely 
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driven by the increase in the medication rate for platelet aggregation inhibitors (excluding 
heparin) over this period. 
In 2007–08, platelet aggregation inhibitors—a type of antithrombotic medicines—were the 
most commonly prescribed medicines for cerebrovascular problems at a rate of 23 per 100 
cerebrovascular problems managed (Table 4.3). In 2007–08, clinical treatments, such as 
counselling and advice, were used in the treatment of 16 per 100 cerebrovascular problems. 
The international normalised ratio (INR) blood test—a test of blood clotting for patients on 
warfarin—was used in 1.4 per 100 cerebrovascular problems managed in 2007–08 (Table 4.3) 
(Britt & Miller 2009). 
Table 4.3: Medication, other treatments and pathology rates (per 100 cerebrovascular problems) in 
general practice in 2007–08 
 
Rate per 100 
cerebrovascular 
problems 95% CI 
Change between 
1998–99 and  
2007–08 
All medications 67.1 58.5–75.8 ↑↑ 
Prescribed medications 63.3 54.5–72.0 ↑↑ 
Platelet aggregation inhibitors (excl. heparin) 22.7 18.2–27.3 ↑↑ 
HMG CoA reductase inhibitors 5.1 2.7–7.5 ↑↑ 
Phenothiazines with piperazine structure 1.3 0.3–2.4 ↑↑ 
Other treatments 20.4 16.3–24.5 steady 
Clinical treatments 16.4 12.6–20.1 steady 
Procedures 4.0 2.1–6.0 steady 
INR test 1.4 0.1–2.6 ↑↑ 
Source: Britt & Miller 2009. 
Comorbidity management rates 
In 2007–08, the most common problems associated with the management of cerebrovascular 
problems were hypertension (19 per 100 cerebrovascular problems managed), followed by 
diabetes (7 per 100 cerebrovascular problems managed) and lipid disorders (5 per 100 
cerebrovascular problems managed) (Table 4.4). The same pattern was observed in 1998–99.  
Table 4.4: Other problems management rate (per 100 cerebrovascular  
problems) in general practice in 2007–08 
 
Rate per 100  
cerebrovascular 
problems 95% CI 
Change between 1998  
and 2007–08 
Hypertension 18.8 14.5–23.1 steady 
Diabetes 6.7 3.8–9.3 steady 
Lipid disorders 5.2 3.0–7.5 steady 
Source: Britt & Miller 2009. 
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Referrals, pathology and imaging  
Over the period April 1998 to March 2004, GPs referred 14% of patients with cerebrovascular 
problems to other health professionals and services (AIHW: Senes 2006). Of these referrals, 
4% were to hospital, 4% to rehabilitation, 4% to specialists and 1% to other services such as 
aged-care assessment, home support service and nursing homes.  
Over the same 5-year period, pathology tests were ordered for 12% of cerebrovascular 
encounters. Coagulation tests to monitor the effect of anticoagulation drugs were the most 
common (4%). Other tests included full blood count (2%) and lipids (1%). 
Between April 1998 and March 2004, imaging was requested for 7% of cerebrovascular 
problems. The most frequent investigations were CT scan of the brain (2%), CT scan of the 
head (1%), chest X-ray (1%) and Carotid Doppler (1%).  
Although these referral, pathology and imaging data for cerebrovascular problems managed 
by GPs are relatively old, there have been no changes in the rates of referrals to specialists or 
allied health services, or in ordering rates of pathology or imaging since 2000–01 (Britt & 
Miller 2009). 
Supply of stroke medications in the community 
This section examines the current supply of stroke-related medicines in the community and 
the number of prescriptions based on data for government-subsidised and non-subsidised 
prescription medicines listed on the Pharmaceutical Benefits Scheme and Repatriation 
Pharmaceutical Scheme (PBS/RPBS). Note that the use of prescription medicines dispensed 
to admitted patients in public hospitals are not included (DoHA 2011).  
Non-subsidised medicines listed on the PBS/RPBS are those for which the cost is below the 
patient contribution, capped at $32.90 for general patients and $5.30 for pensioner and 
concessional patients in 2009. Estimates of non-subsidised PBS/RPBS medicines are 
calculated from the Pharmacy Guild Survey. For further information see Appendix C.  
Note that estimates in this section refer to medicine supply rather than use. The reason is that 
patients may not fill all prescriptions (and therefore will not be included in these data) or use 
all the medicines dispensed. In addition, there are some medicines not included on the 
PBS/RPBS and so these will also not be included here. Note that some of the medicines 
reported here may be used for a range of different conditions other than stroke, such as 
medicines commonly used to manage other cardiovascular conditions or their associated risk 
factors such as high blood pressure and high blood cholesterol.  
Medicine supply is expressed as ‘defined daily dose per 1,000 population per day 
(DDD/1,000/day)’. This measure is based on an assumed average dose per day of a 
medicine used for its main indication (the main reason for which the medicine was 
prescribed) in adults. The DDD allows comparisons between medicines to be made 
independently of differences in price, preparation and quantity per prescription. However, 
the DDD is only a technical unit of use and does not necessarily reflect the recommended or 
average prescribed dose in Australia (DoHA 2011). 
The main group of medicines related to the prevention or treatment of stroke are 
antithrombotic, blood-pressure lowering and lipid-modifying medicines. 
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Antithrombotic medicines  
Antithrombotic medicines act by preventing the formation of blood clots or by dissolving 
existing blood clots. These medicines are usually taken over a long period to reduce the risk 
of subsequent strokes and disability among patients with a history of ischaemic stroke, and 
to reduce the risk of heart attack and death among people with coronary heart disease 
(AIHW 2010a). Medicines in this class include antiplatelet agents, such as aspirin, and 
anticoagulants, such as warfarin. This class also includes thrombolytic drugs, which act by 
dissolving blood clots. They are given to patients suffering a heart attack or ischaemic stroke. 
However, thrombolytics are powerful drugs that are always given in hospital or by 
paramedics, and so do not appear in the Pharmaceutical Benefits Scheme database. 
Number of prescriptions  
In 2009, 8.4 million prescriptions for antithrombotic medicines were supplied to the 
Australian population. The most commonly prescribed antithrombotic medicines were 
platelet aggregation inhibitors (58%), which included aspirin (16%), followed by vitamin K 
antagonists (37%) and heparin (5%) (Table D4.1).  
Between 2001 and 2009, there was a 110% increase in the number of prescriptions for 
antithrombotic medicines from 4.0 million to 8.4 million. The number of prescriptions for 
heparin in 2009 was 3.5 times as high as that in 2001 (385,000 compared with 111,000); the 
number of prescriptions for platelet aggregation inhibitors in 2009 was 2.5 as high as in 2001 
(4.9 million compared with 2.0 million); aspirin prescriptions in 2009 were 1.5 times as high 
as in 2001 (1.4 million compared with 900,000); and vitamin K antagonists prescriptions in 
2009 were 1.6 times as high as in 2001 (3.1 million compared with 1.9 million) (Table D4.1). 
Daily defined dose per 1,000 per day 
In 2009, platelet aggregation inhibitors (excluding heparin) were prescribed at a rate of 
32 DDD/1,000/day, heparin was prescribed at a rate of 1.8 DDD/1,000/day and vitamin K 
antagonists were prescribed at a rate of 6.2 DDD/1,000/day.  
Between 1995 and 2009, the supply of antithrombotic medicines in the community increased 
substantially. This rise was mainly due to the increase in the prescription rate of platelet 
aggregation inhibitors (excluding heparin) from 0.6 DDD/1,000/day to 32 DDD/1,000/day 
over the 15-year period (Figure 4.1). This was consistent with the substantial increase in the 
prescription rate of platelet aggregation inhibitors (excluding heparin) in general practice 
between 1998–99 and 2007–08, as described above. The prescription rate for vitamin K 
antagonists also increased between 1995 and 2009, from 2.7 DDD/1,000/day to 6.2 
DDD/1,000/day, as did that of heparin, from 0.1 DDD/1,000/day to 1.8 DDD/1,000/day. 
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Note: Combination medications are excluded. 
Sources: AIHW: Senes & Penm 2007 based on data from the Drug Utilisation Sub-Committee Database, DoHA; DoHA 2007; DoHA 2008;  
DoHA 2009a; DoHA 2009b and DoHA 2011. 
Figure 4.1 Trends in the supply of antithrombotic medicines to the community, 1995 to 2009 
Blood-pressure-lowering medicines 
Blood-pressure lowering medicines, or antihypertensives, are used to treat high blood 
pressure and have been shown to significantly reduce the number of deaths from stroke and 
heart attacks. The main types of blood-pressure lowering medicines are (AIHW 2010a): 
• diuretics, which increase the rate of urination, leading to a reduction in blood volume  
• beta-blockers, which reduce the heart’s activity by suppressing certain signals to it that 
cause it to beat faster and harder 
• calcium-channel blockers, which, depending on the type of channel blocker, act on 
particular ion channels in different parts of the heart and circulation, having the effect of 
reducing the force of contraction of the heart, reducing both blood pressure and the 
effects of angina 
• renin-angiotensin system agents, which are used to reduce blood pressure by blocking 
the effects of the renin-angiotensin system: a hormone system of the body that regulates 
blood pressure. 
Number of prescriptions  
In 2009, 52.2 million prescriptions for blood-pressure lowering medicines were supplied to 
the Australian population, representing more than a half of all prescribed medicines (59%) 
commonly used for stroke. The most frequently prescribed blood-pressure lowering 
medicines were agents acting on the renin-angiotensin system (58%), followed by calcium 
channel blockers (19%) and beta-blocking agents (15%) (Table D4.1). 
Between 2001 and 2009, the number of prescriptions for blood-pressure lowering medicines 
increased by 45% from 36.0 million to 52.2 million prescriptions (Table D4.1). Over the 9-year 
period, the types of blood-pressure lowering medicines with the greatest increases in the 
number of prescriptions were agents acting on renin-angiotensin system (78% increase), 
beta-blocking agents (36% increase) and antihypertensives (27% increase). However, 
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prescription numbers for peripheral vasodilatators, vasoprotective agents and diuretics fell 
between 2001 and 2009 (Table D4.1). 
Daily defined dose per 1,000 per day 
It should be noted that the statistics presented below for blood-pressure lowering medicines 
exclude combination products. 
In 2009, prescription rates for the main blood-pressure lowering medicines were 139.1 
DDD/1000/day for agents acting on the renin-angiotensin system; 49.2 DDD/1000/day for 
calcium-channel blockers; 26.0 DDD/1000/day for beta-blockers; 27.4 DDD/1000/day for 
diuretics; and 5.7 DDD/1000/day for antihypertensives.  
Between 1995 and 2009, agents acting on the renin-angiotensin system were the most 
commonly prescribed blood-pressure lowering medications in the community, with their use 
increasing by 167% from 52.1 to 139.1 DDD/1000/day over the 14-year period (Figure 4.2). 
The use of calcium-channel blockers also increased by 22% over this period, as did the use of 
beta-blockers (a 21% increase). In contrast, over the 14-year period, the use of diuretics fell by 
36%, antihypertensives fell by 29% and peripheral vasodilators, which were dispensed 
infrequently, fell by 87%. 
 
Note: Combination medications are excluded. 
Sources: AIHW: Senes & Penm 2007 based on data from the Drug Utilisation Sub-Committee Database, DoHA; DoHA 2007; DoHA 2008;  
DoHA 2009a; DoHA 2009b and DoHA 2011. 
Figure 4.2 Trends in the supply of blood pressure lowering medicines to the community,  
1995–2009 
Lipid-modifying medicines  
Lipid-modifying medicines are used to control blood cholesterol level, which is an important 
risk factor for those with, or at risk of having, a stroke. Lipid-modifying medicines may act to 
reduce the levels of blood LDL cholesterol (low-density lipoprotein, the so-called ‘bad’ 
cholesterol) and/or to increase the levels of blood HDL cholesterol (high-density lipoprotein, 
the so-called ‘good’ cholesterol). They may also be used to reduce high levels of blood 
triglyceride, a fat that can be associated with the development of heart disease (AIHW 
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2010a). With respect to stroke, lipid–modifying medicines are used to treat lipid disorders to 
reduce risk of stroke in people with established cardiovascular disease, and to prevent 
cardiovascular disease and deaths in people at high risk of stroke due to the presence of 
multiple risk factors (AIHW: Senes & Penm 2007). 
Number of prescriptions 
Lipid-modifying medicines are commonly prescribed and, in 2009, there were 24.8 million 
prescriptions for them supplied to the Australian population, representing an increase of 
94% compared with the 12.8 million prescriptions in 2001 (Table D4.1). Statins were the most 
commonly prescribed lipid-modifying medicines in 2009, with 21.7 million prescriptions. 
Between 2001 and 2009, the number of prescriptions for statins increased by 76% from 12.3 
million to 21.7 million prescriptions.  
Daily defined dose per 1,000 per day 
In 2009, lipid-modifying medicines were prescribed at a rate of 142.5 DDD/1000/day.  
Between 1995 and 2004, there was a 12-fold increase in the use of statins from 13.5 to 160.4 
DDD/1000/day (Figure 4.3). The DDDs for some statins changed between 2006 and 2007, 
and the revised DDD/1,000/day are available from 2005. Between 2005 and 2009, the use of 
statins increased by 38% from 87 to 120 DDD/1000/day (Figure 4.3). There was little change 
in the use of fibrates, bile acid sequestrants or nicotinic acid between 1995 and 2009. 
However, the use of ezetimibe, which was listed on the Pharmaceutical Benefits Scheme in 
2003 (DoHA 2005), increased from 0.4 to 3.5 DDD/1,000/day between 2004 and 2009. 
 
Notes 
1.  Combination medications are excluded. 
2.  Other serum-lipid-reducing agents include nicotinic acid and ezetimibe. 
3.  There is a break in the time series for statins because the defined daily dose (DDD) for some statins changed between 2006 and 2007. 
However, DDD/1,000/day based on the new DDD are available from 2005 and therefore the break in the time series is shown here from 2005.  
Sources: AIHW: Senes & Penm 2007 based on data from the Drug Utilisation Sub-Committee Database, DoHA; DoHA 2007; DoHA 2008; DoHA 
2009a; DoHA 2009b and DoHA 2011. 
Figure 4.3 Trends in the supply of lipid-lowering agents to the community, 1995–2009 
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5 Managing the consequences of stroke  
Key findings  
• In 2009, around 285,300 stroke survivors also had a current disability.  
• In 2009–10, there were just over 27,000 hospitalisations for rehabilitation care 
associated with stroke or its sequelae. Over a third of these hospitalisations were for 
patients aged under 65. 
• In 2009–10, one in five Aged–care Assessment Program (ACAP) clients with a 
complete ACAT assessment (32,725 people) had a diagnosis of cerebrovascular disease 
or TIA. Compared with other ACAP clients, this group had higher levels of activity 
limitations, particularly communication and movement. 
• In 2009, nearly 75,000 co-resident primary carers provided assistance to people with 
stroke and disability in Australia. The majority of these carers were female (69%) and 
nearly two-thirds were aged 60 and over. More than half (58%) spent 40 hours or more 
per week in their caring role. 
Assistance for people with stroke-related disability 
In 2009, based on data from the ABS Survey of Disability, Ageing and Carers (SDAC), an 
estimated 285,312 people had had a stroke and also had a current disability. For almost half 
(46%) of these people, their disability was caused by stroke (an estimated 131,130 people). 
Of all stroke survivors with disability, 88% (250,600 people) lived in households, with the 
rest living in cared accommodation (i.e. hospitals, nursing homes, aged–care and disability 
hostels, and other homes). The SDAC collected information on assistance needed by people 
with disability who were living in households or cared accommodation, as well as 
information on assistance provided to this group who were living in households. However, 
information on assistance provided to those living in cared accommodation was not collected 
because it was assumed that all people living in cared accommodation receive the assistance 
they require. 
Living in households 
Among stroke survivors who were living in households and whose disability was caused by 
stroke, 64% needed assistance with health care, 58% with mobility and 47% with self-care 
(Table 5.1). At least three-quarters of these stroke survivors received assistance for each of 
the activities for which assistance was needed (Table 5.2). People with stroke-related 
disability who were living in households were more likely to need assistance with activities 
than other people with disability (Table 5.1).  
These results are consistent with national Aged–care Assessment Program (ACAP) data for 
people with cerebrovascular disease or TIA who were clients of ACAP and were assessed by 
Aged Care Assessment Teams (ACATs) over the period July 2009 to June 2010. ACATs 
determine eligibility for entry into Australian Government subsidised aged-care; for more 
details see the section ‘Living in cared accommodation’ below. In 2009–10, ACAP clients 
with cerebrovascular disease or TIA had higher levels of activity limitations than other 
ACAP clients for most activities, particularly communication, movement, moving around 
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places or away from home, self-care, health-care tasks, social and community participation, 
and transport (Table D5.1). 
Table 5.1: Assistance needed by people with disability who live in households, 2009 
 Stroke and disability 
resulting from stroke 
(n = 103,963) 
 Stroke and disability not 
resulting from stroke 
(n = 146,637) 
 Disability but no 
stroke  
(n = 3,529,305 ) 
Area of 
activity 
limitation(a) 
Estimated 
number(b) Per cent  
Estimated 
number(b) Per cent  
Estimated 
number(b) Per cent 
Mobility  60,275 58.0  52,181 35.6  742,235 21.0 
Self-care 48,443 46.6  28,399 19.4  469,567 13.3 
Communication 13,450 12.9  *4,279 2.9  193,746 5.5 
Health care 66,694 64.2  69,010 47.1  880,721 25.0 
Cognitive or 
emotional tasks 32,443 31.2  21,528 14.7  701,550 19.9 
Household 
chores 54,753 52.7  51,910 35.4  829,141 23.5 
Property 
maintenance 62,977 60.6  64,318 43.9  1,007,137 28.5 
Meal 
preparation 32,893 31.6  17,496 11.9  252,371 7.2 
Reading or 
writing 32,283 31.1  20,575 14.0  268,792 7.6 
Private transport 64,491 62.0   56,175 38.3   687,546 19.5 
(a) People may need help with more than one type of activity. 
(b) Estimates marked with an asterisk have an associated relative standard error (RSE) of between 25% (one asterisk) and 50%  
(two asterisks) and should be interpreted with caution. 
Source: AIHW analysis of ABS 2009 Survey of Disability, Ageing and Carers Confidentialised Unit Record File. 
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Table 5.2: Assistance received(a) by people with disability who live in households, 2009 
 Stroke and disability 
resulting from stroke 
 Stroke and disability not 
resulting from stroke 
 Disability but no stroke 
Area of activity 
limitation(b) 
Estimated 
number(c) Per cent(d)  
Estimated 
number(c) Per cent(d)  
Estimated 
number(c) Per cent(d) 
Mobility   48,803   81.0    46,191   88.5    652,047   87.8  
Self-care  41,230   85.1    27,696   97.5    440,504   93.8  
Communication  10,948   81.4    * 4,279   100.0    119,348   61.6  
Health care  52,338   78.5    57,127   82.8    736,975   83.7  
Cognitive or 
emotional tasks  24,242   74.7    15,145   70.3    407,383   58.1  
Household 
chores  41,244   75.3    41,411   79.8    711,874   85.9  
Property 
maintenance  51,484   81.8    49,432   76.9    867,741   86.2  
Meal 
preparation  30,970   94.2    15,925   91.0    236,418   93.7  
Reading or 
writing  31,297   96.9    20,575   100.0    258,069   96.0  
Private transport  55,606   86.2     50,914   90.6     636,808   92.6  
(a) Only people who needed assistance were asked about assistance received. 
(b) People may need help with more than one type of activity. 
(c) Estimates marked with an asterisk have an associated relative standard error (RSE) of between 25% (one asterisk) and 50% (two asterisks) 
 and should be interpreted with caution. 
(d) Percentages calculated as a proportion of those who need assistance with the activity. 
Source: AIHW analysis of ABS 2009 Survey of Disability, Ageing and Carers Confidentialised Unit Record File. 
Among stroke survivors who were living in households and whose disability was caused by 
stroke, 87% were receiving some type of assistance for core or non-core activities (Table 5.3). 
In contrast, 69% of those with stroke and disability not caused by stroke, and 53% of those 
with disability but no stroke, were receiving some type of assistance.  
Excluding those who did not need assistance, almost two-thirds (64%) of people with stroke-
related disability who were living in households received a combination of informal and 
formal care, 29% obtained informal help only and 6% received formal assistance only, while 
1% received no assistance.  
The most common type of assistance provided to people with stroke-related disability who 
were living in households was assistance from informal providers (93%), followed by 
assistance from private providers (53%) and government-organised help (40%) (Table 5.4). 
These stroke survivors were more likely to be receiving assistance from informal providers, 
government-organised providers and privately organised non-profit providers than stroke 
survivors with disability not caused by stroke and people with disability but no stroke.  
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Table 5.3: Type of assistance received for core and non-core activities(a) by people with disability 
who live in households, 2009 
 Stroke and 
disability resulting 
from stroke  
Stroke and disability not 
resulting from stroke  
Disability but no 
stroke 
Type of 
assistance 
received 
Estimated 
number(b) Per cent  
Estimated 
number(b) Per cent  
Estimated 
number(b) Per cent 
Not applicable(a) 12,832 12.3   34,677  23.6  1,506,698 42.7 
None **1,136 1.1   11,137  7.6  139,822 4.0 
Informal only 26,199 25.2   31,532  21.5  787,025 22.3 
Formal only *5,455 5.2   16,421  11.2  246,220 7.0 
Informal and 
formal 
58,340 56.1   52,870  36.1  849,539 24.1 
Total 103,963 100.0   146,637  100.0  3,529,305 100.0 
(a) People who do not need assistance with any core or non-core activity. 
(b) Estimates marked with an asterisk have an associated relative standard error (RSE) of between 25% (with one asterisk) and 50%  
(with two asterisks) and should be interpreted with caution. 
Source: AIHW analysis of ABS 2009 Survey of Disability, Ageing and Carers Basic Confidentialised Unit Record File on CD-ROM. 
Table 5.4: Assistance providers to people with disability who live in households and receive 
assistance(a), 2009 
 Stroke and disability 
resulting from stroke  
Stroke and disability not 
resulting from stroke  
Disability but no 
stroke 
Provider 
Estimated 
number 
Per 
cent(b)  
Estimated 
number Per cent(b)  
Estimated 
number Per cent(b) 
Government 
organised 36,432 40.5    36,250  36.0   524,642 27.9 
Privately 
organised and 
non-profit 13,934 15.5    11,392  11.3   165,450 8.8 
Privately 
organised for 
profit 33,653 37.4    43,090  42.7   695,987 37.0 
Informal 
provider 84,539 93.9    84,402  83.7   1,636,565 86.9 
(a) Recipients of care may receive assistance from more than one type of provider concurrently. 
(b) Percentage of those receiving assistance. 
Source: AIHW analysis of ABS 2009 Survey of Disability, Ageing and Carers Basic Confidentialised Unit Record File on CD-ROM. 
Living in cared accommodation 
In 2009, nearly all (99%) of the estimated 27,167 stroke survivors with stroke-related 
disability who were living in cared accommodation needed assistance with health care. 
Similarly, 98% needed assistance with self-care, 94% with mobility, 88% with cognitive or 
emotional tasks and 72% with oral communication (Table 5.5). Further, these stroke 
survivors were more likely to need assistance with these activities than those whose 
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disability was not caused by stroke. They were also more likely to need assistance with these 
activities than people who had disability but had not had a stroke (Table 5.5). 
Table 5.5: Assistance needed by people with disability who live in cared accommodation(a), 2009 
 Stroke and disability 
resulting from stroke 
(n = 27,167) 
 Stroke and disability not 
resulting from stroke  
(n = 7,546) 
 Disability but no 
stroke  
(n = 123,136) 
Area of 
activity 
limitation(b) 
Estimated 
number Per cent  
Estimated 
number Per cent  
Estimated 
number Per cent 
Mobility  25,634 94.4   6,369  84.4  104,797 85.1 
Self-care 26,586 97.9   6,778  89.8  113,454 92.1 
Communication 19,560 72.0   4,125  54.7  71,489 58.1 
Health care 26,984 99.3   7,305  96.8  119,989 97.4 
Cognitive or 
emotional tasks 23,955 88.2   6,275  83.2  102,841 83.5 
Reading or 
writing 22,423 82.5   5,686  75.4  95,216 77.3 
(a) Cared accommodation includes hospitals, homes for the aged such as nursing homes and aged-care hostels, cared components of 
retirement villages and other 'homes' such as children's homes. 
(b) People may need help with more than one type of activity. 
Source: AIHW analysis of ABS 2009 Survey of Disability, Ageing and Carers Basic Confidentialised Unit Record File on CD-ROM. 
Community services for stroke survivors 
For those who survive a stroke, the course of life may need to change significantly and 
assistance in aspects of daily living may be needed, depending on any impairment caused by 
the stroke. Government programs such as Home and Community Care (HACC), Community 
Aged Care Packages (CACP), Extended Aged Care at Home Packages (EACH) and Day 
Therapy Centres (DTC) are available mostly to enable frail people to remain in their own 
home and to prevent them from premature or inappropriate admission to residential care 
(Box 5.1). Additional assistance to veterans is available through Veterans Home Care, which 
is provided by the Australian Government Department of Veterans Affairs. Respite care is 
also available to support carers by providing a break from caring responsibilities. 
Aged-care assessments in the community 
Before people can access Australian Government-subsidised residential aged-care or aged-
care packages, they need to obtain approval for entry into that care from an Aged Care 
Assessment Team (ACAT). (Box 5.2). 
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Box 5.1 Main type of community care services 
Home and Community Care (HACC) 
A range of different service agencies may provide particular types of assistance such as 
personal care, domestic assistance, nursing care, social support, allied health care, respite 
care, centre-based day care, meals and other food services, home maintenance, home 
modification, transport, formal linen services, counselling/support, information and 
advocacy, assessment, case planning/review and coordination.  
Community Aged Care Packages (CACP)  
This program provides a coordinated package of care to care recipients with complex needs 
who are eligible for low-level residential care. Approval must be given by an ACAT before 
the Australian Government-subsidised coordinated package of care can be provided. 
Services provided as part of a package include personal care, social support, transport to 
appointments, home help, meal preparation and gardening. Services are coordinated 
through a care manager/coordinator.  
Extended Aged Care at Home (EACH) packages 
This is a coordinated package of care designed for care recipients who are eligible for high-
level residential aged–care. Approval must be given by an Aged Care Assessment Team 
before the Australian Government subsidised coordinated package of care can be provided. 
Services provided by an EACH package include those available to CACP care recipients 
plus nursing care and allied health care.  
Extended Aged Care at Home Dementia (EACHD) packages 
This is a coordinated package of care designed for care recipients who are eligible for high 
level residential aged-care. Approval must be given by an ACAT before the Australian 
Government-subsidised coordinated package of care can be provided. Services provided by 
an EACHD package include those available to EACH care recipients plus additional levels 
of service to meet the specific needs of care recipients who experience behaviours of 
concern and psychological symptoms associated with dementia. 
Day Therapy Centres (DTC) 
Day therapy centres provide a range of therapies, such as physiotherapy, speech therapy 
and occupational therapy, aimed at helping frail older people regain or retain the physical 
capacity needed to remain in their own homes or in low-level residential care.  
Respite care  
Respite care is designed to give a carer a break from their caring duties, and can be centre-
based day care, in-home respite care (funded through any of the previous programs or by 
the National Respite for Carers Program) or can be in the form of residential respite care for 
the care recipient.  
Source: AIHW 2012d. 
Although the target group for ACAP is frail older people, access to Australian Government-
subsidised aged–care is neither age limited nor means tested. People can self-refer for an 
assessment, or be referred by medical or health-care professionals. A complete ACAT 
assessment results in recommendations to the ACAT delegate for the client’s most 
appropriate types of care, including approval for Australian Government-subsidised 
residential and community aged-care services. Recommendations to use HACC or Veterans’ 
Home Care can also be made, but these programs each have their own assessment process, 
and an ACAT approval or referral is not required to access them (AIHW 2011d).  
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Box 5.2: ACAT assessments 
An assessment by an Aged Care Assessment Team (ACAT) assessor determines eligibility 
based on the care needs of individuals. The assessor makes recommendations to the ACAT 
delegate on the types of assistance and programs appropriate for the individual. The 
assessor also assesses the living environment considered most appropriate to the long-term 
care needs of the client (i.e. whether the recommended care setting is in the person’s home 
or in a residential care facility with either a low or high level of care).  
Where appropriate, an ACAT delegate approves the type of Australian Government-
subsidised aged-care from residential aged-care service, flexible care and community aged-
care packages such as CACP, EACH and EACHD. An individual may be approved to 
receive assistance from more than one type of aged-care program. The ACAT assessment 
also includes a decision about which of two levels of care is required for an individual. 
These two levels are low care and high care.  
What is low care? 
Types of care that may be required for low-care include:  
• bathing, eating and other personal care  
• communication  
• mobility  
• continence maintenance.  
What is high care? 
High-care can require more hours and a greater level of care compared with low-care. 
High-care includes those services provided for low care, with additional ones that may 
include:  
• nursing services  
• therapy services  
• basic pharmaceuticals and administration of medication.  
Source: AIHW 2011a. 
A complete ACAT assessment is defined as an assessment where the reason for ending the 
assessment was ‘Assessment complete—care plan developed’. Clients may have more than 
one complete assessment in the year but this analysis covers the last complete assessment for 
the client in that year. In 2009–10, there were 162,384 clients who had at least one complete 
assessment by an ACAT team in Australia. One in five of these clients had a diagnosis of a 
cerebrovascular disease or TIA (32,725). The age distribution of ACAP clients who had 
cerebrovascular disease or TIA was similar to that of other ACAP clients (Tables D5.2 and 
D5.3). However, proportionately more ACAP clients with cerebrovascular disease or TIA 
were males compared with other ACAP clients (45% compared with 36%).  
Among ACAP clients with a complete ACAT assessment, the first face-to-face contact setting 
was more likely to be a hospital setting for those diagnosed with a cerebrovascular disease or 
TIA, compared with other ACAP clients (42% compared with 33%) (Table D5.4). The 
majority of ACAP clients with a complete ACAT assessment were usually living 
independently in a private residence at the time of the assessment (81% of those diagnosed 
with a cerebrovascular disease or TIA, compared with 82% of the other ACAP clients) (Table 
D5.5). After the assessment, 47% of ACAP clients diagnosed with cerebrovascular disease or 
TIA were recommended to live in a private residence or independent living within a 
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retirement village, compared with 53% of other ACAP clients. A third of ACAP clients 
diagnosed with cerebrovascular disease or TIA were recommended to live in high-level 
residential aged–care compared with a quarter of the other ACAP clients (Table D5.5). It 
should be noted that the ACAP client may not want or agree to live in the residential setting 
recommended by the ACAT and it is not possible to tell from the ACAP data where a client 
ends up living.  
As previously discussed, ACAP clients with cerebrovascular disease or TIA have higher 
levels of activity limitations than other ACAP clients for most activities. In 2009–10, at the 
time of their complete assessment, 37% of ACAP clients with cerebrovascular disease or TIA 
were not receiving any type of assistance with activities, compared with 36% of other ACAP 
clients. After the assessment only one in 10 did not receive a recommendation for assistance 
(Table D5.6).  
At the time of assessment, clients diagnosed with cerebrovascular disease or TIA were 
receiving assistance with activities such as self-care, movement and communication at 
slightly higher rates than other clients (Figure 5.1, Table D5.6).  
After the assessment, formal assistance was recommended more commonly for clients with a 
diagnosis of cerebrovascular disease or TIA than other clients in most areas of assistance 
(Figure 5.1). However, it should be noted that ACAP clients may receive assistance from a 
number of different programs and it is not possible to tell from the ACAP data which 
programs, if any, provide assistance after the ACAP assessment.  
 
Source: DoHA Ageing and Aged–care Data Warehouse (unpublished). 
Figure 5.1: Type of care received by ACAP clients (by diagnosed cerebrovascular disease of TIA 
status) at the time of the ACAT assessment for 2009–10. 
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Aged-care appraisals among permanent aged-care residents 
The Aged Care Funding Instrument (ACFI) is a funding tool used to assess a resident’s 
dependency or need for care across three care domains: with activities of daily living, with 
behaviour and with complex health care. Payment of care subsidies to service providers is 
based on the resident’s ratings in each of these three domains. Residents are assessed as 
having either ‘nil’ (meaning they have minimal or no need for assistance in that area), ‘low’, 
‘medium’ or ‘high’ need for assistance in each of the three domains (Box 5.3).  
Box 5.3: The Aged Care Funding Instrument (ACFI)  
An assessment undertaken with the ACFI is called an appraisal. Each ACFI appraisal has 
information on:  
• up to three mental or behavioural diagnoses  
• up to three other medical diagnoses  
• five questions about the need for assistance with activities of daily living: nutrition, 
mobility, personal hygiene, toileting and continence  
• five questions on the need for assistance with the resident’s behaviour: cognitive skills, 
wandering, verbal behaviour, physical behaviour and depression  
• two questions on the need for assistance with the use of medication and complex 
health-care procedures.  
The resident’s need for assistance in relation to each question is given a rating of A, B, C, or 
D and corresponds to a score, the scores are then added up and used to categorise the needs 
as nil, low, medium or high within each of the three domains. Subsidy levels are based on 
the resident’s rating for each of the three funding/care domains (DoHA 2009c).  
The ACFI replaced the Resident Classification Scale (RCS) on 20 March 2008 and is used to 
assess new residents. Existing residents were reappraised using the ACFI on the 
anniversaries of their RCS appraisals. This transition process is now complete. 
Source: AIHW 2011e. 
In 2009–10, there were 213,634 permanent aged-care residents with an ACFI appraisal. Of 
these residents, one in five (42,747) had a diagnosis of cerebrovascular disease or TIA (Table 
D5.7). In general, the level of care required among residents diagnosed with a 
cerebrovascular disease was higher than for other residents, in particular for activities of 
daily living for which 56% of residents with a cerebrovascular disease needed a high level of 
care compared with 42% of other residents (Table D5.7). A high level of complex health care 
was needed for 26% of residents with cerebrovascular disease or TIA, compared with 23% of 
other residents (Table D5.7).  
Impact of stroke on primary carers 
This section presents information on co-resident primary carers of people with stroke drawn 
from the 2009 SDAC. The SDAC is the main source of national population data about carers, 
with information collected about carers and primary carers of care recipients living in the 
community. Although information on the number of both co-resident (i.e. living in the same 
household as the care recipient) and non-co-resident carers was collected in the 2009 SDAC, 
more detailed information was only collected about co-resident carers. Note that the SDAC 
data on the characteristics of carers reported here relate only to co-resident primary carers 
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(i.e. they lived with the care recipient with stroke), because the stroke status or any other 
condition status of people not living in the surveyed household could not be confirmed.  
In 2009, there were an estimated 74,965 co-resident primary carers (see Box 5.4) providing 
assistance to people with stroke and disability in Australia (Table 5.6). The majority of these 
primary carers were female (69%) and nearly two-thirds were aged 60 and over. Almost 
three-quarters of co-resident primary carers of people with stroke and disability were a 
spouse or partner and 21% were a son or daughter (Figure 5.2).  
Box 5.4: Primary carers in the ABS Survey of Disability, Ageing and Carers 2009 
Primary carer: A person who provides the most informal assistance, in terms of help or 
supervision, to a person with one or more disabilities or aged 60 and over. The assistance 
has to be ongoing, or likely to be ongoing, for at least 6 months and be provided for one or 
more of the core activities (communication, mobility and self-care). In the 2009 SDAC, 
primary carers only included persons aged 15 and over for whom a personal interview was 
conducted.  
Source: ABS 2011b. 
Table 5.6: Co-resident primary carers(a) of people with stroke and disability, by sex and age, 2009 
 Estimated number(b)  Per cent 
Age group 
(years) Males Females Persons 
 
Males Females Persons 
15–49  *4,336   9,154   13,490   18.8 17.6 18.0 
50–59  *4,410   9,596   14,006   19.2 18.5 18.7 
60–69  6,822   17,033   23,855   29.6 32.8 31.8 
70–79  *3,097   11,130   14,227   13.4 21.4 19.0 
80+  *4,363   *5,024   9,387   18.9 9.7 12.5 
15+(c)   23,028   51,937   74,965   100.0 100.0 100.0 
(a) Primary carers only include persons aged 15 and over for whom a personal interview was conducted. 
(b) Estimates marked with an asterisk have a relative standard error (RSE) of between 25% (one asterisk) and 50% (two asterisks) and should 
be interpreted with caution. 
(c) Components may not add to totals due to rounding 
Source: AIHW analysis of ABS 2009 Survey of Disability, Ageing and Carers Basic Confidentialised Unit Record File on CD-ROM. 
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(a) Primary carers only include persons aged 15 and over for whom a personal interview was conducted. 
Source: AIHW analysis of ABS 2009 Survey of Disability, Ageing and Carers Basic Confidentialised Unit Record File on CD-ROM. 
Figure 5.2: Relationship of co-resident primary carers(a) to people with stroke and disability, 2009 
Table 5.7: Weekly hours of care provided by co-resident primary carers to people with stroke and 
disability, 2009 
 Co-resident primary carers(a) of people with disability and stroke 
Hours per week Estimated number(b) Per cent 
Less than 20 hours  19,183  25.6 
20 to less than 40 hours  10,320  13.8 
40 hours or more  43,088  57.5 
Not stated *2,374  3.2 
Total co-resident primary carers 74,965 100.0 
(a) Primary carers only include persons aged 15 and over for whom a personal interview was conducted. 
(b) Estimates marked with an asterisk have a relative standard error (RSE) of between 25% (one asterisk) and 50% (two asterisks) and should 
be interpreted with caution. 
Source: AIHW analysis of ABS 2009 Survey of Disability, Ageing and Carers Basic Confidentialised Unit Record File on CD-ROM. 
More than half (58%) of co-resident primary carers of people with stroke and disability spent 
40 hours or more per week in their caring role (Table 5.7). Although 43% of co-resident 
primary carers reported that their income had not been affected by their caring role, 21% 
reported that their income had decreased because of their caring role and another 24% had 
extra expenses. Almost a third (31%) of co-resident primary carers said that they had 
difficulty meeting everyday living costs (Table 5.8). 
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Table 5.8: Effect of caring role on co-resident primary carer’s income, living costs and work, 2009 
 Co-resident primary carers(a) of people with 
disability and stroke 
 Estimated number(b) Per cent 
Effect on financial situation   
Income not affected  32,492  43.3 
Income has increased * 2,803  3.7 
Income has decreased  15,830  21.1 
Has extra expenses  17,782  23.7 
Not stated  *6,057  8.1 
Whether has difficulty meeting everyday costs as a result of caring role   
Not applicable (income not affected or increased)  35,295  47.1 
Has difficulty meeting everyday living costs  23,239  31.0 
Does not have difficulty meeting everyday living costs  10,954  14.6 
Not stated  *5,477  7.3 
Effect on weekly hours worked since commencing caring role   
Not applicable (unemployed or not in the labour force)  58,635  78.2 
Weekly hours worked are unchanged  10,885  14.5 
Weekly hours worked are changed  5,445  7.3 
Total co-resident primary carers 74,965 100.0 
(a) Primary carers only include persons aged 15 and over for whom a personal interview was conducted. 
(b) Estimates marked with an asterisk have a relative standard error (RSE) of between 25% (one asterisk) and 50% (two asterisks) and should 
be interpreted with caution. 
Source: AIHW analysis of ABS 2009 Survey of Disability, Ageing and Carers Basic Confidentialised Unit Record File on CD-ROM. 
Just over three-quarters of co-resident primary carers were not employed, but, among those 
who were employed, the majority were able to undertake their carer responsibilities without 
changing the hours they worked (Table 5.8). 
The physical and psychological demands of the caring role can lead to adverse effects on the 
physical health and emotional wellbeing of carers, their personal relationships and 
participation in social activities (AIHW 2004; Edwards et al. 2008). In 2009, 35% of co-
resident primary carers of people with stroke and disability reported that their physical and 
emotional wellbeing had changed due to their caring role (Table D5.8). Despite this, 71% of 
co-resident primary carers reported not feeling satisfied due to their caring role, and around 
a third reported feeling weary or lacking energy and frequently feeling worried or 
depressed. In the majority of cases, caring for a person with stroke and disability did not 
affect the personal relationships of carers; nevertheless, 27% of carers reported that they had 
lost, or were losing, contact with their existing friends (Table D5.9). 
Government programs, such as respite care, are available to help reduce the load on carers 
(AIHW 2012d). In 2009, the majority (82%) of co-resident primary carers of people with 
stroke and disability had never used respite care and most of them (69%) did not want it 
(Table 5.9). However, 13% of carers reported that they needed respite care but were not 
receiving it. 
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Table 5.9: Need for and use of respite care by co-resident primary carers of people with stroke  
and disability, 2009 
 Co-resident primary carers(a) of 
people with stroke and disability 
  Estimated number(b) Per cent 
Received respite care in last 3 months and does not need further care  4,717  6.3 
Received respite care in last 3 months but needs further care  **1,930  2.6 
Did not receive respite care in last 3 months and does not need further 
care 
 *3,963  5.3 
Did not receive respite care in last 3 months but needs further care  *2,625  3.5 
Has never received respite care and does not need or want further care  51,909  69.2 
Has never received respite care but needs further care  *9,823  13.1 
Total co-resident primary carers  74,965  100.0 
(a) Primary carers only include persons aged 15 and over for whom a personal interview was conducted. 
(b) Estimates marked with an asterisk have a relative standard error (RSE) of between 25% (one asterisk) and 50% (two asterisks) and should 
be interpreted with caution. 
Source: AIHW analysis of ABS 2009 Survey of Disability, Ageing and Carers Basic Confidentialised Unit Record File on CD-ROM. 
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6 Social and geographical inequalities 
for stroke  
Key findings  
• Stroke has a significant impact on Aboriginal and Torres Strait Islander people. In 
2004–05, the estimated prevalence in this group was 1.7 times as high as that of non-
Indigenous Australians. In 2009–10, the hospitalisation rate for stroke for Indigenous 
Australians was twice as high as that of other Australians, and in 2009 the stroke death 
rate 1.6 times as high as that of non-Indigenous Australians. 
• In 2009–10, the age-adjusted stroke hospitalisation rate for people living in Remote and 
very remote areas was 1.4 times as high as that of people living in Major cities. 
• Inequalities in the impact of stroke also exist by socioeconomic status. Compared with 
people from the highest socioeconomic group, those from the lowest socioeconomic 
group had: a prevalence of stroke that was 1.8 times as high in 2007–08; a stroke 
hospitalisation rate 1.3 times as high in 2009–10; and a stroke death rate 1.2 times as 
high in 2007. 
 
This chapter examines available information on health inequalities for stroke by Indigenous 
status, remoteness and socioeconomic groups. 
Aboriginal and Torres Strait Islander people 
Prevalence 
According to self-reported data from the 2004–05 National Aboriginal and Torres Strait 
Islander Health Survey (NATSIHS), an estimated 1,400 Aboriginal and Torres Strait Islander 
people (0.3% of the population) had experienced cerebrovascular disease (of which it is 
expected stroke would be the most common condition) (Table 6.1). There was no difference 
in the age-adjusted prevalence of cerebrovascular disease between Aboriginal and Torres 
Strait Islander males and females (AIHW: Penm 2008). After adjusting for differences in the 
age structure of the Indigenous and non-Indigenous populations, the prevalence of 
cerebrovascular disease among Aboriginal and Torres Strait Islander people was 1.7 times as 
high as that for non-Indigenous Australians (Table 6.1). 
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Table 6.1: Prevalence(a) of cerebrovascular disease in Aboriginal and Torres Strait Islander people, 
by sex, 2004–05 
Sex Number(b) Per cent(b) 
Standardised prevalence 
ratio(c) 
Males *700 *0.3 *ⱡ1.5(d) 
Females 700 0.3 1.9 
Persons 1,400 0.3 1.7 
(a) Based on self-reported data. 
(b) Estimate with an asterisk has a relative standard error of 25–50% and should be interpreted with caution. 
(c)  The standardised prevalence ratio is the ratio of the observed number of cases to the number of expected cases if Indigenous Australians 
had experienced the same age-sex specific prevalence rates as non-Indigenous Australians. 
(d) Estimate with ⱡ shows that the standardised prevalence ratio is not significantly different from 1.0. That is, the rate for Aboriginal and Torres 
Strait Islander males is not significantly different from that for non-Indigenous males. 
Sources: AIHW: Penm 2008; AIHW analysis of the ABS 2004–05 NATSIHS CURF. 
Hospitalisations 
Comparisons of hospitalisation rates for stroke between Aboriginal and Torres Strait Islander 
people and other Australians are based on hospital data from New South Wales, Victoria, 
Queensland, Western Australia, South Australia and public hospitals in the Northern 
Territory where the quality of Indigenous identification is considered to be adequate. For 
further information refer to ‘Reporting Indigenous data’ in Appendix A. 
In 2009–10, the age-adjusted stroke hospitalisation rate in Aboriginal and Torres Strait 
Islanders people was about twice as high as that of other Australians (284 per 100,000 
population compared with 147 per 100,000) (Table D6.1). At all ages, hospitalisation rates for 
stroke in Aboriginal and Torres Strait Islander people were higher than those of the other 
Australians, particularly between the ages of 35 and 64 where rates were 3 to 4 times as high 
(Figure 6.1; Table D6.1).  
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Notes 
1.  Age-standardised to the Australian population as at 30 June 2001.  
2.  Hospitalisations from New South Wales, Victoria, Queensland, Western Australia, South Australia and Northern Territory  
(public hospitals only). 
Source: AIHW analysis of the National Hospital Morbidity Database. 
Figure 6.1: Stroke hospitalisation rates, by Indigenous status and age, 2009–10 
In 2009–10, ischaemic stroke was the most common type of stroke for both Aboriginal and 
Torres Strait Islanders people and other Australians but the age-adjusted ischaemic stroke 
rate for Indigenous people was 1.7 times as high as that for other Australians (122 
hospitalisations per 100,000 population compared with 71 per 100,000) (Table D6.1). The age-
adjusted rate of haemorrhagic stroke for Indigenous people was also 1.7 times as high as that 
for other Australians (72 hospitalisations per 100,000 population compared with 43 per 
100,000). At all ages, hospitalisation rates for both ischaemic and haemorrhagic stroke were 
higher in Indigenous people than other Australians (Figure 6.2).  
It is possible to examine trends in hospitalisations for stroke by Indigenous status over the 
period 2004–05 to 2009–10 based on hospital data from New South Wales, Victoria, 
Queensland, Western Australia, South Australia and public hospitals in the Northern 
Territory. Over this period, the age-adjusted rate of stroke hospitalisations among 
Indigenous women fell by 7% while for Indigenous men it rose by 10%. Among Other 
Australians, the rates for men and women fell by 8% and 7%, respectively.  
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Notes  
1.  Age-standardised to the Australian population as at 30 June 2001.  
2.  Hospitalisations from New South Wales, Victoria, Queensland, Western Australia, South Australia and the Northern Territory  
(public hospitals only). 
Source: AIHW analysis of the National Hospital Morbidity Database. 
Figure 6.2: Ischaemic and haemorrhagic stroke hospitalisation rates, by Indigenous status and age, 
2009–10 
Deaths 
Indigenous identification in deaths data is considered of sufficient quality for national 
reporting for New South Wales, Queensland, Western Australia, South Australia and the 
Northern Territory only. For further information refer to ‘Reporting Indigenous data’ in 
Appendix A. 
Over the period 2006–2010, in the jurisdictions for which the Indigenous identification is 
considered to be sufficiently reliable for national reporting, the age-adjusted rate of deaths 
with an underlying cause of stroke among Indigenous people (56.2 per 100,000 population) 
was 1.5 times as high as that for non-Indigenous Australians (37.1 per 100,000 population) 
(Table D6.2). Indigenous males had a stroke death rate that was 1.7 times as high as that for 
non-Indigenous males, while the stroke death rate among Indigenous females was 1.4 times 
as high as that for non-Indigenous females (Figure 6.3). 
Stroke death rates were higher among Indigenous people than non-Indigenous Australians 
across all age groups, with Indigenous people aged 35–44 and 45–54 having rates that were 5 
times as high as non-Indigenous Australians of the same age (Figure 6.4; Table D6.3). 
It is not possible to examine trends in stroke deaths by Indigenous status due to changes in 
the coding of Indigenous status and the quality of Indigenous identification by state and 
territory on the National Mortality Database over time. 
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Notes 
1. Age-standardised to the Australian population as at 30 June 2001. 
2. Data from New South Wales, Queensland, Western Australia, South Australia and the Northern Territory only. 
3. Queensland deaths data for 2010 have been adjusted to minimise the impact of late registration of deaths on mortality indicators by 
excluding deaths registered in Queensland in 2010 that occurred in Queensland before 2007. 
Source: AIHW analysis of the AIHW National Mortality Database. 
Figure 6.3: Stroke death rates, by Indigenous status and sex, 2006–2010 
 
 
Notes 
1. Age-standardised to the Australian population as at 30 June 2001. 
2. Data from New South Wales, Queensland, Western Australia, South Australia and the Northern Territory only. 
3. Queensland deaths data for 2010 have been adjusted to minimise the impact of late registration of deaths on mortality indicators by 
excluding deaths registered in Queensland in 2010 that occurred in Queensland before 2007 
Source: AIHW analysis of the AIHW National Mortality Database. 
Figure 6.4: Stroke death rates, by Indigenous status and age, 2006–2010 
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Remoteness 
Prevalence 
In 2009, the prevalence of stroke was similar across remoteness areas for both males and 
females (Figure 6.5). Although the prevalence of stroke was higher in males than females in 
all remoteness areas, the difference was only statistically significant for Major cities (2.0% 
compared with 1.3%) (Table D6.4). 
 
Source: AIHW analysis of ABS 2009 Survey of Disability, Ageing and Carers Confidentialised Unit Record File. 
Figure 6.5: Stroke prevalence, by remoteness and sex, 2009 
Hospitalisations 
In 2009–10, the age-adjusted stroke hospitalisation rate for people living in Remote and very 
remote areas (212 hospitalisations per 100,000 population) was 1.5 times as high that of people 
living in Major cities (139 per 100,000) (Table D6. 5). Similar patterns were observed for males 
and females (Figure 6.6). A similar pattern was found for haemorrhagic stroke, with a higher 
age-adjusted hospitalisation rate in Remote and very remote areas (51 hospitalisations per 
100,000 population) than in Major cities (41 per 100,000) (Table D6.5). This inequality in the 
hospitalisation rate of haemorrhagic stroke by remoteness was particularly striking for 
males, for whom the age-adjusted rate in Remote and very remote areas was 1.3 times as high 
as that in Major cities (61 haemorrhagic stroke hospitalisations per 100,000 population 
compared with 48 per 100,000) (Figure 6.7). However, for ischaemic stroke, age-adjusted 
hospitalisation rates were higher for people living in Major cities than people living in Remote 
and very remote areas (Figure 6.7).  
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Note: Age-standardised to the Australian population as at 30 June 2001. 
Source: AIHW analysis of the National Hospital Morbidity Database. 
Figure 6.6: Stroke hospitalisation rates, by remoteness of patient’s usual residence and sex, 2009–10 
 
 
Note: Age-standardised to the Australian population as at 30 June 2001. 
Source: AIHW analysis of the National Hospital Morbidity Database. 
Figure 6.7: Hospitalisation rate for main types of stroke by remoteness in 2009–10 
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Deaths 
In 2006–2010, the age-adjusted stroke death rate was 34 per 100,000 population for people 
living Major cities compared with rates of 37 to 38 per 100,000 for people living in Inner 
regional, Outer regional and Remote and very remote areas (Table D6.6). A similar pattern was 
observed for both males and females (Figure 6.8).  
 
Note: Age-standardised to the Australian population as at 30 June 2001. 
Source: AIHW analysis of the AIHW National Mortality Database. 
Figure 6.8: Stroke death rates, by remoteness and sex, 2006–2010 
Socioeconomic status 
Prevalence 
The ABS 2009 SDAC database does not include a variable for socioeconomic group that is 
derived from the Socio-Economic Indexes for Areas (SEIFA) index (see Appendix A for more 
information about the SEIFA index). Therefore data from the ABS 2007–08 National Health 
Survey (NHS) have been included here to provide information about stroke prevalence by 
socioeconomic group. It should be noted that the 2007–08 NHS only collected information 
from people living in private dwellings and not from those living in cared accommodation, 
and this could affect results by socioeconomic status. 
In 2007–08, people in the lowest socioeconomic group had a prevalence of stroke that was 1.8 
times as high as those in the highest socioeconomic group (1.7% compared with 0.9%). For 
females, the prevalence rate of stroke increased with decreasing socioeconomic position 
(Figure 6.9, Table D6.7). However for males, although those in the lowest socioeconomic 
group had the highest stroke prevalence (1.8%), those in the middle-ranked group had a 
lower prevalence rate of stroke (0.5%) than those in the highest socioeconomic group (0. 9%) 
(Figure 6.9). 
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Note: Age-standardised to the Australian population as at 30 June 2001. 
Source: AIHW 2011c. 
Figure 6.9: Stroke prevalence, by socioeconomic group and sex, 2007–08 
Hospitalisations  
In 2007–08, the age-adjusted hospitalisation rate for stroke declined with increasing 
socioeconomic status for both males and females (Figure 6.10). The age-adjusted stroke 
hospitalisation rate for people in the lowest socioeconomic group was 1.3 times as high as 
that of those in the highest socioeconomic group (173 stroke hospitalisations per 100,000 
population compared with 130 per 100,000) (Table D6.8).  
Deaths 
In 2007, for both males and females, there was an inverse relationship between the age-
adjusted stroke death rate and socioeconomic status, with rates highest for those in lowest 
socioeconomic group and lowest for those in the highest socioeconomic group (Figure 6.11, 
Table D.6.9). There was little difference in the age-adjusted rates between males and females 
in any socioeconomic group (Table D6.9). 
There is evidence that socioeconomic inequality is increasing over time for stroke mortality 
in Australia. Although stroke death rates declined for both males and females in all 
socioeconomic groups between 1979–1983 and 2004–2006, it declined at a slower rate in the 
lowest socioeconomic group (compared with the highest socioeconomic group (Page et al. 
2011).  
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Note: Age-standardised to the Australian population as at 30 June 2001. 
Source: AIHW analysis of the National Hospital Morbidity Database. 
Figure 6.10: Hospitalisation rate for stroke by socioeconomic group, 2007–08 
 
 
Note: Age-standardised to the Australian population as at 30 June 2001  
Source: AIHW analysis of the AIHW National Mortality Database. 
Figure 6.11: Stroke death rates, by socioeconomic group and sex, 2007 
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7 Discussion  
Stroke poses a significant burden on patients and their families, as well as on the health 
system and aged-care services. It is associated with serious outcomes for patients and their 
carers. Stroke caused around 8,300 deaths in Australia in 2010, accounting for 23 deaths each 
day and 6% of all deaths in that year. One in seven stroke hospitalisations ended in death. In 
2009, there were an estimated 375,800 survivors of stroke, and one in every three survivors 
had a disability caused by stroke. 
Overall, in 2009–10, there were over 35,300 hospitalisations with a principal diagnosis of 
stroke and 25,800 hospitalisations for rehabilitation care associated with stroke or its 
sequelae. Importantly, people with stroke stay in hospital much longer than average—the 
average length of stay for stroke hospitalisations, excluding same day hospitalisations, was 
10.4 days compared with 5.9 days for all hospitalisations in 2009–10 (AIHW 2011b). 
Hospitalisations for stroke and subsequent rehabilitation took up 706,189 patient days in 
2009–10. The effect of this is that, although stroke hospitalisations accounted for 0.7% of all 
hospitalisations for that year, they represented almost 3% of all patient days.  
Most stroke survivors live at home, with only 9% in cared accommodation in 2009. This is 
also the case for people disabled as a result of stroke, 21% of whom live in cared 
accommodation. Many stroke survivors are able to avoid moving into residential care 
because a range of community services is available to assist them. In 2009, it was estimated 
that around 133,100 people with stroke and disability received formal assistance, either on its 
own or in combination with informal assistance, while around 57,700 people received 
informal assistance only.  
The role of an Aged Care Assessment Team (ACAT) is to assess the care needs of frail older 
people and to assist them in gaining access to the most appropriate types of care, including 
approval for Australian Government-subsidised aged-care services. In 2009–10, one in five 
Aged Care Assessment Program (ACAP) clients with a complete ACAT assessment (32,725 
people) had a diagnosis of cerebrovascular disease or TIA. Compared with other ACAP 
clients, those with cerebrovascular disease or TIA were much more likely to require high-
level residential care, suggesting greater care needs.  
One in five permanent aged-care residents with an Aged Care Funding Instrument (ACFI) 
appraisal (around 42,700 people) also had a diagnosis of cerebrovascular disease or TIA in 
2009–10. Compared with other permanent aged-care residents with an ACFI appraisal, those 
with cerebrovascular disease or TIA needed a higher level of care, particularly for activities 
of daily living. 
Informal caregivers play an important part in the care of stroke survivors. In 2009, there were 
an estimated 75,000 co-resident primary carers providing assistance to people with stroke 
and disability in Australia. The majority of these primary carers were female (69%) and 
nearly two-thirds were aged 60 and over. More than half of co-resident primary carers spent 
40 hours or more each week in their caring role and, for about one in five, their caring 
responsibilities adversely affected their income. Despite the heavy workload of caring for a 
person with stroke, most primary carers had never used respite care and did not want it. 
However, one in eight carers who had not received respite care said they needed it.  
Stroke imposes a significant financial burden on the health system. In 2008–09, total health-
care expenditure for stroke in Australia was around $606 million, which accounted for 8% of 
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total health-care expenditure for all cardiovascular disease ($7.7 billion) and 0.5% of total 
health-care expenditure ($113.6 billion). Hospital-admitted patients accounted for 92% of the 
health expenditure for stroke. 
There are inequalities in the impact of stroke across population groups, with higher 
prevalence rates in Aboriginal and Torres Strait Islander people compared with non-
Indigenous Australians, and in people from the lowest socio-economic group compared with 
those from the highest socio-economic group. 
Stroke and the recurrence of stroke are highly preventable (Hankey 2011; Vecchione 2011; 
Silver 2012; National Stroke Foundation 2010). Reducing the prevalence of modifiable risk 
factors, such as high blood pressure, physical inactivity, smoking, abdominal obesity, poor 
diet and increased alcohol intake, could prevent many strokes. In people who have had 
TIAs, rapid access to investigations and starting preventive measures immediately are 
essential.  
Encouragingly, a few local Australian studies have shown that stroke incidence and event 
rates have been declining over time (Islam et al. 2008; Marsden et al. 2010), and this may be 
the result of improved primary and secondary prevention (Rothwell et al. 2004). However, 
due to lack of national stroke incidence data, we do not know with certainty that this is 
happening Australia-wide. 
National data also show that the death rate from stroke in Australia has fallen by about 70% 
since 1979. This decline has been attributed in part to a reduction in risk factors such as 
tobacco smoking and high blood pressure, as well as to improvements in medical treatment 
for stroke (Gillum 1997; National Stroke Foundation 2010; OECD 2011). However, although 
the average rate of decline in stroke death rates has accelerated over time for people aged 55 
and over, it has slowed for those aged 35–54. 
The care of stroke patients also seems to be improving. The number of stroke units in public 
hospitals increased from 54 to 74 between 2007 and 2011. In addition, hospitals with stroke 
units in 2011 were more likely to have rapid triage and rapid assessment of patients with 
acute stroke, on-site access to diagnostic equipment, care protocols in place and 
rehabilitation services.  
Another encouraging finding is that, in 2009, the majority of people with stroke and 
disability who live at home and needed assistance with core activities, such as health care, 
self-care, mobility, transport, household chores and property maintenance, were receiving 
the necessary assistance. 
However, there are a number of apparent gaps in treatment: 
• In Australia in 2011, 39% of hospitals participating in the National Stroke Foundation’s 
Acute Services Organisational Survey had a stroke unit. This is an improvement 
compared with the 19% of public hospitals that had a stroke unit in 2004 (Cadilhac et al. 
2006). However, it compares poorly with some countries such as Sweden where 83% of 
hospitals have stroke units. In Norway and Sweden, 60–70% of patients are cared for in 
stroke care units (Moon et al. 2003; Rudd & Matchar 2004).  
• Timeliness in receiving hospital care for ischaemic stroke patients is a crucial factor in 
accessing access to thrombolysis, a drug treatment that can significantly improve the 
outcomes if administered within at least 4.5 hours of stroke onset. In 2011, thrombolysis 
was only given to 18% of ischaemic stroke patients arriving within the required 
timeframe (National Stroke Foundation 2011a).  
  Stroke and its management in Australia: an update 81 
• The guidelines recommend that a CT scan of the brain be performed in all stroke patients 
within 24 hours of the onset of symptoms. Based on hospital statistics this diagnostic 
procedure was used at least once in only two-thirds of hospitalisations for stroke. 
However, this may not accurately reflect whether or not patients had a scan because the 
number of procedures may be an underestimate resulting from the limitations of 
hospital data collections. For example, the CT scan could have been performed in the 
emergency department before the patient was admitted, and therefore not be recorded in 
the hospital data, or the patient may have died during transfer to a hospital that had the 
facility. 
• In 2011, only half of stroke patients received a discharge care plan, despite the fact that 
this is seen as an essential component of stroke management (National Stroke 
Foundation 2011a). 
• There appears to be limited awareness among the general public of the signs and 
symptoms of stroke, or what to do about them if they developed any symptoms, even 
after national awareness campaigns have been run (Spark et al. 2011). Not being able to 
identify that a person is having a stroke can lead to delays in presentation for treatment 
and result in worse outcomes. However, there is evidence that stroke awareness 
campaigns can improve knowledge of stroke warning signs in the population (Trobbiani 
et al. 2012; Spark et al. 2011). 
There are also gaps in our knowledge: 
• With the exception of the National Stroke Foundation’s audit data, there are no national 
data on the time elapsed between onset of stroke symptoms, presentation to hospital and 
start of emergency care. Nor are there national data on the uptake of clinical guidelines 
or on medications given in acute care or at discharge. 
• It is difficult to ascertain the extent of formal care services actually delivered to stroke 
survivors because there is a myriad of programs, with data held in separate collections 
and the diagnoses of users are not recorded in some cases. Record linkage of these 
collections would be complex but potentially valuable. 
• There are no regular, up-to-date national data on the incidence of stroke that would 
allow us to determine incidence trends over time. Data linkage would enable this. 
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Appendix A Methods and definitions 
Age-specific rates 
Age-specific rates are calculated by dividing the number of cases occurring in each specified 
age group by the corresponding population in the same age group, expressed as a rate (e.g. 
number per 100,000 persons). Information on the populations used in this report in provided 
in the section on population data below. 
Age-standardised rates 
Age-standardisation is a method used to eliminate the effect of differences in population age 
structures when comparing populations with different age structures, and where age affects 
the variable being compared. This is the case with CVD, which is occurs more often among 
the elderly. Age-standardisation is used in this report when comparing rates across different 
periods of time, different geographical areas, different socioeconomic groups or other 
different populations. The direct method of age-standardisation is used throughout this 
report. 
Direct age-standardisation 
This method of age-standardisation is used when the population under study is large and 
the age-specific rates can be reliably estimated. The calculation of direct age-standardised 
rates consists of three steps: 
Step 1: Calculate the age-specific rate for each age group. 
Step 2: Calculate the expected number of cases in each age group by multiplying the  
age-specific rates by the corresponding standard population for each age group. 
Step 3: Sum the expected number of cases in each age group and divide this sum by the total  
 of the standard population to give the age-standardised rate.  
For most of the age-standardised rates, the standard population used is the Australian 
estimated resident population as at 30 June 2001. See the section on population data for more 
information. 
Average annual rate of change 
Log linear modelling is used to estimate the average annual percentage change, taking into 
account all points in the time series in ensuring that a rate of zero will never be predicted. 
The formula is: 
loge(Rt)= constant + αt, where t is the time period (years), Rt is the observed rate in year t, and 
α is the estimated average annual rate of change (increase or decrease).  
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Significance testing 
The observed value of a rate may vary because of the influence of chance and natural 
variation. Therefore, to provide an approximate indication of whether two rates are 
statistically different, 95% confidence intervals can be calculated, and significant differences 
highlighted.  
A 95% confidence interval describes a span of numbers around the estimate that has a 95% 
chance of including the true value. When comparing two groups, if the two confidence 
intervals do not overlap, the reader can be confident that the difference between the groups 
is real, and not due to chance. 
Confidence intervals were calculated for survey data in this report. 
Calculation of confidence intervals for survey data 
The delete-a-group Jackknife weight replication method was used to derive the standard 
error of estimates for the 2009 SDAC, 2004–05 NATSHIS and the 2007–08 NHS surveys. 
The variability between these replicate estimates (denoting X (w) for group number w) is 
used to measure the SE of the original weighted estimate X, using the formula: 
𝑆𝐸(𝑋) = ��(𝑤 − 1)
𝑤
× ∑�𝑋(𝑤) − 𝑋��2 
Where w = the number of replicate weights 
 X(w) = estimate obtained using replicate weights for replicate group w 
 X = estimate from using full sample weights 
Standard error of the ratio of two number estimates 
Once the standard error for the number estimates was produced, the standard error for the 
proportion was derived as follows: SE �𝑋
𝑌
� = RSE �𝑋
𝑌
� × �𝑋
𝑌
� 
where RSE �X
Y
� is calculated as shown below. 
Relative standard error of estimates (number and ratio) 
The relative standard error (RSE) of an estimate is a measure of the percentage errors likely 
to have occurred due to sampling. The RSE of an estimate is calculated as follows: RSE(X)% = � SEEstimate�× 100 
Caution should be used when a RSE is between 25% and 50% and estimates with a RSE 
above 50% are considered unreliable. 
The relative standard error for the proportion was derived from the standard error of both 
the estimate for the numerator (X) and the denominator (Y) as follows: 
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RSE �XY� = �RSE(X)2 − RSE(Y)2 
Where X is a subset of Y and Y is a survey estimate of the number of people in a group.  
Confidence interval for estimates (number and ratio) 
The 95% confidence interval around the proportion estimates (P) or number estimates was 
derived as follows: UCL = X + 1.96 × SE(X) LCL = X − 1.96 × SE(X) 
 UCL = P + 1.96 × SE �XY� LCL = P − 1.96 × SE �XY� 
 
Where UCL = upper confidence limit 
LCL = lower confidence limit 
As with all statistical comparisons, care should be exercised in interpreting the results. A 
non-significant difference between two rates may indicate no true difference, or could 
indicate that numbers of observations are too small to detect a true statistically significant 
difference. Judgment should be exercised in deciding whether the size of the difference 
observed is of practical importance.  
Reporting deaths 
Data on deaths in this report are sourced from the AIHW National Mortality Database (see 
Appendix C). Unless otherwise specified, the cause of death identified in this report is based 
on the ‘underlying cause’—the disease or injury that initiated the train of events leading 
directly to death, or the circumstances of the accident or violence that produced the fatal 
injury. Any other condition or event that is not the underlying cause, but is still considered 
to contribute to the death, is known as an associated cause. In Australia, the underlying 
cause is derived from information on the death certificate, using an automated process.  
In this report, death data are collated according to the year of registration of the death and 
not the year of death. Although, for the most part, year of death and registration coincide, 
deaths at the end of each calendar year may be held over until the following year, as will 
deaths in which the cause requires further examination by a coroner. Typically around 5% of 
deaths are held over from one year to the next for processing.  
See the section below on ‘Population data used in this report’ for information on the 
population used to calculate death rates in this report. 
Comparability factors 
In processing deaths from 1 January 1997, Australia adopted the use of the automated coding 
system and introduced ICD-10 codes (see Appendix B). As a result, there is a break in the 
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underlying cause of death series between 1996 and 1997. Comparability factors have been 
calculated that can be applied to deaths data coded using ICD-9 (1979–1996) to make them 
comparable with data coded to ICD-10 (from 1997 onwards). A comparability factor of 0.83 
was applied to the observed number of deaths for stroke (ICD-10 codes I60–I64) for the 
period 1979–1996. This comparability factor was calculated at the population level—that is, 
the same comparability factor was applied to the number of stroke deaths for each age and 
sex group combination.  
Reporting hospitalisations  
Information on hospitalisations in Australia is contained in the AIHW NHMD (see Appendix 
C for more information). In this report a ‘hospitalisation’ refers to an episode of admitted 
care, which can be a total hospital stay (from admission to discharge, transfer or death) or a 
portion of a hospital stay beginning or ending in a change of type of care (e.g. from acute to 
rehabilitation). The same person can have multiple ‘separations’ within the same 
hospitalisation period and, because the database is event based, it is currently not possible to 
track individuals. For this reason, the data presented in this report do not represent the 
number or proportion of people admitted to hospital in Australia with CVD. Note also that 
some care types, such as unqualified neonates, hospitalised boarders and organ procurement 
hospitalisations, are not included in the count of hospital separations.  
There are two distinct types of diagnoses recorded in the database—principal and additional. 
The principal diagnosis is the diagnosis established after study to be chiefly responsible for 
occasioning an episode of admitted patient care. The principal diagnosis is usually a disease, 
injury or poisoning, but can also be the specific care or service provided for a current 
condition (e.g. dialysis for kidney disease), or other reasons for hospitalisation. Unless stated 
otherwise, hospitalisation rates presented in this report refer to the principal diagnosis. The 
additional diagnosis is a condition or complaint that coexists with the principal diagnosis or 
arises during the episode of care. 
Additional diagnoses should be interpreted as conditions that affect patient management in 
terms of requiring any of the following: 
• commencement, alteration or adjustment of therapeutic treatment  
• diagnostic procedures  
• increased clinical care and/or monitoring. 
Additional diagnoses form the basis of the analyses of comorbidity presented in this report. 
Also note that the principal diagnosis is determined at the end of the hospitalisation episode. 
It is therefore possible for the principal diagnosis to be different from the complaint that 
caused a person to present to hospital. Hospitals data therefore report the condition a patient 
was hospitalised with, rather than the condition they were hospitalised for. 
See the section below for information on ‘The population data used in this report’ to 
calculate hospitalisation rates in this report. 
Comparability factors 
The NHMD adopted the use of the automated coding system and introduced ICD-10 coding 
in the 1998–99 financial year (see Appendix B). As a result, there is a break in the underlying 
cause of death series between 1997–98 and 1998–99. Unlike for deaths data, no comparability 
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factors are available for hospitalisation data. It is important to be aware of the potential for 
coding changes to have affected the trends in hospitalisations presented in this report.  
Reporting Indigenous data 
Reporting Indigenous death and hospitalisation data are problematic because of the  
under-identification of Indigenous Australians in these databases. Not all states and 
territories in Australia are able to report the Indigenous status of patients in their death and 
hospitalisation data accurately. In this report, data on Indigenous deaths and hospitalisations 
were limited to specific jurisdictions (based on the patient’s state of usual residence) because 
these are the ones that have been judged to have sufficiently accurate Indigenous 
identification. 
Deaths 
The ABS has assessed the quality of Indigenous deaths in death registration data by state and 
territory in the Census Data Enhancement Indigenous Mortality Quality Study. This study 
involved linking Census records with death registration records to examine differences in 
reporting of Indigenous status across two data sets. This assessment indicates that the 
Indigenous identification rate is 87% or higher in New South Wales, Queensland, Western 
Australia and the Northern Territory, and around 65% for the remaining jurisdictions. 
Historically, Indigenous identification in South Australia, Western Australia and the 
Northern Territory has been of sufficient quality to include in analyses from 1991 onwards. 
Queensland was included in analyses from 1998 onwards and, in 2010, a decision was made 
to include data from New South Wales from 2001 onwards. 
Hospitalisations 
In February 2010, the AIHW released a report on the quality of Indigenous identification in 
hospital separations data (AIHW 2010c). The report recommended that, from 2004–05, the 
level of Indigenous identification in hospitalisations data was acceptable for analysis 
purposes (i.e. the level of Indigenous identification was 80% or greater) for data from New 
South Wales, Victoria, Queensland, Western Australia, South Australia and the Northern 
Territory (public hospitals only). Data are reported based on the state or territory of the 
patient’s usually residence for these six jurisdictions. As at June 2010, the proportion of the 
Indigenous population covered by these six jurisdictions was 96% (ABS 2009b). 
Reporting data by remoteness 
Comparisons of region in this report use the Australian Standard Geographical Classification 
(ASGC). The ASGC is a classification system developed by the ABS that groups Australian 
regions into six areas, called remoteness areas, based on their distance from major 
population centres and services. The six remoteness areas are: 
• Major cities 
• Inner regional 
• Outer regional 
• Remote  
• Very remote 
• Migratory 
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Data from Migratory areas are not analysed in this report. Also, throughout the report Remote 
and Very remote areas are grouped together to allow sufficient numbers for analysis. The 
boundaries of the different remoteness areas are re-drawn after each Census to account for 
changes to available services and population change. The remoteness areas used in this 
report are based on the 2006 Census.  
Reporting data by socioeconomic group 
The ABS has constructed a number of socioeconomic indexes to classify areas on the basis of 
social and economic information collected in the Census of Population and Housing.  
In this report, the SEIFA index of relative socioeconomic disadvantage is used. This is 
derived from social and economic characteristics of the local area, such as low income, low 
educational attainment, high levels of public sector housing, high unemployment and jobs in 
relatively unskilled occupations.  
For analysis, the population was divided into five groups with roughly equal populations 
(each around 20% of the total) based on the level of disadvantage of the statistical local area 
(SLA) of their usual residence. So the first group includes the 20% of the population living in 
areas with the highest levels of relative disadvantage, while the last group includes the 20% 
of the population living in areas with the lowest levels of relative disadvantage.  
It is important to note that the index of relative socioeconomic disadvantage relates to the 
average disadvantage of all people living in a SLA, not to the level of disadvantage of a 
specific individual. Because the population of many areas covers a broad range of 
socioeconomic disadvantage, these measures will generally underestimate the true effect of 
disadvantage on health.  
The index of relative socioeconomic disadvantage values used in this report are based on the 
2006 Census. These values have been mapped to the 2007 year SLA boundaries for both 
death and hospitalisation analyses.  
Population data used in this report 
Population data are used throughout this report to calculate rates. The population data used 
are estimated resident populations (ERPs) derived from the ABS Census of Population and 
Housing. ERPs adjust Census data to add people missed by the Census and people overseas 
on Census night, and to remove overseas visitors. In between census years, the ERPs are 
updated using indicators of population change such as deaths, births and net migration. The 
ERPs used in this report are based on the 2006 Census.  
Where a rate is calculated for a calendar year (e.g. with death data), the population used is 
the ERP as reported at 30 June of that year. Where a rate is calculated for a financial year (e.g. 
with hospitalisation data), the population used is the ERP for 31 December of the year in the 
middle of the span. For example, to calculate the hospitalisation rate of the 2007–08 financial 
year, the population from 31 December 2007 is used.  
Throughout this report, rates of deaths and hospitalisations are age-standardised. In these 
cases, the standard population used to calculate the age-standardised rate is the Australian 
ERP as at 30 June 2001.  
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Aboriginal and Torres Strait Islander population 
Australia’s Indigenous population is calculated from the Census and uses ERPs as described 
above. The Aboriginal and Torres Strait Islander population used to calculate Indigenous 
death and hospitalisation rates in this report are the 30 June Experimental Estimates and 
Projections for Aboriginal and Torres Strait Islander people by states and territories, 2006–2021—
Series B (ABS 2009).  
Remoteness area population 
For both deaths and hospitalisations, the remoteness area populations used to calculate rates 
in this report are the ERPs at 30 June for the given year. In the case of hospitalisations, which 
are reported by financial year, the population used is from the beginning of the relevant 
financial year. For example, hospitalisation rates by region in 2007–08 would use the 
remoteness area ERP for 30 June 2007.  
Population of socioeconomic areas 
Populations of socioeconomic areas used in this report are derived from 2007 estimates of 
SLA populations (as at 30 June of that year). SLAs are ranked according to their score on the 
index of relative socioeconomic disadvantage, and then divided into five roughly equal 
groups based on their population. That is, the 20% of the population with the highest relative 
disadvantage score are allocated to the first group, the next 20% to the second, and so on. 
The same populations were used to calculate rates for both deaths and hospitalisations.  
Defined daily dose per 1,000 population per day 
The information in this section describing defined daily dose per 1,000 population per day 
comes from Australian statistics on medicines 2009 (DoHA 2011). 
To classify medicines in Australia, the Drug Utilisation Sub-Committee (DUSC) and the 
Department of Health and Ageing (DoHA) have adopted the anatomical therapeutic 
chemical (ATC) code as recommended by the WHO. The international unit of drug 
utilisation adopted by the DUSC to accompany the classification is the defined daily doses, 
per thousand population per day (DDDs/1000/day). The defined daily dose is established 
by the Nordic Council on Medicines and the WHO Drug Utilisation Research Group on the 
basis of the assumed average dose per day of the drug, when used for its main indication by 
adults. 
The DDDs/1000/day figure is calculated from prescription data in the following way:  
𝑁 × 𝑀 × 𝑄 × 1000
𝐷𝐷𝐷 × 𝑃 × 𝐷  
Where:  
N is the number of prescriptions dispensed in the year  
M is the drug mass in each unit (tablet, capsule, injection, pack, etc.) (e.g. milligrams or 
grams, expressed in the same unit as DDD)  
Q is the average dispensed quantity (i.e. number of units) per prescription  
P is the mid-year Australian population for the year of data collection  
D is the number of days in the year.  
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The DDDs/1000/day can be calculated over other time periods such as monthly or 
quarterly. 
For PBS items, the mass amount (M) is the amount of active drug contained in an individual 
dose unit (e.g. tablet, capsule, suppository, etc.). Non-PBS items are estimated from the 
Pharmacy Guild survey. The data from the survey does not include information on the 
quantity supplied per prescription, therefore the mass amount for non-subsidised items is 
the total amount of active drug contained in the pack.  
For prescriptions forwarded for subsidy, the average quantity dispensed (Q), is available 
from Medicare Australia data. For prescriptions that are priced under the general co-
payment, the quantity is assumed to be the average quantity of the subsidised prescriptions 
for that drug (i.e. as concession, safety net and Veterans Affairs (Repatriation) prescriptions). 
For private prescriptions, the quantity dispensed is assumed to be the retail pack size.  
For a chronically administered drug, the DDDs/1000/day figure indicates how many 
people, per 1000 of the population, may, in theory, have received a standard dose (as defined 
by the DDD) daily.  
For drugs used intermittently, such as anti-infectives, usage expressed in DDDs/1000/day 
may similarly give a rough estimate of the average proportion of the population using these 
drugs every day. To estimate the number of patients treated during the year supplementary 
information, such as the average duration of treatment, is necessary. 
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Appendix B Classifications 
Anatomical therapeutic chemical (ATC) 
classification 
ATC codes are used in this report to classify medicines. This classification groups medicines 
according to the body organ or system they act upon, their therapeutic characteristics and 
their chemical characteristics. A complete list of the medicine classes included in this report 
is shown in Table B1. 
Table B1: Anatomic therapeutic chemical medicine classes included in this report 
ATC code Description 
B01 Antithrombotic agents 
B01AA Vitamin K antagonists 
B01AB Heparin group 
B01AC Platelet-aggregation inhibitors (excluding heparin) 
B01AC06 Aspirin 
B02 Antihaemorrhagics 
C01 Cardiac therapy agents 
C01B Antiarrhythmics 
C01DA Nitrates 
C02 Antihypertensives 
C03 Diuretics 
C07 Beta-blocking agents 
C08 Calcium-channel blockers 
C09 Renin-angiotensin system agents 
C10 Lipid-modifying agents 
International Classification of Disease (ICD) codes 
Mortality 
Australia uses the International Statistical Classification of Diseases and Related Health 
Conditions for coding causes of death. Analyses in this report of the years between 1987 and 
1996 used the Ninth Revision (ICD-9); analyses after 1996 used the Tenth Revision (ICD-10). 
ICD-10 classifications for coding deaths are updated annually.  
Morbidity 
For hospital diagnoses and procedures, a slightly different classification, modified for 
Australia, is used. However, this classification does not affect the codes used in this report. In 
this report, hospital data up to 1997–98 used the ICD-9-CM (International Classification of 
Diseases and Related Health Conditions, Ninth Revision, Clinical Modification) 
classification. After 1997–98, the ICD-10-AM classification (International Statistical 
  Stroke and its management in Australia: an update 91 
Classification of Diseases and Related Health Conditions, Tenth Revision, Australian 
Modification) was used. The Australian Classification of Health Interventions (ACHI) is 
Australia’s intervention classification and is used in conjunction with ICD-10-AM to code 
interventions. Procedure codes used in this report are from the ACHI, noting that not all 
procedures are surgical. ICD and ACHI codes are routinely updated about every 2 years. 
Details of the ICD codes used for diagnosis and procedures in this report are shown in 
Tables B2 and B3.  
Table B2: International Classification of Disease (ICD) codes for cerebrovascular disease, stroke 
and TIA 
Disease codes ICD-9 and ICD-9-
CM codes 
ICD-10 and ICD-10-AM 
codes 
Cerebrovascular disease 430–438 I60–I69 
Stroke 430–434,436 I60–I64 
Haemorrhagic stroke 430–432 I60–I62 
Subarachnoid haemorrhage 430 I60 
Intracerebral haemorrhage 431 I61 
Other non-traumatic intracranial haemorrhage 432 I62 
Ischaemic stroke (i.e. cerebral infarction) 433 I63 
Stroke not specified as haemorrhage or infarction 436 I64 
TIA 435 G45 
 
Rehabilitation for stroke and its sequelae  Z500, Z501, Z504,Z505,Z506, 
Z507,Z508,Z509' as principal 
diagnosis with I60–I69 as 
associated diagnosis 
(excluding I69.8)  
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Table B3: Australian Classification of Health Interventions (ACHI) codes for procedures in 
hospital data 
Procedure codes ACHI code (7th edition) 
Generalised allied health Block 1916 
Dietetics 95550–00 
Social work 95550–01 
Occupational therapy 95550–02 
Physiotherapy 95550–03 
Podiatry 95550–04 
Speech pathology 95550–05 
Audiology 95550–06 
Orthoptics 95550–07 
Prosthetics and orthotics 95550–08 
Pharmacy 95550–09 
Psychology 95550–10 
Pastoral care 95550–12 
Music therapy 95550–13 
Diabetes education 95550–14 
Other allied health interventions 95550–11 
Imaging procedures  
Duplex ultrasound of cranial, carotid or vertebral 
vessels 
55274–00,55280–00 
Heart ultrasound  55113–00,55118–00,55130–00 
CT brain scan 56001–00,56007–00,56010–02,56010–03 
MRI of the brain 90901–00,90901–09 
MRA of head or neck 90902–00 
Chest X-ray 58509–00,58500–00,58506–00 
Cerebral angiography 59970–02 
Surgical procedures  
Carotid endarterectomy 33500–00 
Carotid embolectomy or thrombectomy 33800–00 
Intracranial vein or artery transcatheter embolisation 35321–02,35321–08 
Destruction of intracranial aneurysm or other 
vascular lesion 
39815–00, 90033–00,39812–00,39806–00,39800–00 
Removal of intracranial haematoma or abscess 39603–00,39603–01 
Carotid artery repair 33827–00,33830–00 
Carotid bypass 32700–00,32700–01,32700–05,32700–06 
Carotid aneurysm graft 33100–00 
Carotid resection with reanastomosis 32703–00 
Carotid transluminal balloon angioplasty 35307–00,35307–01 
Pharmacotherapy  
Invasive administration of thrombolytic medicines 35317–00,35319–00,35320–00 
Non-invasive administration of thrombolytic agents 96196–01,96199–01, 96200-01, 96201-01, 96202-01, 96203-01, 
96205-01, 96205-01, 96206-01, 96209-01 
Source: NCCH 2008 
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Classifications from other sources 
Details of the classifications and codes from other data sources used in this report are shown 
in Table B4. 
Table B4: Classifications and codes from other data sources used in this report 
Data Disease or procedure Classification Code 
Disability and carers Stroke SDAC 923 (equivalent to ICD-10 
code I64) 
Aged–care Assessment Program Cerebrovascular disease ACAP 0910–0916 (equivalent to 
ICD-10-AM codes I60–I69) 
 TIA ACAP 0605 (equivalent to ICD-
10-AM codes G45–G46) 
Aged–care Funding Instrument Cerebrovascular disease ACAP 0910–0916 (equivalent to 
ICD-10-AM codes I60–I69) 
 TIA ACAP 0605 (equivalent to ICD-
10-AM codes G45–G46) 
Bettering the Evaluation and Care 
of Health  
General practice 
stroke/cerebrovascular 
encounters ICPC-2/ICPC-2-PLUS 
K90/K90002 (2004–05 to 
2010–2011) 
 Transient ischaemic attack 
(TIA) ICPC-2 K89 (1998–2011) 
2007–08 National Health Survey Cerebrovascular 
disease/stroke ICD10 
19396 (equivalent to ICD-
10-AM codes I60–I69) 
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Appendix C  Main data sources 
ABS National Aboriginal and Torres Strait Islander 
Health Survey (NATSIHS) (2004–05) 
The NATSIHS is conducted by the ABS to obtain national information on the health of 
Indigenous Australians, their use of health services and health-related aspects of their 
lifestyle. The 2004–05 survey collected information from a sample of 10,439 people (about 
one in 45 of the total Indigenous population) from all states and territories, including Remote 
and very remote areas, from August 2004 to July 2005. 
Information about the data quality of the 2004–05 NATSIHS can be found in Chapter 7 of the 
ABS publication National Aboriginal and Torres Strait Islander Health Survey: users' guide (ABS 
cat. no. 4715.0.55.004). 
<http://www.abs.gov.au/AUSSTATS/abs@.nsf/DetailsPage/4715.0.55.0042004-
05?OpenDocument>. 
ABS National Health Survey (NHS) (2007–08)  
The 2007–08 NHS was conducted by the ABS in all states and territories and across all age 
groups. One adult (aged 18 or over) and one child (where applicable) for each sampled 
dwelling were included in the survey. The survey was designed to obtain national 
benchmarks on a wide range of health issues, and to enable change in health to be monitored 
over time—similar surveys were conducted by the ABS in 2001 and 2004–05. Information 
was collected about the health status of the population; health-related aspects of lifestyle and 
other health risk factors; and the use of health services and other actions people had recently 
taken for their health. 
Information about the data quality of the 2007–08 NHS can be found in Chapter 7 of the ABS 
publication National Health Survey: users' guide—electronic publication, 2007-08 (ABS cat. no. 
4363.0.55.001) 
<http://www.abs.gov.au/ausstats/abs@.nsf/Latestproducts/4363.0.55.001Main%20Feature
s82007-08?opendocument&tabname=Summary&prodno=4363.0.55.001&issue=2007-
08&num=&view>. 
ABS Surveys of Disability, Ageing and Carers 
(SDAC) (1998, 2003 and 2009) 
These surveys were conducted by the ABS to collect information about: people of all ages 
with a disability; older people (aged 60 and over); and people who provide assistance to 
older people and people with disabilities. The surveys included people in both private and 
non-private dwellings, including people in establishments where care is provided, but 
excluded those in correctional institutions. 
The 2009 SDAC collected information from a sample of 64,213 persons for the household 
component and 9,470 persons for the cared-accommodation component over the period 
April to December 2009. The final sample sizes for the 2003 survey were 36,241 for the 
household component and 5,145 for the cared-accommodation component, and the sample 
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was conducted from June to November 2003. The 1998 SDAC was conducted from March to 
May 1998, and collected data from a sample of 37,580 persons for the household component 
and 5,716 persons for the cared-accommodation component. 
The SDAC data presented in this report for 2009 were extracted from the SDAC 2009 
confidentialised unit record file (CURF). To protect confidentiality, some records were 
removed from the CURF by the ABS before making it available for analysis (ABS 2011a). 
Therefore, data shown in this report may not exactly match those in ABS published reports. 
The data quality declaration for the 2009 SDAC can be found in the ABS publication 
Disability, ageing and carers, Australia: summary of findings, 2009 (ABS cat. no. 4430.0) 
<http://www.abs.gov.au/Ausstats/abs@.nsf/0/FB632AC7C773292BCA2577FA0011C48D?
OpenDocument>. 
Information about the data quality of the 2003 SDAC can be found in the ABS information 
paper Disability, ageing and carers, Australia: user guide, 2003 (ABS cat. no. 4431.0.55.001) 
<http://www.ausstats.abs.gov.au/ausstats/free.nsf/0/87ED9753078BFCECCA256F6F00771
DAE/$File/4431055001_2003.pdf>. 
Information about the data quality of the 1998 SDAC can be found in the ABS technical 
paper Survey of Disability, Ageing and Carers, Australia: Confidentialised unit record file, 1998 
(ABS 1999). 
Definitions for main concepts in the Surveys of Disability, Ageing 
and Carers 
The definitions used in the 1998, 2003 and 2009 SDACs for the main concepts relating to 
disability and to what constituted a household or establishment are provided below (ABS 
2011b).  
Cared accommodation: The cared-accommodation component covered residents of 
hospitals, nursing homes, aged-care and disability hostels and other homes such as 
children's homes, who had been, or were expected to be, living there for at least 3 months. 
Carer: A person of any age who provides any informal assistance, in terms of help or 
supervision, to persons with disabilities or long-term conditions or persons who are elderly 
(i.e. aged 60 and over). This assistance has to be ongoing, or likely to be ongoing, for at least 
6 months. Assistance to a person in a different household relates to 'everyday types of 
activities', without specific information on the activities. Where the care recipient lives in the 
same household, the assistance is for one or more of the following activities: 
• cognition or emotion 
• communication 
• health care 
• household chores 
• meal preparation 
• mobility 
• property maintenance 
• reading or writing 
• self-care 
• transport. 
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Core activities: include communication, mobility and self-care. 
Disability: A person has a disability if they report they have a limitation, restriction or 
impairment, which has lasted, or is likely to last, for at least 6 months and restricts everyday 
activities. This includes, for example: 
• loss of sight (not corrected by glasses or contact lenses) 
• loss of hearing where communication is restricted, or an aid to assist with, or substitute 
for, hearing is used 
• speech difficulties 
• shortness of breath or breathing difficulties causing restriction 
• chronic or recurrent pain or discomfort causing restriction 
• blackouts, fits, or loss of consciousness 
• difficulty learning or understanding 
• incomplete use of arms or fingers 
• difficulty gripping or holding things 
• incomplete use of feet or legs 
• nervous or emotional condition causing restriction 
• restriction in physical activities or in doing physical work 
• disfigurement or deformity 
• mental illness or condition requiring help or supervision 
• long-term effects of head injury, stroke or other brain damage causing restriction 
• receiving treatment or medication for any other long-term conditions or ailments and 
still being restricted 
• any other long-term conditions resulting in a restriction. 
Formal assistance/providers: Help provided to persons with one or more disabilities by: 
• organisations or individuals representing organisations (whether profit making or non-
profit making, government or private) or 
• other persons (excluding family, friends or neighbours as described in Informal 
assistance/providers) who provide assistance on a regular, paid basis and who were not 
associated with any organisation. 
Household: A group of two or more related or unrelated people who usually reside in the 
same dwelling and who make common provision for food and other essentials for living; or 
a person living in a dwelling who makes provision for his or her own food and other 
essentials for living without combining with any other person. Thus a household may consist 
of: 
• one person 
• one family 
• one family and related individual(s) 
• related families with or without unrelated individual(s) 
• unrelated families with or without unrelated individual(s) 
• unrelated individuals. 
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Informal assistance/providers: Informal assistance is unpaid help or supervision that is 
provided to persons with one or more disabilities or persons aged 60 and over living in 
households. It only includes assistance that is provided because of a person's disability or 
because they are older. Informal assistance may be provided by family, friends or 
neighbours. For this survey, any assistance received from family or friends living in the same 
household was considered to be informal assistance regardless of whether or not the 
provider was paid. It does not include providers whose care is privately organised (see 
Formal assistance/providers). 
Levels of core activity limitation: core activity limitation levels are based on whether a 
person needs help, has difficulty, or uses aids or equipment with any of the core activities. A 
person’s overall level of core activity limitation is determined by their highest level of 
limitation in these activities. The four levels of limitation are: 
• profound: the person is unable to do, or always needs help with, a core activity task 
• severe: the person sometimes needs help with a core activity task, has difficulty 
understanding or being understood by family or friends or can communicate more easily 
using sign language or other non-spoken forms of communication. 
• moderate: the person needs no help but has difficulty with a core activity task 
• mild: the person needs no help and has no difficulty with any of the core activity tasks, 
but uses aids and equipment, cannot easily walk 200 metres, cannot walk up and down 
stairs without a handrail, cannot easily bend to pick up an object from the floor, cannot 
use public transport, can use public transport but needs help or supervision, needs no 
help or supervision but has difficulty using public transport. 
Long-term condition: A disease or disorder which has lasted or is likely to last for at least 
6 months; or a disease, disorder or event (e.g. stroke, poisoning, accident etc.) which 
produces an impairment or restriction which has lasted or is likely to last for at least 6 
months. This includes conditions resulting from accidents or injuries, lasting for at least 6 
months. The International Statistical Classification of Diseases and Related Health Problems, 
Tenth Revision (ICD-10), was used in the 1998, 2003 and 2009 surveys as the basis for the 
coding of long-term conditions. 
Primary carer: A person who provides the most informal assistance, in terms of help or 
supervision, to a person with one or more disabilities or aged 60 and over. The assistance has 
to be ongoing, or likely to be ongoing, for at least 6 months and be provided for one or more 
of the core activities (communication, mobility and self-care). In the 2009 SDAC, primary 
carers only included persons aged 15 and over for whom a personal interview was 
conducted.  
Specific limitation or restriction: People were identified as having a specific limitation or 
restriction if they needed assistance, had difficulty, or used aids or equipment to do selected 
tasks relating to the core activities—self-care, mobility and communication; or if their 
participation in schooling or employment was restricted because of their condition. 
AIHW Disease Expenditure Database  
A comprehensive database that allocates health expenditure estimates by condition types, by 
disease category, area of expenditure, and by age and sex.  
This report provides direct health expenditure on stroke under three categories: 
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• Admitted patient hospital services covering the expenditure on services provided to an 
admitted patient, including expenditure on medical services delivered to private 
admitted patients in hospitals. 
• Prescription pharmaceuticals including prescriptions subsidised under government 
schemes (e.g. the Pharmaceutical Benefits Scheme and Repatriation Pharmaceutical 
Benefits Scheme), private prescriptions and under co-payment prescriptions. 
Pharmaceuticals dispensed in hospitals were included in the estimates of hospital costs. 
• Out-of hospital medical services comprising medical services primarily funded under 
the Medical Benefits Schedule, such as primary health visits, pathology and specialist 
services. Practice Incentive Payments are also included. In addition, medical services 
funded by DVA, compulsory motor vehicle third party insurance, workers 
compensation insurance, private health insurance funds and the Australian Government 
premium rebates allocated to medical services, as well as Medicare co-payments and 
other out-of-pocket payments are all included. In-hospital medical expenditure for 
private patients was not included here but as part of admitted patient hospital services.  
Estimated out-of-hospital medical services and prescription pharmaceuticals costs for stroke 
used in this report are derived using the BEACH survey in conjunction with data from a 
number of other sources including the Medicare Benefits Schedule (Medicare) data, 
Pharmaceutical Benefits Scheme, Repatriation Pharmaceutical Benefits Scheme, and script 
volumes for private and under co-payment drugs. The BEACH data were collected by the 
Family Medicine Research Centre of the University of Sydney under a previous collaboration 
with the AIHW. For out-of-hospital medical services, the BEACH survey data were 
aggregated over 3 years to estimate the proportion of GP encounters in which stroke was a 
‘problem managed’. This proportion was then applied to the Medicare data for the reference 
year. For prescription pharmaceuticals, the BEACH survey data were aggregated over 
3 years to allocate expenditure on prescription drugs to each disease group, based on the 
problems managed in the GP encounter that related to the prescribing of a particular drug. 
The Anatomical Therapeutic Chemical Classification System classification codes were 
mapped to codes for prescription drugs used in the BEACH survey. Due to the use of this 
methodology, time series comparisons for both out-of-hospital medical services and 
prescription pharmaceuticals should be treated with caution. 
AIHW National Hospital Morbidity Database  
The NHMD is a compilation of episode-level records from admitted patient morbidity data 
collection systems in Australian hospitals. It is a comprehensive data set that has records for 
all episodes of admitted patient care from essentially all public and private hospitals in 
Australia.  
The data supplied are based on the National Minimum Data Set (NMDS) for Admitted 
Patient Care and include demographic, administrative and length of stay data, as well as 
data on the diagnoses of the patients, the procedures they underwent in hospital and 
external causes of injury and poisoning. 
The counting unit for the NHMD is the ‘separation’. Separation is the term used to refer to 
the episode of admitted patient care, which can be a total hospital stay (from admission to 
discharge, transfer or death) or a portion of a hospital stay beginning or ending in a change 
of type of care (e.g. from acute care to rehabilitation).  
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The NHMD contains records from 1993–94 to 2010–11. For each reference year, the NHMD 
includes records for admitted patient separations between 1 July and 30 June.  
Since 1998–99, diagnoses in the NHMD have been coded to the International Statistical 
Classification of Diseases and Related Health Problems, Tenth Revision, Australian 
Modification (ICD-10-AM) by clinical coders in each hospital, based on the diagnoses 
recorded in the patient’s medical record. The diagnosis is recorded for each hospital episode 
and is specific to that episode. The diagnosis-related hospital morbidity data presented in 
this report mainly cover the financial year from 1 July 2009 to 30 June 2010, but trends are 
reported for the period 1 July 1998 to 30 June 2010. In 2009–10, diagnoses and external causes 
of injury, were recorded using the Sixth Edition of the International Statistical Classification 
of Diseases and Related Health Problems, Tenth Revision, Australian modification (ICD-10-
AM) (NCCH 2008). 
Separations for which the care type was reported as ‘newborn without qualified days’, and 
records for ‘hospital boarders’ and ‘posthumous organ procurement’ have been excluded 
from statistics on hospital separations reported here. 
Procedures for 2009–10 were classified, coded and reported to the NHMD by all states and 
territories, using the Sixth Edition of the Australian Classification of Health Interventions 
(ACHI) (NCCH 2008). 
One or more procedures can be reported for each separation, but procedures are not 
undertaken for all hospital admissions, so only some of the separation records include 
procedure data. 
The data quality statement for the AIHW NHMD can be found at on the AIHW’s Metadata 
Online Registry (METeOR)—National Hospital Morbidity Database Data Quality Statement: 
2010-11. 
AIHW National Mortality Database 
The mortality data included in this report were provided by the Registries of Births, Deaths 
and Marriages, the ABS and the National Coronial Information System. These data are 
maintained at the AIHW in the National Mortality Database. 
The National Mortality Database contains coded causes of death from the information 
documented by the medical practitioner certifying the death or by a coroner. Registration of 
deaths is the responsibility of the state and territory Registrars of Births, Deaths and 
Marriages. These data are then collated and coded by the ABS to the International Statistical 
Classification of Diseases and Related Health. Since 1997, deaths in Australia have been 
coded to the Tenth Revision of the International Classification of Diseases (ICD-10).  
Data on deaths from stroke (ICD-10 I60–I64) and TIA (G45) in this report have been 
identified based on the ‘underlying cause’—the disease or injury that initiated the train of 
events leading directly to death, or the circumstances of the accident or violence that 
produced the fatal injury. In Australia, the underlying cause is derived from information on 
the death certificate, using an automated process.  
In addition, the death data presented in this report have been collated according to the year of 
registration of the death and cover the period 1 January 1979 to 31 December 2010. It should be 
noted that deaths data for 2009 and 2010 are revised and preliminary data respectively and 
are subject to further revision. 
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The data quality statements underpinning the AIHW National Mortality Database can be 
found in the following ABS publications: ABS Quality declaration summary for Causes of 
death 2010 (Cat. no. 3303.0) 
<http://www.abs.gov.au/Ausstats/abs@.nsf/0/D4A300EE1E04AA43CA2576E800156A24?
OpenDocument> and ABS Quality declaration summary for Deaths, Australia 2010 (ABS cat. 
no. 3302.0) 
<http://www.abs.gov.au/Ausstats/abs@.nsf/0/9FD0E6AAA0BB3388CA25750B000E3CF5?
OpenDocument.> 
Drug Utilisation Sub-Committee database (DUSC) 
The data on the supply of stroke medications in the community included in this report are 
from the DUSC database, which database is held at the DoHA, and monitors the community 
(i.e. non-public hospital) use of prescription medicines in Australia (DoHA 2011). The DUSC 
database combines information on prescriptions subsidised by the PBS, the RPBS and an 
estimate from the Pharmacy Guild Survey of those prescriptions that are not subsidised (i.e. 
private prescriptions and PBS prescriptions priced under the general patient co-payment 
threshold).  
The Pharmacy Guild Survey collects dispensing information each month from a random 
sample of about 370 pharmacies that are members of the Pharmacy Guild throughout 
Australia (DoHA 2011). The pharmacies in the survey are selected to be representative of the 
population of operational pharmacies with regard to PBS dispensing volume and 
geographical location. 
Information on drugs prescribed in public hospitals and on highly specialised drugs 
available to outpatients through public hospital pharmacies under section 100 of the 1953 
National Health Act are not included in the DUSC database.  
The Bettering the Evaluation and Care of Health 
(BEACH) program  
BEACH is a continuous national study of general practice activity in Australia. Data 
presented here were collected by the Family Medicine Research Centre of the University of 
Sydney, in collaboration with the AIHW. BEACH began in April 1998 and involves changing 
random samples of about 1,000 GPs per year, each of whom records details about 
100 consecutive patient encounters. To be eligible to participate, GPs must have claimed at 
least 375 general practice Medicare items in the previous 3 months. Data include information 
about the GP encounter, the problems managed and the treatments delivered. BEACH 
encounter data are weighted to be representative of all encounters and adjustments are made 
in analyses to allow for the tendency for patients to cluster around an individual GP or 
practice.  
National extrapolation of the number of problems managed at general practice encounters 
for cerebrovascular disease in this report were based on the following method as described 
by Britt & Miller (2009): National estimate of problems managed = Number of cerebrovascular problems per 100 
encounters in 2007–08 × Total number of GP services claimed through Medicare in 2007–08 
(rounded to the nearest 100,000; i.e. 109.5 million GP MBS items).  
For more details on the method see Britt & Miller (2009). 
  Stroke and its management in Australia: an update 101 
World Health Organization Global Health 
Observatory 
The international comparisons data presented in this report have come from the World 
Health Organization (WHO) Global Health Observatory data repository. This data 
repository provides access to over 50 data sets on priority health topics, including mortality 
and burden of diseases, the Millennium Development Goals (child nutrition, child health, 
maternal and reproductive health, immunisation, HIV/AIDS, tuberculosis, malaria, 
neglected diseases, water and sanitation), non-communicable diseases and risk factors, 
epidemic-prone diseases, health systems, environmental health, violence and injuries, and 
equity, among others. 
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Appendix D Supplementary tables 
Table D2.1: Estimated number and rate of stroke events, by sex, 1997 to 2009 
 Number of stroke events   Stroke events per 100,000 population(a) 
Year Males Females Persons  Males Females Persons 
1997  15,543   16,335   31,878   213.3 162.6 186.1 
1998  15,193   16,156   31,349   203.1 156.5 177.9 
1999  15,829   16,508   32,337   205.1 154.9 178.0 
2000  15,904   16,927   32,831   200.0 153.6 175.1 
2001  15,883   16,771   32,654   192.2 147.3 168.2 
2002  15,648   16,707   32,355   184.3 142.6 162.1 
2003  15,867   16,601   32,468   181.6 138.5 158.7 
2004  15,815   16,714   32,529   175.9 136.9 155.3 
2005  16,028   16,267   32,295   171.8 129.7 149.8 
2006  16,432   16,588   33,020   170.9 129.3 149.1 
2007  16,536   16,700   33,236   166.2 126.1 145.4 
2008  16,833   17,137   33,970   164.2 126.3 144.5 
2009  16,679   16,999   33,678   157.3 122.5 139.5 
(a) Age-standardised to the Australian population as at 30 June 2001. 
Sources: AIHW analysis of the National Hospital Morbidity Database and the AIHW National Mortality Database. 
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Table D2.2: Stroke prevalence, by age and sex, 2009 
 Number  Per cent (95% CI) 
Age group 
(years) Males Females Persons  Males Females Persons 
0–44 9,546 10,350 19,896   0.1 (0.1–0.2)   0.2 (0.1–0.2)   0.2 (0.1–0.2)  
45–54  15,311  15,325  30,637   1.1 (0.8–1.3)  1.0 (0.7–1.3)   1.0 (0.8–1.3)  
55–64 33,215  29,494  62,709   2.8 (2.2–3.3)  2.4 (1.9–2.9)   2.6 (2.2–3.0)  
65–74 63,069  27,170  90,240   8.4 (7.1–9.7)  3.5 (2.7–4.2)   5.9 (5.2–6.6)  
75–84 64,457  49,953  114,410   14.5 (12.6–16.4)  9.3 (8.0–10.5)   11.6 (10.4–12.8)  
85+ 20,199  37,668  57,867   16.8 (13.5–20.1)  15.2 (13.1–17.3)   15.7 (14.1–17.3)  
All ages 205,798  169,961  375,759   2.0 (1.8–2.1)  1.6 (1.5–1.7)   1.8 (1.7–1.9)  
All ages 
ASR%(a)         1.9 (1.8–2.1)   1.3 (1.2–1.4)   1.6 (1.5–1.7)  
Aged 65+ 
years (per 
cent) 71.8 67.5 69.9     
(a) ASR for age-standardised rate to the Australian population as at 30 June 2001. 
Source: AIHW analysis of ABS 2009 Survey of Disability, Ageing and Carers Confidentialised Unit Record File. 
 
Table D2.3: Stroke prevalence, by sex, 1998, 2003 and 2009 
 Number  Per cent(a) (95% CI) 
Year Males Females Persons  Males Females Persons 
1998  131,535   150,532   282,067    1.7 (1.5–1.9)   1.5 (1.4–1.7)   1.6 (1.5–1.7)  
2003  178,334   168,377   346,711    2.0 (1.7–2.2)   1.5 (1.3–1.7)   1.7 (1.6–1.9)  
2009  205,798   169,961   375,759    1.9 (1.8–2.1)   1.3 (1.2–1.4)   1.6 (1.5–1.7)  
(a) Age-standardised to the Australian population as at 30 June 2001. 
Sources: AIHW analysis of ABS 1998, 2003 and 2009 Survey of Disability, Ageing and Carers Confidentialised Unit Record Files. 
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Table D2.4: Prevalence of disability resulting from stroke, by age and sex, 2009 
 Number  Proportion of people with stroke (per cent with 95% CI) 
Age group 
(years) Males Females Persons  Males Females Persons 
0–44  3,317   3,838   7,154    34.7 (15.4–54.1)   37.1 (17.3–56.9)   36.0 (22.0–49.9)  
45–54  4,012   5,812   9,824   26.2 (12.7–39.7)  37.9 (21.7–54.1)   32.1 (22.0–42.2)  
55–64  12,677   6,430   19,107   38.2 (27.9–48.4)  21.8 (12.8–30.8)   30.5 (22.6–38.3)  
65–74  21,639   7,257   28,895   34.3 (28.3–40.3)  26.7 (16.7–36.7)   32.0 (27.2–36.9)  
75–84  23,204   15,618   38,822   36.0 (29.0–43.0)  31.3 (26.7–35.8)   33.9 (29.1–38.8)  
85+  10,137   17,190   27,327   50.2 (37.6–62.8)  45.6 (38.9–52.3)   47.2 (40.6–53.9)  
All ages  74,984   56,145   131,130   36.4 (32.9–40.0)  33.0 (29.0–37.1)   34.9 (32.1–37.7)  
Percentage 
aged 65+  73.3 71.4 72.5  
   
Source: AIHW analysis of ABS 2009 Survey of Disability, Ageing and Carers Confidentialised Unit Record File. 
 
Table D2.5: Prevalence of disability resulting from stroke, by sex, 1998, 2003 and 2009 
 Number  Per cent(a) (95% CI) 
Year Males Females Persons  Males Females Persons 
1998 56,144 69,295 125,439  43.2 (36.6–49.9) 46.1 (40.1–52.0) 45.1 (40.8–49.3) 
2003 78,323 68,084 146,406  44.8 (40.1–49.5) 39.6 (34.2–45.1) 42.2 (37.9–46.6) 
2009 74,984 56,145 131,130   36.8 (33.0–40.6) 32.4 (28.6–36.1) 35.0 (32.4–37.7) 
(a) Age-standardised to the estimated number of people with stroke in 2003. 
Sources: AIHW analysis of ABS 1998, 2003 and 2009 Survey of Disability, Ageing and Carers Confidentialised Unit Record Files. 
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Table D2.6: Stroke deaths, by age and sex, 2010 
 Number of deaths  Deaths per 100,000 population 
Age group (years) Males Females Persons  Males Females Persons 
< 25 8 5 13  0.2 0.1 0.2 
25–34 17 13 30  1.1 0.8 1.0 
35–44 43   44   87   2.8 2.8 2.8 
45–54 93   97   190   6.2 6.4 6.3 
55–64 224   151   375   17.9 11.9 14.9 
65–74 493   393   886   62.4 48.0 55.1 
75–84 1,133   1,317   2,450   256.3 239.9 247.3 
85+ 1,238   3,035   4,273   946.9 1191.2 1108.4 
All ages 3,249   5,055   8,304      
All ages (crude rate)     29.6 45.6 37.6 
All ages (age-standardised rate)(a)     30.9  31.4 32.1 
(a) Age-standardised to the Australian population as at 30 June 2001; age-standardised rates have been calculated using finer age groups 
than those shown. 
Note: Data for 2010 are preliminary and are subject to further revision.  
Source: Analysis of the AIHW National Mortality Database. 
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Table D2.7: Stroke deaths, by type of stroke, age and sex, 2010 
 Number of deaths  Deaths per 100,000 population 
Type of stroke/  
age group (years) Males Females Persons  Males Females Persons 
Haemorrhagic stroke(a)        
0–54 126   131   257   1.5 1.6 1.6 
55–64 127   116   243   10.2 9.1 9.6 
65–74 219   189   408   27.7 23.1 25.4 
75–84 381   418   799   86.2 76.2 80.6 
85+ 261   460   721   199.6 180.5 187.0 
All ages 1,114   1,314   2,428   10.2 11.8 11.0 
All ages (age-standardised rate)(d)    10.3 10.5 9.4 
Ischaemic stroke(b)         
0–54 21 16 37  0.3 0.2 0.2 
55–64 41 9 50  3.3 0.7 2.0 
65–74 70 40 110  8.9 4.9 6.8 
75–84 131 148 279  29.6 27.0 28.2 
85+ 130 324 454  99.4 127.2 117.8 
All ages 393 537 930  3.6 4.8 4.2 
All ages (age-standardised rate)(d)    3.7 3.8 3.4 
Stroke not specified as haemorrhage or 
infarction(c)  
 
    
0–54 14   12   26   0.2 0.1 0.2 
55–64 56   26   82   4.5 2.0 3.3 
65–74 204   164   368   25.8 20.0 22.9 
75–84 621   751   1,372   140.5 136.8 138.5 
85+ 847   2,251   3,098   647.9 883.5 803.6 
All ages 1,742   3,204   4,946   15.9 28.9 22.4 
All ages (age-standardised rate)(d)    16.9 17.2 19.3 
(a) ICD-10 I60–I62. 
(b) ICD-10 I63. 
(c) ICD-10 I64. 
(d) Age-standardised to the Australian population as at 30 June 2001; age-standardised rates have been calculated using finer age groups 
than those shown for people aged 65 and over. 
Note: Data for 2010 are preliminary and are subject to further revision.  
Source: Analysis of the AIHW National Mortality Database. 
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Table D2.8: Stroke deaths, by sex, 1979 to 2010 
 Number of deaths  Deaths per 100,000 population(a) 
Year Males Females Persons  Males Females Persons 
1979 4,916 6,773 11,689  107.7 99.0 103.2 
1980 5,109 6,957 12,066  108.0 98.8 103.8 
1981 4,981 7,094 12,075  105.6 97.5 101.6 
1982 5,061 7,306 12,367  103.6 97.2 101.0 
1983 4,520 6,518 11,038  89.5 84.0 87.3 
1984 4,379 6,346 10,725  83.8 79.2 82.1 
1985 4,462 6,758 11,220  83.4 81.1 83.1 
1986 4,297 6,385 10,682  76.7 73.5 75.7 
1987 4,328 6,265 10,593  76.1 70.3 73.5 
1988 4,301 6,217 10,518  73.4 67.7 70.7 
1989 4,306 6,295 10,601  70.9 66.6 69.2 
1990 4,143 6,274 10,417  66.0 64.7 66.4 
1991 4,169 6,086 10,255  64.5 60.8 63.1 
1992 4,215 6,131 10,346  63.0 59.0 61.5 
1993 4,179 6,312 10,491  61.0 58.5 60.3 
1994 4,457 6,459 10,916  63.7 57.7 60.8 
1995 4,348 6,455 10,803  59.5 55.6 57.9 
1996 4,427 6,575 11,002  58.7 54.6 56.9 
1997 3,745 5,381 9,126  57.0 51.9 54.6 
1998 3,688 5,391 9,079  54.5 50.3 52.5 
1999 3,673 5,466 9,139  52.5 49.1 51.0 
2000 3,638 5,367 9,005  50.2 46.3 48.3 
2001 3,530 5,194 8,724  46.6 43.0 44.9 
2002 3,575 5,403 8,978  45.6 43.3 44.8 
2003 3,605 5,401 9,006  44.6 42.2 43.8 
2004 3,510 5,236 8,746  42.3 39.9 41.4 
2005 3,347 4,848 8,195  38.6 35.9 37.4 
2006 3,348 5,147 8,495  37.1 37.0 37.5 
2007 3,469 5,162 8,631  37.1 35.7 36.7 
2008 3,473 5,319 8,792  36.0 35.7 36.3 
2009 3,296 4,975 8,271  33.0 32.5 33.2 
2010 3,249 5,055 8,304  31.4 32.1 32.2 
(a) Age-standardised to the Australian population as at 30 June 2001. 
Notes 
1. Death rates for 1979–1996 have been adjusted to ICD-10 standards using a comparability factor of 0.83. 
2. Data from New South Wales, Queensland, Western Australia, South Australia and the Northern Territory only. 
3. Data for 2009 and 2010 are revised and preliminary data respectively and are subject to further revision. 
Sources: Analysis of the AIHW National Mortality Database; AIHW 2010b. 
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Table D2.9: Estimated health expenditure on stroke by area of expenditure, age and sex, 2008–09 ($ 
million) 
Age 
(years) Sex 
Hospital-admitted 
patients(a) 
Out-of-hospital 
medical services 
Prescription 
pharmaceuticals(b)  
Total expenditure 
allocated for stroke(c) 
$ million 
0–4 Males 1.0 0.0 0.0 1.0 
 Females 0.7 0.0 0.6 1.2 
 All persons 1.6 0.0 0.6 2.2 
5–14 Males 0.7 0.0 0.0 0.7 
 Females 0.6 0.0 0.0 0.6 
 All persons 1.3 0.0 0.0 1.3 
15–24 Males 2.2 0.0 0.0 2.2 
 Females 2.4 0.0 0.0 2.4 
 All persons 4.6 0.0 0.0 4.6 
25–34 Males 5.9 0.3 0.0 6.2 
 Females 3.8 0.0 0.0 3.8 
 All persons 9.7 0.3 0.0 10.0 
35–44 Males 11.1 0.6 0.1 11.8 
 Females 12.4 0.2 0.0 12.7 
 All persons 23.5 0.8 0.2 24.5 
45–54 Males 25.6 0.5 0.3 26.3 
 Females 21.6 0.6 0.8 22.9 
 All persons 47.2 1.0 1.1 49.3 
55–64 Males 43.0 2.1 2.4 47.5 
 Females 27.5 1.1 0.8 29.4 
 All persons 70.5 3.2 3.2 76.9 
65–74 Males 57.9 2.6 2.5 63.0 
 Females 41.6 1.7 2.8 46.1 
 All persons 99.5 4.3 5.2 109.0 
75–84 Males 71.0 2.8 6.2 80.1 
 Females 78.0 4.7 5.4 88.0 
 All persons 149.0 7.5 11.6 168.1 
85+ Males 37.6 0.7 1.9 40.2 
 Females 66.1 2.6 2.0 70.8 
 All persons 103.8 3.3 3.9 111.0 
Total Males 256.0 9.6 13.4 279.0 
 Females 254.5 11.0 12.3 277.8 
 All persons 510.5 20.6 25.7 556.8 
(a) Includes private medical services provided in hospital. 
(b) Includes all pharmaceuticals for which a prescription is needed, including private prescriptions and under co-payment prescriptions but 
excludes highly specialised drugs. Also excludes over-the-counter medicines such as vitamins and minerals, first aid and wound care 
products, pain-killers and a number of complementary health products sold in both pharmacies and other retail outlets.   
(c) Does not include expenditure on research. 
Source: AIHW Disease Expenditure Database.  
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Table D2.10: Estimated health-care expenditure on stroke, per person, by age, sex and area of 
expenditure, 2008–09 ($) 
Age 
(years) Sex 
Admitted patients(a) 
Out-of-hospital 
medical services 
Prescription 
pharmaceuticals(b)  
Total expenditure 
allocated for stroke(c) 
$ per person(d) 
0–4 Male 1.4 0.0 0.0 1.4 
 Female 1.0 0.0 0.8 1.8 
 All persons 1.2 0.0 0.4 1.6 
5–14 Male 0.5 0.0 0.0 0.5 
 Female 0.4 0.0 0.0 0.4 
 All persons 0.5 0.0 0.0 0.5 
15–24 Male 1.4 0.0 0.0 1.4 
 Female 1.6 0.0 0.0 1.6 
 All persons 1.5 0.0 0.0 1.5 
25–34 Male 3.9 0.2 0.0 4.1 
 Female 2.5 0.0 0.0 2.5 
 All persons 3.2 0.1 0.0 3.3 
35–44 Male 7.1 0.4 0.1 7.6 
 Female 7.9 0.2 0.0 8.1 
 All persons 7.5 0.3 0.1 7.9 
45–54 Male 17.3 0.3 0.2 17.8 
 Female 14.4 0.4 0.5 15.3 
 All persons 15.8 0.4 0.4 16.5 
55–64 Male 35.4 1.7 2.0 39.1 
 Female 22.5 0.9 0.6 24.0 
 All persons 28.9 1.3 1.3 31.6 
65–74 Male 77.9 3.5 3.3 84.6 
 Female 53.6 2.2 3.6 59.4 
 All persons 65.5 2.8 3.4 71.8 
75–84 Male 164.0 6.6 14.4 184.9 
 Female 143.2 8.6 9.9 161.7 
 All persons 152.4 7.7 11.9 172.0 
85+ Male 312.0 5.7 15.8 333.5 
 Female 275.6 10.9 8.4 294.9 
 All persons 287.8 9.2 10.9 307.8 
Total Male 23.8 0.9 1.3 26.0 
 Female 23.5 1.0 1.1 25.6 
 All persons 23.7 1.0 1.2 25.8 
(a) Includes private medical services provided in hospital. 
(b) Includes all pharmaceuticals for which a prescription is needed, including private prescriptions and under co-payment prescriptions but 
excludes highly specialised drugs. Also excludes over-the-counter medicines such as vitamins and minerals, first aid and wound care 
products, pain-killers and a number of complementary health products sold in both pharmacies and other retail outlets.   
(c) Does not include expenditure on research. 
(d) Based on the December 2008 estimated resident Australian population. 
Source: AIHW Disease Expenditure Database.  
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Table D3.1: Stroke(a) hospitalisations, by age and sex, 2009–10 
 Number of hospitalisations  Hospitalisations per 100,000  
Age-group (years) Males Females Persons  Males Females Persons 
<25 185 155 340  5.0 4.4 4.7 
25–34 230 191 421  14.7 12.4 13.5 
35–44 622 617 1,239  40.0 39.0 39.5 
45–54 1,545 1,167 2,712  103.5 76.8 90.0 
55–64 2,967 1,631 4,598  239.6 130.1 184.5 
65–74 4,323 2,659 6,982  558.8 331.0 442.7 
75–84 5,651 5,444 11,095  1288.4 995.5 1125.8 
85+ 2,843 5,115 7,958  2233.6 2048.5 2111.0 
All ages 18,366 16,979 35,345  168.4 154.1 161.2 
Age-standardised rates     171.7 125.0 147.0 
(a) Principal diagnosis of stroke defined using ICD-10-AM codes I60 to I64. 
Source: AIHW analysis of the National Hospital Morbidity Database. 
 
Table D3.2: Ischaemic stroke(a) hospitalisations, by age and sex, 2009–10 
 Number of hospitalisations  Hospitalisations per 100,000  
Age-group (years) Males Females Persons  Males Females Persons 
<25 50 49 99  1.3 1.4 1.4 
25–34 88 85 173  5.6 5.5 5.6 
35–44 256 226 482  16.5 14.3 15.4 
45–54 685 407 1,092  45.9 26.8 36.2 
55–64 1,569 651 2,220  126.7 51.9 89.1 
65–74 2,259 1,301 3,560  292.0 161.9 225.7 
75–84 2,789 2,797 5,586  635.9 511.4 566.8 
85+ 1,323 2,544 3,867  1039.4 1018.8 1025.8 
All ages 9,019 8,060 17,079  82.7 73.1 77.9 
Age-standardised rates     84.0 58.9 70.9 
(a) Principal diagnosis of ischaemic stroke defined using the ICD-10-AM code I63 . 
Source: AIHW analysis of the National Hospital Morbidity Database. 
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Table D3.3: Haemorrhagic stroke(a) hospitalisations, by age and sex, 2009–10 
 Number of hospitalisations  Hospitalisations per 100,000  
Type of haemorrhagic stroke/ age 
group (years) Males Females Persons  Males Females Persons 
Intra-cerebral and other non-traumatic 
haemorrhagic stroke 
   
    
<25 77 53 130  2.1 1.5 1.8 
25–34 52 35 87  3.3 2.3 2.8 
35–44 142 96 238  9.1 6.1 7.6 
45–54 338 189 527  22.6 12.4 17.5 
55–64 644 326 970  52.0 26.0 38.9 
65–74 1,016 562 1,578  131.3 70.0 100.1 
75–84 1,393 1,114 2,507  317.6 203.7 254.4 
85+ 635 883 1,518  498.9 353.6 402.7 
All ages 4,297 3,258 7,555  39.4 29.6 34.5 
Age-standardised rates     40.3 24.3 31.6 
Subarachnoid haemorrhagic stroke        
<25 48 36 84  1.3 1.0 1.2 
25–34 71 54 125  4.5 3.5 4.0 
35–44 143 193 336  9.2 12.2 10.7 
45–54 266 368 634  17.8 24.2 21.0 
55–64 250 348 598  20.2 27.8 24.0 
65–74 178 253 431  23.0 31.5 27.3 
75–84 112 242 354  25.5 44.3 35.9 
85+ 35 93 128  27.5 37.2 34.0 
All ages 1,103 1,587 2,690  10.1 14.4 12.3 
Age-standardised rates     9.9 13.2 11.6 
All haemorrhagic stroke        
<25 125 89 214  3.4 2.5 3.0 
25–34 123 89 212  7.9 5.8 6.8 
35–44 285 289 574  18.3 18.3 18.3 
45–54 604 557 1,161  40.4 36.6 38.5 
55–64 894 674 1,568  72.2 53.8 62.9 
65–74 1,194 815 2,009  154.3 101.4 127.4 
75–84 1,505 1,356 2,861  343.1 247.9 290.3 
85+ 670 976 1,646  526.4 390.9 436.6 
All ages 5,400 4,845 10,245  49.5 44.0 46.7 
Age-standardised rates     50.2 37.5 43.3 
(a) Principal diagnosis of haemorrhagic stroke defined using ICD-10-AM codes I60 to I62. 
Source: AIHW analysis of the National Hospital Morbidity Database. 
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Table D3.4: Unspecified stroke(a) hospitalisations, by age and sex, 2009–10 
 Number of hospitalisations  Hospitalisations per 100,000  
Age-group (years) Males Females Persons  Males Females Persons 
<25 10 17 27  0.3 0.5 0.4 
25–34 19 17 36  1.2 1.1 1.2 
35–44 81 102 183  5.2 6.4 5.8 
45–54 256 203 459  17.1 13.4 15.2 
55–64 504 306 810  40.7 24.4 32.5 
65–74 870 543 1,413  112.5 67.6 89.6 
75–84 1,357 1,291 2,648  309.4 236.1 268.7 
85+ 850 1,595 2,445  667.8 638.8 648.6 
All ages 3,947 4,074 8,021  36.2 37.0 36.6 
Age-standardised rates     37.5 28.7 32.8 
(a) Principal diagnosis of unspecified stroke defined using ICD-10-AM code I64. 
Source: AIHW analysis of the National Hospital Morbidity Database. 
Table D3.5: Transient ischaemic attack(a) hospitalisations, by age and sex, 2009–10 
 Number of hospitalisations  Hospitalisations per 100,000  
 Males Females Persons  Males Females Persons 
Age-groups        
<25 19 32 51  0.5 0.9 0.7 
25–34 82 75 157  5.2 4.9 5.1 
35–44 277 270 547  17.8 17.1 17.4 
45–54 706 606 1,312  47.3 39.9 43.5 
55–64 1,367 982 2,349  110.4 78.3 94.3 
65–74 1,890 1,507 3,397  244.3 187.6 215.4 
75–84 2,310 2,397 4,707  526.7 438.3 477.6 
85+ 1,177 2,037 3,214  924.7 815.8 852.6 
All ages 7,828 7,906 15,734  71.8 71.7 71.8 
Age-standardised rates     72.9 59.2 65.5 
(a) Principal diagnosis of transient ischaemic attack defined using ICD-10-AM code G45. 
Source: AIHW analysis of the National Hospital Morbidity Database. 
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Table D3.6: Hospitalisations with a principal diagnosis of stroke(a), by sex, 1998–99 to 2009–10 
 Number of hospitalisations  Hospitalisations per 100,000 population(b) 
Year Males Females Persons  Males Females Persons 
1998–99 15,655 15,503 31,158  202 150 173 
1999–00 16,494 15,981 32,475  207 150 176 
2000–01 16,780 16,566 33,346  204 151 175 
2001–02 16,636 16,386 33,022  196 145 168 
2002–03 16,654 16,264 32,918  191 140 163 
2003–04 16,852 16,564 33,416  187 140 162 
2004–05 17,015 16,415 33,435  184 136 158 
2005–06 17,826 16,529 34,355  186 133 158 
2006–07 17,635 16,837 34,476  179 132 154 
2007–08 17,991 16,954 34,945  178 130 153 
2008–09 18,500 17,086 35,586  178 129 152 
2009–10 18,366 16,979 35,345  172 125 147 
(a) Principal diagnosis of stroke defined using ICD-10-AM codes I60 to I64. 
(b) Age-standardised to the Australian population as at 30 June 2001. 
Source: AIHW analysis of the National Hospital Morbidity Database. 
 
Table D3.7: Hospitalisations with a principal diagnosis of ischaemic and haemorrhagic stroke(a), by 
sex, 1998–99 to 2009–10 
 Hospitalisation per 100,000 population(b) 
 Ischaemic stroke  Haemorrhagic stroke 
Year Males Females Persons  Males Females Persons 
1998–99 87.7 61.4 73.6  47.2 40.0 43.2 
1999–00 91.2 63.4 76.3  49.9 39.1 44.0 
2000–01 90.2 62.0 74.9  50.0 39.6 44.2 
2001–02 86.9 60.4 72.6  49.0 39.0 43.4 
2002–03 82.8 58.3 69.8  50.4 38.1 43.5 
2003–04 83.5 58.5 70.2  49.9 39.9 44.3 
2004–05 83.0 58.2 70.0  48.5 38.6 42.9 
2005–06 86.7 58.6 71.9  50.1 38.0 43.5 
2006–07 85.3 60.2 72.2  50.6 38.8 44.2 
2007–08 86.0 59.8 72.3  49.2 38.1 43.0 
2008–09 83.7 58.4 70.4  50.6 37.6 43.5 
2009–10 84.0 58.9 70.9  50.2 37.5 43.3 
(a) Principal diagnoses of ischaemic and haemorrhagic stroke defined using ICD-10-AM codes I60 to I63. 
(b) Age-standardised to the Australian population as at 30 June 2001. 
Source: AIHW analysis of the National Hospital Morbidity Database. 
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Table D3.8: Hospitalisations with a principal diagnosis of unspecified type stroke(a), by sex, 1998–
99 to 2009–10 
 Hospitalisations per 100,000 population(b) 
Year Males Females Persons 
1998–99 66.8 48.8 56.7 
1999–00 65.6 47.3 55.3 
2000–01 63.5 48.9 55.7 
2001–02 60.2 45.2 51.9 
2002–03 57.3 43.9 50.0 
2003–04 53.9 42.0 47.4 
2004–05 52.1 39.1 45.1 
2005–06 49.2 36.8 42.5 
2006–07 43.2 33.4 38.1 
2007–08 42.7 32.5 37.3 
2008–09 43.4 32.9 37.8 
2009–10 37.5 28.7 32.8 
(a) Principal diagnosis of unspecified stroke defined using ICD-10-AM code I64. 
(b) Age-standardised to the Australian population as at 30 June 2001. 
Source: AIHW analysis of the National Hospital Morbidity Database. 
 
Table D3.9: Hospitalisations with a principal diagnosis of transient ischaemic attack(a), by sex,  
1998–99 to 2009–10 
 Hospitalisations per 100,000 population(b) 
Year Males Females Persons 
1998–99 79.5 58.1 67.7 
1999–00 76.8 56.9 65.8 
2000–01 75.4 57.5 65.5 
2001–02 73.8 58.0 65.1 
2002–03 71.5 57.0 63.6 
2003–04 69.0 55.2 61.5 
2004–05 67.8 52.2 59.4 
2005–06 68.7 55.9 61.7 
2006–07 71.3 55.2 62.6 
2007–08 70.6 56.9 63.3 
2008–09 72.8 58.0 64.9 
2009–10 72.9 59.2 65.5 
(a) Principal diagnosis of transient ischaemic attack defined using ICD-10-AM code G45. 
(b) Age-standardised to the Australian population as at 30 June 2001. 
Source: AIHW analysis of the National Hospital Morbidity Database. 
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Table D3.10: Hospitalisations with a principal diagnosis of stroke(a) that had at least one MRI brain 
scan(b), by sex, 2000–01 to 2009–10 
 Number of hospitalisations that had at 
least one MRI brain scan 
 
Percentage of all stroke hospitalisations(c) 
Year Males Females Persons  Males Females Persons 
2000–01 1,581 1,076 2,657  8.6 7.3 8.0 
2001–02 1,676 1,283 2,959  9.3 8.9 9.1 
2002–03 2,054 1,450 3,504  11.4 10.0 10.7 
2003–04 2,401 1,731 4,132  13.1 11.4 12.4 
2004–05 2,762 1,911 4,673  15.1 12.8 13.9 
2005–06 3,337 2,292 5,629  17.5 15.1 16.4 
2006–07 3,410 2,507 5,918  18.1 16.3 17.3 
2007–08 3,717 2,551 6,268  19.5 16.6 18.1 
2008–09 4,007 2,920 6,927  20.5 18.5 19.6 
2009–10 4,101 2,881 6,982  21.2 18.4 19.9 
(a) Principal diagnosis of stroke defined using ICD-10-AM codes I60 to I64. 
(b) MRI brain scan defined as per the ACHI version 6 codes 90901–00, 90901–09 was counted once only for one hospitalisation with a 
principal diagnosis of stroke even if several MRI brain scans could have been performed during one hospitalisation. 
(c) Age-standardised to the number of hospitalisations in 2000–01 with a principal diagnosis of stroke. 
Source: AIHW analysis of the National Hospital Morbidity Database.  
 
Table D3.11: Hospitalisations with a principal diagnosis of stroke that had at least one 
computerised tomography (CT) brain scan(a), by sex, 2000–01 to 2009–10 
 Number of hospitalisations that had at 
least one CT brain scan 
 
Percentage of all stroke hospitalisations(b) 
Year Males Females Persons  Males Females Persons 
2000–01 10,667 10,154 20,821  63.0 62.0 62.4 
2001–02 10,734 10,440 21,174  64.3 64.3 64.2 
2002–03 10,882 10,409 21,291  64.9 64.5 64.7 
2003–04 11,160 10,904 22,064  65.9 66.2 66.1 
2004–05 11,761 11,356 23,119  68.8 69.7 69.2 
2005–06 12,526 11,611 24,137  70.2 70.5 70.3 
2006–07 12,522 11,820 24,345  70.9 70.7 70.8 
2007–08 12,611 11,934 24,545  70.1 70.7 70.4 
2008–09 12,805 11,662 24,467  69.3 68.6 68.9 
2009–10 12,012 10,869 22,881  65.3 64.5 64.9 
(a) Principal diagnosis of stroke defined using ICD-10-AM codes I60 to I64. 
(b) CT brain scan, defined as per the ACHI version 6 codes 56001–00,56007–00,56010–02,56010–03, was counted once only for one 
hospitalisation with a principal diagnosis of stroke even if several CT brain scans could have been performed during one hospitalisation. 
Source: AIHW analysis of the National Hospital Morbidity Database. 
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Table D3.12: Hospitalisations with at least one carotid endarterectomy(a), 
by principal diagnosis, 2000–01 to 2009–10 
Year Number of hospitalisations with at least one carotid endarterectomy 
CVD(b) or TIA as 
principal diagnosis 
 Other principal 
diagnosis 
 
All 
2000–01 3,311  104  3,415 
2001–02 3,377  187  3,564 
2002–03 3,185  33  3,218 
2003–04 2,902  40  2,942 
2004–05 2,719  35  2,754 
2005–06 2,527  49  2,576 
2006–07 2,401  36  2,437 
2007–08 2,422  27  2,449 
2008–09 2,348  28  2,376 
2009–10 2,488  27  2,515 
(a) Carotid endarterectomy, defined as per the ACHI version 6 codes 33500–00, was counted once only 
for one hospitalisation with a principal diagnosis of stroke even if several carotid endarterectomies 
could have been performed during on hospitalisation. 
(b) Principal diagnosis of CVD and TIA defined using ICD-10-AM codes I00 to I99 and G45. 
Source: AIHW analysis of the National Hospital Morbidity Database. 
 
Table D3.13: Hospitalisations for rehabilitation(a) for stroke and its sequelae(b), by age and sex,  
2009–10 
 Number of hospitalisations  Hospitalisations per 100,000 population 
 Males Females Persons  Males Females Persons 
Age-groups        
<25  74   59   133   2.0 1.7 1.8 
25–34  175   216   391   11.2 14.0 12.6 
35–44  370   485   855   23.8 30.6 27.3 
45–54  1,539   1,048   2,587   103.1 68.9 85.9 
55–64  2,690   1,789   4,479   217.3 142.7 179.7 
65–74  3,889   2,300   6,189   502.7 286.3 392.4 
75–84  3,878   3,547   7,425   884.2 648.6 753.4 
85+  1,652   2,099   3,751   1297.9 840.6 995.0 
All ages  14,267   11,543   25,810   130.8 104.7 117.7 
Age-standardised rates     131.2 89.6 108.6 
Rate ratio (ASR 
male/ASR female)     
1.5   
(a) Principal diagnosis of rehabilitation defined using ICD-10-AM codes Z500, Z501 and Z504–Z509. 
(b) Associated diagnosis of stroke and its sequelae defined using ICD-10-AM codes I60–I64 and I69 (excluding I69.8) with a principal 
diagnosis of rehabilitation defined using ICD-10-AM codes Z500, Z501 and Z504–Z509.  
Source: AIHW analysis of the National Hospital Morbidity Database. 
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Table D4.1: Number of prescriptions of stroke medicines by year  
 Prescriptions supplied in the community  
 2001 2009 Change (2001–2009) 
Medicine groups Number Per cent Number Per cent Per cent 
Antithrombotic agents 4,010,826 100.0 8.413,091 100.0 109.8 
Vitamin K antagonist 1,897,839 47.3 3,105,114 36.9 63.6 
Heparin group 110,518 2.8 385,053 4.6 248.4 
Platelet aggregation inhibitors      
Aspirin 943,906 23.5 1,357,176 16.1 43.8 
Other agents than aspirin 1,057,680 26.4 3,560,033 42.3 236.6 
Other antithrombotic agents 883 < 0.1 5,715 0.1 547.2 
Antihaemorrhagic agents 22,698 100.0 37,549 100.0 65.4 
Cardiac therapy 3,907,524 100.0 3,602,877 100.0 -7.8 
Antiarrhytmics 575,489 14.7 593,852 16.5 3.2 
Nitrates 2,589,152 66.3 1,943,809 54.0 -24.9 
Other vasodilatators agents 112,120 2.9 238,217 6.6 112.5 
Other cardiac therapeutic agents 
(glycosides, adrenergic agents and 
other cardiac preparations) 630,763 16.1 826,999 23.0 31.1 
Blood-pressure-lowering agents 35,973,617 100.0 52,242,178 100.0 45.2 
Antihypertensives 940,161 2.6 1,199,632 2.3 27.6 
Diuretics 3,317,558 9.2 2,851,123 5.5 -14.1 
Peripheral vasodilatators 8,646 < 0.1 3,530 < 0.1 -59.2 
Vasoprotective agents 118,410 0.3 62,286 0.1 -47.4 
Beta-blocking agents 5,869,542 16.3 8,003,071 15.3 36.3 
Calcium-channel blockers 8,637,257 24.0 9,722,359 18.6 12.6 
Renin-angiotensin system agents 17,082,043 47.5 30,400,177 58.2 78.0 
Lipid-modifying agents 12,778,930 100.0 24,819,117 100.0 94.2 
TOTAL 56,693,595  89,114,812   
Sources: DoHA 2004, 2011. 
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Table D5.1: Activity limitations, by diagnosed cerebrovascular disease/TIA status(a), for ACAP 
clients with a complete(b) ACAT assessment, 1 July 2009 to 30 June 2010 
 
ACAP clients with 
cerebrovascular disease/TIA(a) 
 
Other ACAP clients(c) 
Activity limitation Number Per cent  Number Per cent 
Self-care 25,725 78.6  89,832 69.3 
Movement activities 12,556 38.4  35,752 27.6 
Moving around places at or away from home 21,861 66.8  73,775 56.9 
Communication 8,996 27.5  25,196 19.4 
Health-care tasks 27,760 84.8  101,381 78.2 
Transport 30,540 93.3  115,516 89.1 
Activities involved in social and community 
participation 29,074 88.8  108,969 84.0 
Domestic assistance 28,561 87.3  113,540 87.6 
Meals 26,610 81.3  101,526 78.3 
Home maintenance 23,254 71.1  91,655 70.7 
Other 1,809 5.5  7,071 5.5 
None 140 0.4  1031 0.8 
Unable to determine 38 0.1  387 0.3 
Not stated/inadequately described 263 0.8  1,338 1.0 
Total ACAP clients with complete assessment 32,725 100.0   129,659 100.0 
(a) A client’s diagnosed cerebrovascular disease/TIA status is based on the last complete ACAT assessment conducted during the 2009–10 
financial year. 
(b) A complete ACAT assessment is an assessment where the reason for ending the assessment was ‘Assessment complete—care plan 
developed’. 
(c) Other ACAP clients are ACAP clients with health conditions other than cerebrovascular diseases or TIA or with no other health conditions. 
Source: AIHW analysis of DoHA Ageing and Aged Care Data Warehouse (unpublished). 
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Table D5.2: Diagnosed cerebrovascular disease/TIA status(a) of ACAP clients with a complete(b) 
ACAT assessment, by age and sex, 1 July 2009 to 30 June 2010 
 
ACAP clients 
with a 
diagnosis of 
cerebrovascular 
disease or TIA(d) 
Other ACAP 
clients(e) 
All ACAP 
clients with a 
complete 
assessment  
ACAP clients 
with a 
diagnosis of 
cerebrovascular 
disease or TIA(d) 
Other ACAP 
clients(e) 
All ACAP 
clients with a 
complete 
assessment 
Sex/age 
group(c) 
(years) Number(d)  Per cent 
Males        
0–49 54 244 298  0.4 0.5 0.5 
50–54 78 306 384  0.5 0.6 0.6 
55–59 150 524 674  1.0 1.1 1.1 
60–64 406 1,167 1,573  2.7 2.5 2.5 
65–69 802 2,485 3,287  5.4 5.3 5.3 
70–74 1,521 4,269 5,790  10.2 9.1 9.3 
75–79 2,493 7,359 9,852  16.8 15.6 15.9 
80–84 3,872 11,893 15,765  26.1 25.2 25.4 
85–89 3,588 11,706 15,294  24.1 24.8 24.7 
90+ 1,899 7,196 9,095  12.8 15.3 14.7 
Total 14,863 47,149 62,012  100 100 100 
Females        
0–49 39 228 267  0.2 0.3 0.3 
50–54 59 288 347  0.3 0.3 0.3 
55–59 125 543 668  0.7 0.7 0.7 
60–64 273 1,310 1,583  1.5 1.6 1.6 
65–69 615 2,896 3,511  3.4 3.5 3.5 
70–74 1,191 5,860 7,051  6.7 7.1 7.0 
75–79 2,417 11,129 13,546  13.5 13.5 13.5 
80–84 4,390 20,309 24,699  24.6 24.6 24.6 
85–89 5,219 23,188 28,407  29.2 28.1 28.3 
90+ 3,532 16,755 20,287  19.8 20.3 20.2 
Total 17,860 82,506 100,366   100.0 100.0 100.0 
(a) A client’s diagnosed cerebrovascular disease/TIA status is based on the last complete ACAT assessment conducted during the 2009–10 
financial year. A complete ACAT assessment is an assessment where the reason for ending the assessment was ‘Assessment complete—
care plan developed’. 
(b) Age as at 30 June 2010. 
(c) A diagnosis of cerebrovascular disease or TIA is defined as at least one ACAP health condition code of 0605 or 0910-0916. 
(d) Other ACAP clients are ACAP clients with health conditions other than cerebrovascular diseases or TIA or with no other health conditions. 
(e) Excludes clients whose sex was not stated or inadequately described, i.e. 2 ACAP clients with a diagnosis of cerebrovascular disease or 
TIA and 4 other ACAP clients. 
Source: AIHW analysis of DoHA Ageing and Aged Care Data Warehouse (unpublished). 
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Table D5.3: Diagnosed cerebrovascular disease/TIA status(a) of ACAP clients with a complete(b) 
ACAT assessment, by age, 1 July 2009 to 30 June 2010 
 
ACAP clients 
with a 
diagnosis of 
cerebrovascular 
disease or TIA(d) 
Other ACAP 
clients(e) 
All ACAP 
clients with a 
complete 
assessment  
ACAP clients 
with a 
diagnosis of 
cerebrovascular 
disease or TIA(d) 
Other ACAP 
clients(e) 
All ACAP 
clients with a 
complete 
assessment 
Sex/age 
group(c) 
(years) Number  Per cent 
Persons        
0–49 93 472 565  0.3 0.4 0.3 
50–54 137 594 731  0.4 0.5 0.5 
55–59 275 1,067 1,342  0.8 0.8 0.8 
60–64 679 2,477 3,156  2.1 1.9 1.9 
65–69 1,417 5,381 6,798  4.3 4.2 4.2 
70–74 2,712 10,129 12,841  8.3 7.8 7.9 
75–79 4,910 18,489 23,399  15.0 14.3 14.4 
80–84 8,264 32,203 40,467  25.3 24.8 24.9 
85–89 8,807 34,895 43,702  26.9 26.9 26.9 
90+ 5,431 23,952 29,383  16.6 18.5 18.1 
Total 32,725 129,659 162,384   100.0 100.0 100.0 
(a) A client’s diagnosed cerebrovascular disease/TIA status is based on the last complete ACAT assessment conducted during the 2009–10 
financial year.. 
(b) A complete ACAT assessment is an assessment where the reason for ending the assessment was ‘Assessment complete—care plan 
developed’. 
(c) Age as at 30 June 2010. 
(d) A diagnosis of cerebrovascular disease or TIA is defined as at least one ACAP health condition code of 0605 or 0910-0916. 
(e) Other ACAP clients are ACAP clients with health conditions other than cerebrovascular diseases or TIA or with no other health conditions. 
Source: AIHW analysis of DoHA Ageing and Aged Care Data Warehouse (unpublished). 
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Table D5.4: First face-to-face contact setting by diagnosed cerebrovascular disease/TIA status(a) for 
ACAP clients with a complete ACAT assessment(a), 1 July 2009 to 30 June 2010 
 
ACAP clients with 
a diagnosis of 
cerebrovascular 
disease or TIA(c) 
Other 
ACAP 
clients(d) 
All ACAP 
clients with a 
complete 
assessment  
ACAP clients with 
a diagnosis of 
cerebrovascular 
disease or TIA(c) 
Other 
ACAP 
clients(d) 
All ACAP 
clients with a 
complete 
assessment 
Contac setting Number  Per cent 
Private residence/ 
other community 16,906 79,115 96,021  51.7 61.0 59.1 
Hospital (acute 
care) 8,292 25,632 33,924  25.3 19.8 20.9 
Other hospital 
inpatient setting 5,494 16,846 22,340  16.8 13.0 13.8 
Residential aged-
care service 2,014 7,869 9,883  6.2 6.1 6.1 
Not stated/ 
inadequately 
described(b) 19 197 216 
 
0.1 0.2 0.1 
Total 32,725 129,659 162,384   100.0 100.0 100.0 
(a) A client’s diagnosed cerebrovascular disease/TIA status is based on the last complete ACAT assessment during the 2009–10 financial 
year. A diagnosis of cerebrovascular disease or TIA is defined as at least one ACAP health condition code of 0605 or 0910-0916. 
(b) Recorded for people who were permanent residents of residential aged–care services, hospitals or other institutional settings at the time of 
assessment. 
(c) A complete ACAT assessment is an assessment where the reason for ending the assessment was ‘Assessment complete—care plan 
developed’. 
(d) Other ACAP clients are the people with health conditions other than cerebrovascular diseases or TIA or with no other health conditions. 
Source: AIHW analysis of DoHA Ageing and Aged Care Data Warehouse (unpublished). 
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Table D5.5: Usual residence at assessment and recommended long-term care setting, by diagnosed 
cerebrovascular disease/TIA status(a), for ACAP clients with a complete ACAT assessment(b), 1 July 
2009 to 30 June 2010 
 Residence at the assessment  Recommended residence 
Residence types 
ACAP clients with a 
diagnosis of 
cerebrovascular 
disease or TIA(c) 
Other ACAP 
clients(d) 
 ACAP clients with 
a diagnosis of 
cerebrovascular 
disease or TIA(c) 
Other ACAP 
clients(d) 
 Number 
Private residence 26,538 106,044  15,321 68,612 
Independent living within a retirement 
village 2,997 12,077  1,037 4,721 
Supported community accommodation 446 1,911  181 916 
Residential aged-care—low level 1,947 6,601  5,026 21,929 
Residential aged-care—high level 226 655  10,941 32,624 
Hospital 72 243  7 87 
Other institutional care 58 262  16 69 
Other 416 1,621  180 635 
Not stated/inadequately described 25 245  16 66 
Total 32,725 129,659  32,725 129,659 
 Per cent 
Private residence 81.1 81.8  46.8 52.9 
Independent living within a retirement 
village 9.2 9.3  3.2 3.6 
Supported community accommodation 1.4 1.5  0.6 0.7 
Residential aged-care—low level 5.9 5.1  15.4 16.9 
Residential aged-care—high level 0.7 0.5  33.4 25.2 
Hospital 0.2 0.2  < 0.1 0.1 
Other institutional care 0.2 0.2  < 0.1 0.1 
Other 1.3 1.3  0.6 0.5 
Not stated/inadequately described 0.1 0.2  < 0.1 0.1 
Total 100.0 100.0   100.0 100.0 
(a) A client’s diagnosed cerebrovascular disease/TIA status is based on the last complete ACAT assessment conducted during the 2009–10 
financial year. 
(b) A complete ACAT assessment is an assessment where the reason for ending the assessment was ‘Assessment complete—care plan 
developed’. 
(c) A diagnosis of cerebrovascular disease or TIA is defined as at least one ACAP health condition code of 0605 or 0910-0916. 
(d) Other ACAP clients are the people with health conditions other than cerebrovascular diseases or TIA or with no other health conditions. 
Source: AIHW analysis of DoHA Ageing and Aged Care Data Warehouse (unpublished). 
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Table D5.6: Current and recommended assistance with activities, by diagnosed cerebrovascular 
disease/TIA status(a), for persons with a complete ACAT assessment(b), 1 July 2009 to 30 June 2010  
 Current assistance(c)  Recommended assistance(d) 
Type of activity 
ACAP clients with 
a diagnosis of 
cerebrovascular 
disease or TIA(e) 
Other ACAP 
clients(f)  
ACAP clients with a 
diagnosis of 
cerebrovascular 
disease or TIA(e) 
Other ACAP 
clients(f) 
 Number 
Self-care 16,662 59,680  12,631 46,786 
Movement 6,467 21,009  4,064 12,426 
Moving around places  
at or away from home 14,011 51,073  8,789 31,706 
Communication 5,946 20,376  2,536 7,391 
Health-care tasks 20,295 78,195  13,195 52,326 
Transport 24,217 95,725  13,806 56,855 
Activities involved in social and 
community participation 22,235 88,004  13,824 56,523 
Domestic assistance 26,490 106,151  16,541 71,433 
Meals 23,485 91,304  12,178 51,219 
Home maintenance 19,853 80,577  9,289 40,304 
Other 2,314 9,370  1,190 5,105 
None 11,378 43,486  2,119 8,863 
Unable to determine 10,370 41,152  203 965 
Not stated/inadequately described 23 97  125 559 
Not applicable(g) 2,242 7,444  12,033 40,300 
Total ACAP clients 32,725 129,659  32,725 129,659 
 Per cent 
Self-care 50.9 46.0  38.6 36.1 
Movement 19.8 16.2  12.4 9.6 
Moving around places  
at or away from home 42.8 39.4  
26.9 24.5 
Communication 18.2 15.7  7.7 5.7 
Health-care tasks 62.0 60.3  40.3 40.4 
Transport 74.0 73.8  42.2 43.8 
Activities involved in social and 
community participation 67.9 67.9  
42.2 43.6 
Domestic assistance 80.9 81.9  50.5 55.1 
Meals 71.8 70.4  37.2 39.5 
Home maintenance 60.7 62.1  28.4 31.1 
Other 7.1 7.2  3.6 3.9 
None 34.8 33.5  6.5 6.8 
Unable to determine 31.7 31.7  0.6 0.7 
Not stated/inadequately described 0.1 0.1  0.4 0.4 
Not applicable(g) 6.9 5.7  36.8 31.1 
Total ACAP clients 100.0 100.0   100.0 100.0 
(continued) 
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Table D5.6 (continued): Current and recommended assistance with activities, by diagnosed 
cerebrovascular disease/TIA status(a), for persons with a complete ACAT assessment(b), 1 July 2009 
to 30 June 2010  
(a)  A client’s diagnosed cerebrovascular disease/TIA status is based on the last complete ACAT assessment conducted during the 2009–10 
financial year. 
(b) A complete ACAT assessment is an assessment where the reason for ending the assessment was ‘Assessment complete—care plan 
developed’. 
(c)  Current assistance includes formal and informal assistance. 
(d)  Recommended assistance includes only formal assistance with a higher representation of people hospitalised for stroke and assessed at 
their discharge. 
(e)  A diagnosis of cerebrovascular disease or TIA is defined as at least one ACAP health condition code of 0605 or 0910-0916. 
(f)  Other ACAP clients are people with health conditions other than cerebrovascular diseases or TIA or with no other health conditions. 
(g)  Includes clients who were permanent residents of residential aged-care services, hospitals or other institutional settings at the time of 
assessment.  
Source: AIHW analysis of DoHA Ageing and Aged Care Data Warehouse (unpublished). 
Table D5.7: Level of assistance needed in each ACFI care domain, by diagnosed cerebrovascular 
disease/TIA status(a), for permanent aged-care residents with an ACFI appraisal, 1 July 2009 to 30 
June 2010 
ACFI care domain 
Residents with a diagnosis of 
cerebrovascular disease or TIA(b) Other residents(c) 
 Number 
Activities of daily living   
High 23,786 72,094 
Medium 11,056 49,031 
Low care 6,725 41,439 
Nil 1,180 8,323 
Behaviour   
High 18,810 78,560 
Medium 11,757 41,814 
Low care 8,148 31,633 
Nil 4,032 18,880 
Complex health care   
High 11,158 39,009 
Medium 13,543 53,103 
Low care 14,249 57,200 
Nil 3,797 21,575 
Total residents with an ACFI 
appraisal 
42,747 170,887 
(continued) 
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Table D5.7 (continued): Level of assistance needed in each ACFI care domain, by diagnosed 
cerebrovascular disease/TIA status(a), for permanent aged-care residents with an ACFI appraisal, 1 
July 2009 to 30 June 2010 
 Per cent 
Activities of daily living   
High 55.6 42.2 
Medium 25.9 28.7 
Low care 15.7 24.2 
Nil 2.8 4.9 
Behaviour   
High 44.0 46.0 
Medium 27.5 24.5 
Low care 19.1 18.5 
Nil 9.4 11.0 
Complex health care   
High 26.1 22.8 
Medium 31.7 31.1 
Low care 33.3 33.5 
Nil 8.9 12.6 
Total residents with an ACFI 
appraisal 
100.0 100.0 
(a)  Residents’ diagnosed cerebrovascular disease/TIA status is based on the most recent ACFI appraisal conducted during or before the 
2009–10 financial year. 
(b)  A diagnosis of cerebrovascular disease or TIA is defined as at least one ACAP health condition code of 0605 or 0910-0916. 
(c)  Includes residents with no health condition impacting on care needs (i.e. both Mental and Behavioural and medical code lists have 0) and 
residents for whom both the mental and behavioural and medical code lists were blank. 
Source: AIHW analysis of DoHA Ageing and Aged Care Data (unpublished). 
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Table D5.8: Effects of caring role on co-resident primary carer’s health and wellbeing, 2009 
 Co-resident primary carers of  
people with stroke and disability 
  Number Per cent 
Whether physical/emotional wellbeing changed due to caring role   
Physical or emotional wellbeing has changed due to caring role  25,947  34.6 
Physical or emotional wellbeing has not changed due to caring role  43,429  57.9 
Not stated *5,588  7.5 
Whether feels satisfied due to caring role   
Feels satisfied due to caring role  16,378  21.8 
Does not feel satisfied due to caring role  52,999  70.7 
Not stated  *5,588  7.5 
Whether feels weary or lacks energy due to caring role   
Feels weary or lacks energy due to caring role  24,975  33.3 
Does not feel weary or lack energy due to caring role  44,401  59.2 
Not stated  *5,588  7.5 
Whether frequently feels angry or resentful due to caring role   
Frequently feels angry or resentful due to caring role  9,657  12.9 
Does not frequently feel angry or resentful due to caring role  59,719  79.7 
Not stated  *5,588  7.5 
Whether frequently feels worried or depressed due to caring role   
Frequently feels worried or depressed due to caring role  25,292  33.7 
Does not frequently feel worried or depressed due to caring role  44,084  58.8 
Not stated  *5,588  7.5 
Whether has had a stress-related illness due to caring role   
Has been diagnosed with a stress-related illness due to caring role  10,934  14.6 
Has not been diagnosed with a stress-related illness due to caring role  58,443  78.0 
Not stated  *5,588  7.5 
Total co-resident primary carers  74,965  100.0 
Notes 
1. Estimates marked with an asterisk have an associated relative standard error (RSE) of between 25% and 50% and should be interpreted 
with caution. 
2. Estimates marked with two asterisks have an associated relative standard error (RSE) of more than 50% and should be interpreted with 
caution 
Source: AIHW analysis of ABS 2009 Survey of Disability, Ageing and Carers Basic Confidentialised Unit Record File on CD-ROM. 
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Table D5.9: Effects of caring role on co-resident primary carer’s relationships, 2009 
 
Co-resident primary carers of  
people with stroke and disability 
  Number Per cent 
Effect on relationship with main recipient of care    
Relationship unaffected  36,358  48.5 
Brought closer together  19,423  25.9 
Relationship strained  13,538  18.1 
Not stated  *5,646  7.5 
Effect on relationship with partner   
Not applicable (main recipient is partner)  49,424  65.9 
Relationship unaffected  7,992  10.7 
Brought closer together  *5,938  7.9 
Lack time alone together  **1,595  2.1 
Relationship strained  **1,188  1.6 
Has no spouse or partner  *3,565  4.8 
Not stated  *5,262  7.0 
Effect on relationship with co-resident family members   
Relationships unaffected  19,251  25.7 
Brought closer together  *3,002  4.0 
Less time to spend with them  *5,438  7.3 
Relationships strained  *3,595  4.8 
Relationships affected in another way  **619  0.8 
Has no other co-resident family members  36,810  49.1 
Not stated  *6,250  8.3 
Effect on friendships   
Friendships unaffected  39,697  53.0 
Circle of friends has increased  **802  1.1 
Circle of friends has changed  7,303  9.7 
Lost or losing touch with existing friends  20,313  27.1 
Not stated  6,850  9.1 
Total co-resident primary carers  74,965  100.0 
Notes 
1 Estimates marked with an asterisk have an associated relative standard error (RSE) of between 25% and 50% and should be  
interpreted with caution. 
2 Estimates marked with two asterisks have an associated relative standard error (RSE) of more than 50% and should be interpreted  
with caution. 
Source: AIHW analysis of ABS 2009 Survey of Disability, Ageing and Carers Basic Confidentialised Unit Record File on CD-ROM. 
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Table D6.1: Age-specific hospitalisation rates by main types of stroke and Indigenous status(a) in 
2009–10 
  Hospitalisation rates per 100,000 population 
 Indigenous   Other Australians 
Type of stroke/  
age group (years)  Males Females Persons 
 
Males Females Persons 
All stroke         
0–34  10.6 9.9 10.2 
 
7.7 6.7 7.2 
35–44  148.6 131.3 139.6 
 
37.9 37.0 37.4 
45–54  421.0 307.0 361.5 
 
97.6 70.9 84.1 
55–64  535.9 561.4 549.4 
 
235.0 121.3 177.8 
65 and over 1,338.1 1,156.9 1,234.7 
 
949.4 816.3 877.0 
Crude rate 127.1 127.6 127.4 
 
168.5 153.0 160.7 
ASR(b) 306.0 266.2 284.2 
 
164.1 132.4 147.5 
Rate ratio (Indigenous/Other 
Australians) 1.9 2.0 1.9     
Ischaemic stroke 
       
0–34  4.8 6.6 5.6 
 
2.5 2.5 2.5 
35–44  37.9 61.3 50.1 
 
16.3 13.4 14.8 
45–54  167.5 74.8 119.1 
 
43.3 25.3 34.2 
55–64  203.8 267.3 237.5 
 
125.4 47.6 86.3 
65 and over 702.2 478.7 574.7 
 
472.8 410.8 439.1 
Crude rate 52.8 52.4 52.6 
 
83.2 72.9 78.0 
ASR(b) 139.3 108.8 122.1 
 
80.7 62.7 71.3 
Rate ratio (Indigenous/Other 
Australians) 1.7 1.7 1.7     
Haemorrhagic stroke 
       
0–34  3.7 2.2 3.0 
 
4.7 3.6 4.1 
35–44  88.5 35.0 60.7 
 
17.0 18.0 17.5 
45–54  154.7 122.0 137.6 
 
38.2 34.4 36.3 
55–64  188.7 106.9 145.3 
 
70.4 52.0 61.2 
65 and over 198.7 249.3 227.6 
 
250.3 194.3 219.9 
Crude rate 41.9 32.9 37.4 
 
49.4 43.8 46.6 
ASR(b) 79.9 64.7 72.2   48.2 38.5 43.0 
Rate ratio (Indigenous/Other 
Australians) 1.7 1.7 1.7     
(a) Based on patients usually resident in New South Wales, Victoria, Queensland, Western Australia, South Australia and the Northern 
Territory; excludes private hospitals in the Northern Territory. 
(b) Age-standardised to the Australian population as at 30 June 2001; age-standardised rates have been calculated using finer age groups 
than those shown for people aged 35–64. 
Source: AIHW analysis of the National Hospital Morbidity Database. 
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Table D6.2: Stroke deaths, by Indigenous status(a) and sex, 2006–2010 
 Number of deaths(b)  Deaths per 100,000 population(c) 
 Males Females  Males Females 
Indigenous 189 225  58.0 54.8 
Non-Indigenous 11,918 18,094  34.0 39.0 
Rate ratio (Indigenous/ non- Indigenous)   1.7 1.4 
(a) Excludes people whose Indigenous status was not stated or was inadequately described. 
(b) Queensland deaths data for 2010 have been adjusted to minimise the impact of late registration of deaths on mortality indicators by 
excluding deaths registered in Queensland in 2010 that occurred in Queensland prior to 2010. 
(c) Age-standardised to the Australian population as at 30 June 2001. 
Notes 
1. Data from New South Wales, Queensland, Western Australia, South Australia and the Northern Territory only. 
2. Data for 2009 and 2010 are revised and preliminary data respectively and are subject to further revision. 
Source: AIHW National Mortality Database. 
Table D6.3: Stroke deaths, by Indigenous status(a) and age, 2006–2010 
 Number of deaths(b)  Number per 100,000 population 
Age group (years) Indigenous Non-Indigenous  Indigenous Non-Indigenous 
0–24 10  52   0.7 0.2 
25–34 9  90   2.7 0.9 
35–44 37  258   12.3 2.4 
45–54 75  699   34.9 6.8 
55–64 74  1,318   61.6 15.6 
65–74 71  2,982   135.2 56.4 
75+ 138  24,611   591.0 526.9 
All ages(c)  414  30,012   17.2 40.6 
All ages ASR (per cent)(d)    56.2 37.1 
Rate ratio (Indigenous/ non- Indigenous)   1.5  
(a) Excludes people whose Indigenous status was not stated or was inadequately described. 
(b) Queensland deaths data for 2010 have been adjusted to minimise the impact of late registration of deaths on mortality indicators by 
excluding deaths registered in Queensland in 2010 that occurred in Queensland before. 
(c) Includes people of unknown age at death. 
(d) Age-standardised to the Australian population as at 30 June 2001. 
Notes  
1. Data from New South Wales, Queensland, Western Australia, South Australia and the Northern Territory only. 
2. Data for 2009 and 2010 are revised and preliminary data respectively and are subject to further revision. 
Source: AIHW National Mortality Database. 
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Table D6.4: Stroke prevalence, by remoteness and sex, 2009 
 Number  Per cent(a) (95% CI) 
Remoteness Males Females Persons  Males Females Persons 
Major cities  135,716   113,666   249,382   2.0 (1.8–2.1) 1.3 (1.1–1.4) 1.6 (1.5–1.7) 
Inner regional areas  47,309   41,443   88,752   1.9 (1.6–2.1) 1.5 (1.2–1.7) 1.7 (1.5–1.8) 
Other areas  22,774   14,851   37,625   1.9 (1.5–2.4) 1.2 (0.9–1.5) 1.6 (1.3–1.9) 
(a) Age-standardised to the Australian population as at 30 June 2001. 
Source: AIHW analysis of ABS 2009 Survey of Disability, Ageing and Carers Basic Confidentialised Unit Record File on CD-ROM. 
Table D6.5: Stroke hospitalisation rates, by main types of stroke and remoteness of patient’s 
residence, 2009–10 
 Hospitalisations per 100,000 population(a) 
Remoteness of usual residence Males Females Persons 
All stroke    
Major cities 162.5 118.8 139.1 
Inner regional 181.1 126.7 152.6 
Outer regional 186.6 143.4 165.0 
Remote or very remote 221.5 201.0 212.3 
Rate ratio (Remote, very remote/ Major cities) 1.4 1.7 1.5 
Ischaemic stroke    
Major cities 86.0 60.7 72.8 
Inner regional 81.6 52.1 66.2 
Outer regional 70.4 53.6 62.3 
Remote or very remote 74.2 67.4 71.0 
Rate ratio (Remote, very remote/ Major cities) 0.9 1.1 1.0 
Haemorrhagic stroke    
Major cities 48.3 35.9 41.4 
Inner regional 50.9 39.8 45.1 
Outer regional 53.8 39.5 46.4 
Remote or very remote 60.8 39.2 50.7 
Rate ratio (Remote, very remote/ Major cities) 1.3 1.1 1.2 
(a) Age-standardised to the Australian population as at 30 June 2001. 
Source: AIHW analysis of the National Hospital Morbidity Database. 
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Table D6.6: Stroke deaths, by remoteness and sex, 2006–2010 
 Number of deaths(a)  Deaths per 100,000 population(b) 
Remoteness Males Females Persons  Males Females Persons 
Major cities 10,850 16,696 27,546  33.9 32.7 33.6 
Inner regional 3,912 6,150 10,062  36.0 38.0 37.7 
Outer regional 1,686 2,422 4,107  35.6 38.2 37.7 
Remote and very remote 312 330 642  38.6 39.0 39.6 
(a) The number of stroke deaths in 2006–2010 by remoteness areas does not add to the total number of stroke deaths (42,493) for the 5-year 
period because some deaths could not be allocated to a remoteness area. 
(b) Age-standardised to the Australian population as at 30 June 2001. 
Source: AIHW National Mortality Database. 
Table D6.7: Stroke prevalence, by socioeconomic group and sex, 2007–08 
 Number  Per cent(a) 
Socioeconomic 
group Males Females Persons  Males Females Persons 
1st quintile (lowest) 35,923 36,967 72,890  1.8 1.6 1.7 
2nd quintile 24,137 35,317 59,454  1.1 1.6 1.4 
3rd quintile 11,190 29,941 41,131  0.5 1.3 1.0 
4th quintile 18,639 17,572 36,210  1.0 0.9 1.0 
5th quintile (highest) 19,407 15,558 34,964  0.9 0.7 0.9 
(a) Age-standardised to the Australian population as at 30 June 2001. 
Source: AIHW 2011c. 
Table D6.8: Stroke hospitalisations, by socioeconomic group and sex, 2007–08 
 Number of hospitalisations  Hospitalisations per 100,000 population(a) 
Socioeconomic 
group Males Females Persons  Males Females Persons 
1st quintile (lowest) 4,251 3,902 8,153  199.0 149.0 172.7 
2nd quintile 4,227 3,957 8,184  192.7 143.7 166.8 
3rd quintile 3,423 3,135 6,558  175.0 126.5 149.4 
4th quintile 2,840 2,840 5,928  169.6 118.9 142.5 
5th quintile (highest) 2,861 3,027 5,888  150.1 112.1 129.6 
Rate ratio (lowest 
versus highest) 
   
 
1.3 1.3 1.3 
(a) Age-standardised to the Australian population as at 30 June 2001. 
Source: AIHW 2011c. 
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Table D6.9: Stroke deaths, by socioeconomic group and sex, 2007 
 Number of deaths  Deaths per 100,000 population(a) 
Socioeconomic 
group Males Females Persons  Males Females Persons 
1st quintile (lowest) 803 1,110 1,913  40.2 37.9 39.2 
2nd quintile 799 1,161 1,960  38.5 37.5 38.3 
3rd quintile 654 952 1,606  35.7 34.8 35.6 
4th quintile 596 935 1,531  35.3 35.4 35.8 
5th quintile (highest) 601 989 1,590  32.8 31.6 32.6 
(a) Age-standardised to the Australian population as at 30 June 2001. 
Source: AIHW 2011c. 
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Appendix E 
Thrombolysis exclusion/inclusion criteria  
Indications  
• Onset of ischaemic stroke within the preceding 3 hours. 
• Measurable and clinically significant deficit on NIH Stroke Scale examination. 
• Patient’s computed tomography (CT) scan does not show haemorrhage or non-
vascular cause of stroke. 
• Patient’s age is > 18. 
Absolute contraindications  
• Uncertainty about time of stroke onset (e.g. patients awaking from sleep). 
• Coma or severe obtundation with fixed eye deviation and complete hemiplegia. 
• Only minor stroke deficit, which is rapidly improving. 
• Seizure observed or known to have occurred at onset of stroke. 
• Hypertension: systolic blood pressure greater or equal to 185 mmHg or diastolic blood 
pressure > 110 mmHg on repeated measures before study. 
• Clinical presentation suggestive of subarachnoid haemorrhage even if the CT scan is 
normal. 
• Presumed septic embolus. 
• Patient has received heparin within the last 48 hours and has elevated PTT or has 
known hereditary or acquired haemorrhagic diathesis (e.g. PT or APTT greater than 
normal). 
• INR > 1.5. 
• Platelet count < 100,000/uL. 
• Serum glucose < 2.8 mmol/L or > 22.0 mmol/L.  
Relative contraindications (the benefits should outweigh the risk if the fowling criteria 
are true to use the rt-PA) 
• Severe neurological impairment with NIH Stroke Scale score > 22. 
• Age > 80s. 
• CT evidence of extensive middle cerebral artery (MCA) territory infarction (sulcal 
effacement or blurring of grey-white junction in greater than a third of MCA territory). 
• Stroke or serious head trauma within the past 3 months where the risks of bleeding are 
considered to outweigh the benefits of therapy. 
• Major surgery within the last 14 days. 
• Patient has known history of intracranial haemorrhage, subarachnoid haemorrhage, 
known intracranial arteriovenous malformation or previously known intracranial 
neoplasm such that, in the opinion of the clinician, the increased risk of intracranial 
bleeding would outweigh the potential benefits of treatment. 
• Suspected recent (within 30 days) myocardial infarction. 
(continued) 
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• Recent (within 30 days) biopsy of a parenchymal organ or surgery that, in the opinion 
of the responsible clinician, would increase the risk of unmanageable bleeding (e.g. 
uncontrolled by local pressure). 
• Recent (within 30 days) trauma with internal injuries or ulcerative wounds. 
• Gastrointestinal or urinary tract haemorrhage within the last 30 days or any active or 
recent haemorrhage that, in the opinion of the responsible clinician, would increase the 
risk of unmanageable bleeding (e.g. uncontrolled by local pressure). 
• Arterial puncture at non-compressible site within the last 7 days. 
• Concomitant serious, advanced or terminal illness or any other condition that, in the 
opinion of the responsible clinician, would pose a risk to treatment.  
Source: 2010 Clinical Guidelines for Stroke Management. The National Heart Foundation. 
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Glossary 
Aboriginal or Torres Strait Islander: A person of Aboriginal and/or Torres Strait Islander 
descent who identifies as an Aboriginal and/or Torres Strait Islander and is accepted as such 
by the community in which he or she lives. 
Age-specific rate: A rate for a specific age group. The numerator and denominator relate to 
the same age group. 
Age-standardisation: A method of removing the influence of age when comparing 
populations with different age structures. This is usually necessary because the rates of many 
diseases vary strongly (usually increasing) with age. The age structures of the different 
populations are converted to the same ‘standard’ structure, the disease rates that would have 
occurred with that structure are then calculated and compared. 
Angina: Temporary chest pain or discomfort when the heart’s own blood supply is 
inadequate to meet extra needs, as can occur during exercise. See also unstable angina and 
cardiovascular disease. 
Associated cause(s) of death: Any condition(s), diseases and injuries—other than the 
underlying cause—considered to contribute to a death. See also cause of death. 
Blood cholesterol: Fatty substance produced by the liver and carried by the blood to supply 
the rest of the body. Its natural function is to supply material for cell walls and for steroid 
hormones, but if levels in the blood become too high this can lead to atherosclerosis and heart 
disease. 
Blood pressure: The force exerted by the blood on the walls of the arteries as it is pumped 
around the body by the heart. It is written, for example, as 134/70 mmHg, where the upper 
number is the systolic pressure (the maximum force against the arteries as the heart muscle 
contracts to pump the blood out) and the lower number is the diastolic pressure (the 
minimum force against the arteries as the heart relaxes and fills again with blood). Levels of 
blood pressure can vary greatly from person to person and from moment to moment in the 
same person. See also high blood pressure/hypertension. 
Body mass index (BMI): The most commonly used method of assessing whether a person is 
of normal weight, underweight, overweight or obese. It is calculated by dividing the 
person’s weight (in kilograms) by their height (in metres) squared; that is, kg ÷ m2. For both 
men and women, underweight is a BMI below 18.5, acceptable weight is from 18.5 to less 
than 25, overweight is 25 and above (includes obese), and obese is 30 and over. 
Cardiovascular disease (CVD): Any disease of the circulatory system, namely the heart 
(cardio) or blood vessels (vascular). Includes heart attack, angina, stroke and peripheral vascular 
disease. CVD is also known as circulatory disease. 
Cause of death: From information reported on the medical certificate of cause of death, each 
death is classified by the underlying cause of death according to rules and conventions of the 
Tenth Revision of the International Classification of Diseases. The underlying cause is defined 
as the disease that initiated the train of events leading directly to death. Deaths from injury or 
poisoning are classified according to the circumstances of the violence that produced the fatal 
injury, rather than to the nature of the injury. See also underlying cause of death. 
Cerebral infarction: see also ischaemic stroke. 
 136 Stroke and its management in Australia: an update 
Cerebrovascular disease: Any disorder of the blood vessels supplying the brain or its 
covering membranes. A notable and major form of cerebrovascular disease is stroke. 
Circulatory system: The heart and the blood vessels, comprising the system that circulates 
blood around the body to supply oxygen and nutrients to all body tissues and to carry away 
waste products from them. Also known as the cardiovascular system. 
Comorbidity: When a person has two or more health problems at the same time. 
Confidence interval (CI): A statistical term describing a range (interval) of values within 
which we can be ‘confident’ that the true value lies, usually because it has a 95% or higher 
chance of doing so. 
Crude death rate: The number of deaths in a given period divided by the size of the 
corresponding population indexed to 100,000. 
Disability-adjusted life year (DALY): A year of healthy life lost, either through premature 
death or equivalently through living with disability due to illness or injury. It is the basic 
unit used in burden of disease and injury estimates. 
Disease: A physical or mental disturbance involving symptoms (such as pain or feeling 
unwell), dysfunction or tissue damage, especially if these symptoms and signs form a 
recognisable clinical pattern. 
Haemorrhagic stroke: Is a type of stroke caused by the rupture bleeds of an artery in the 
brain or its surrounding. 
High blood pressure/hypertension: The definition of high blood pressure (also known as 
hypertension) can vary but a well-accepted one is from the World Health Organization: a 
systolic blood pressure of 140 mmHg or more or a diastolic blood pressure of 90 mmHg or 
more, or [the person is] receiving medication for high blood pressure. Also see blood pressure. 
Highly specialised medicines: Under Section 100 of the National Health Act, certain 
medicines can be supplied to community patients only through hospitals because only 
hospitals can provide the facilities and staff necessary for the appropriate use of the drugs. 
These drugs are funded by the Australian Government separately from the Pharmaceuticals 
Benefits Scheme. 
Hypertension: See high blood pressure. 
Ischaemic stroke: a type of stroke due to a reduced or blocked supply of blood in the brain. 
Also known as cerebral infarction.  
Incidence: The number of new cases (of an illness or event, and so on) occurring during a 
given period. Compare with prevalence. 
International Classification of Diseases: The World Health Organization’s internationally 
accepted classification of death and disease. The Tenth Revision (ICD-10) is currently in use. 
In this report, causes of death classified before 1979 under previous revisions have been 
reclassified to ICD-10 by the AIHW. ICD-10-AM is the Australian modification of ICD-10, 
used for diagnoses and procedures recorded for patients admitted to hospitals. 
Length of stay: Duration of hospital stay, calculated by subtracting the date the patient is 
admitted from the day of separation. All leave days, including the day the patient went on 
leave, are excluded. A same-day patient is allocated a length of stay of 1 day. 
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Medicare: A national, government-funded scheme that subsidises the cost of personal 
medical services for all Australians and aims to help them afford medical care. 
Morbidity: Refers to ill health in an individual and to levels of ill health in a population or 
group. 
Obesity: Marked degree of overweight, defined for population studies as a body mass index of 
30 or over. See also overweight. 
Organisation for Economic Co-operation and Development (OECD): An organisation of 30 
developed countries, including Australia. 
Other Australians: People who are not of Aboriginal or Torres Strait Islander descent, or 
whose status is not known.  
Overweight: Defined for the purpose of population studies as a body mass index of 25 or over. 
See also obesity. 
Patient days: The number of full or partial days of stay for patients who were admitted for 
an episode of care and who underwent separation during the reporting period. A patient 
who is admitted and separated on the same day is allocated one patient day. 
Pharmaceutical Benefits Scheme (PBS): A national, government-funded scheme that 
subsidises the cost of a wide range of pharmaceutical drugs, and that covers all Australians 
to help them afford standard medications.  
Peripheral vascular disease: Characterised by pain in the extremities, often the legs, due to 
an inadequate blood supply to them. 
Prevalence: The number or proportion (of cases, instances, and so forth) present in a 
population at a given time. Compare with incidence. 
Principal diagnosis: The diagnosis listed in hospital records to describe the problem that 
was chiefly responsible for the patient’s episode of care in hospital. 
Private hospital: A privately owned and operated institution, catering for patients who are 
treated by a doctor of their own choice. Patients are charged fees for accommodation and 
other services provided by the hospital and relevant medical and allied health practitioners. 
Public hospital: A hospital controlled by a state or territory health authority. In Australia, 
public hospitals offer free diagnostic services, treatment, care and accommodation to all 
Australians who need them. 
Quintile: A group derived by ranking the population of people or elements according to 
specified criteria and dividing it into five equal parts. The term can also mean the cut-points 
that make these divisions—that is, the 20th, 50th and 75th percentiles—but the first use is the 
more common one. 
Risk factor: Any factor which represents a greater risk of a health disorder or other 
unwanted condition or event. Some risk factors are regarded as causes of disease, others are 
not necessarily so. Along with their opposites, protective factors, risk factors are known as 
determinants. 
Same-day patients: Admitted patients who are admitted to hospital and separated on the 
same day. 
Section 100 medicines: See highly specialised medicines. 
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Separation: The formal process by which a hospital records the completion of an episode of 
treatment and/or care for an admitted patient. 
Statistical significance: An indication from a statistical test that an observed difference or 
association may be significant or ‘real’ because it is unlikely to be due just to chance. A 
statistical result is usually said to be ‘significant’ if it would occur by chance only once in 20 
times or less often.  
Stroke: When an artery supplying blood to the brain suddenly becomes blocked or bleeds. 
Often causes paralysis of parts of the body normally controlled by that area of the brain, or 
speech problems and other symptoms. 
Thrombolysis: Emergency ‘clot-busting’ drug treatment for a heart attack or a stroke. 
Thrombosis: Clotting of blood, with the term usually applied to clotting within a blood 
vessel due to disease, as in a heart attack or stroke. 
Transient ischaemic attack (TIA): A ‘mini’ stroke, with temporary problems in speech or 
paralysis that last for 24 hours or less, often only minutes. It is a strong warning sign of a 
more severe stroke. 
Underlying cause of death: The condition, disease or injury initiating the sequence of events 
leading directly to death; that is, the primary or main cause. Compare with associated cause(s) 
of death. 
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This report presents a comprehensive picture about, 
and the latest data on, stroke and how it is managed in 
Australia. It examines the impact of stroke on patients, 
their carers, the health system and aged care services. 
The report includes information on incidence, 
prevalence, hospitalisation, disability, treatment 
and deaths. Stroke trends and inequalities in the 
management of the condition in Australia are also 
examined. In addition, the report contains international 
comparisons and identifies data gaps.
